1	OPEN	NN	MISC	open	nn	3	SENT_1	[p1l241t131r323b155],
2	8	CD	NUMBER	8	num	3	SENT_1	[p1l333t112r365b162],
3	ACCESS	NNP	O	ACCESS	_	0	SENT_1	[p1l372t131r485b155],
4	Freely	RB	O	freely	advmod	3	SENT_1	[p1l501t130r590b162],
5	available	JJ	O	available	dep	6	SENT_1	[p1l597t130r731b155],
6	online	NN	O	online	dep	3	SENT_1	[p1l739t130r832b155],

1	PLOS	NNS	O	plo	_	0	SENT_2	[p1l2003t110r2118b154],
2	PATHOGENS	NNS	O	pathogen	dep	1	SENT_2	[p1l2129t130r2308b154],

1	HIV	NN	O	hiv	nn	3	SENT_3	[p1l248t342r369b398],
2	Vaccine	NNP	O	Vaccine	nn	3	SENT_3	[p1l399t339r674b399],
3	Development	NNP	O	Development	_	0	SENT_3	[p1l711t339r1196b415],
4	in	IN	O	in	_	0	SENT_3	[p1l1230t339r1290b398],
5	the	DT	O	the	det	6	SENT_3	[p1l1324t339r1440b399],
6	Aftermath	NN	O	aftermath	prep_in	3	SENT_3	[p1l1472t338r1836b399],
7	of	IN	O	of	_	0	SENT_3	[p1l1872t338r1945b399],
8	the	DT	O	the	det	10	SENT_3	[p1l1972t339r2088b399],
9	STEP	NN	O	step	nn	10	SENT_3	[p1l2122t341r2291b399],
10	Study	NN	O	study	prep_of	6	SENT_3	[p1l245t431r470b508],
11	:	:	O	:	_	0	SENT_3	[p1l245t431r470b508],
12	Re-Focus	VB	O	re-focus	dep	13	SENT_3	[p1l506t433r822b491],
13	on	IN	O	on	dep	3	SENT_3	[p1l855t448r942b491],
14	Occult	NNP	O	Occult	nn	16	SENT_3	[p1l978t431r1204b491],
15	HIV	NN	O	hiv	nn	16	SENT_3	[p1l1240t434r1362b490],
16	Infection	NN	O	infection	pobj	13	SENT_3	[p1l1396t430r1744b491],
17	?	.	O	?	_	0	SENT_3	[p1l1396t430r1744b491],

1	Klaus	NNP	PERSON	Klaus	nn	2	SENT_4	[p1l245t559r349b590],
2	Uberla	NNP	PERSON	Uberla	_	0	SENT_4	[p1l367t552r514b590],
3	*	NN	O	*	dep	2	SENT_4	[p1l367t552r514b590],

1	Department	NNP	ORGANIZATION	Department	_	0	SENT_5	[p1l244t628r389b654],
2	of	IN	ORGANIZATION	of	_	0	SENT_5	[p1l401t627r426b648],
3	Molecular	JJ	ORGANIZATION	molecular	prep_of	1	SENT_5	[p1l436t627r553b648],
4	and	CC	ORGANIZATION	and	_	0	SENT_5	[p1l564t627r608b648],
5	Medical	JJ	ORGANIZATION	medical	prep_of	1	SENT_5	[p1l621t627r712b648],
6	Virology	NNP	ORGANIZATION	Virology	nn	8	SENT_5	[p1l724t627r830b654],
7	,	,	O	,	_	0	SENT_5	[p1l724t627r830b654],
8	Ruhr	NNP	LOCATION	Ruhr	dep	3	SENT_5	[p1l843t627r1028b654],
9	.	.	O	.	_	0	SENT_5	[p1l843t627r1028b654],

1	—	NN	O	—	_	0	SENT_6	[p1l843t627r1028b654],
2	.	.	O	.	_	0	SENT_6	[p1l843t627r1028b654],

1	University	NNP	O	University	nn	2	SENT_7	[p1l843t627r1028b654],
2	Bochum	NNP	DATE	Bochum	_	0	SENT_7	[p1l1040t627r1143b652],
3	,	,	O	,	_	0	SENT_7	[p1l1040t627r1143b652],
4	Bochum	NNP	O	Bochum	nn	6	SENT_7	[p1l1157t627r1261b652],
5	,	,	O	,	_	0	SENT_7	[p1l1157t627r1261b652],
6	Germany	NNP	LOCATION	Germany	appos	2	SENT_7	[p1l1272t628r1382b654],

1	Only	RB	O	only	advmod	4	SENT_8	[p1l281t715r356b749],
2	two	CD	NUMBER	two	num	4	SENT_8	[p1l383t721r436b741],
3	HIV	NN	MISC	hiv	nn	4	SENT_8	[p1l465t715r534b741],
4	vaccines	NNS	O	vaccine	nsubjpass	7	SENT_8	[p1l561t715r684b741],
5	have	VBP	O	have	aux	7	SENT_8	[p1l713t715r781b741],
6	been	VBN	O	be	auxpass	7	SENT_8	[p1l810t715r880b741],
7	taken	VBN	O	take	_	0	SENT_8	[p1l243t759r323b785],
8	through	IN	O	through	_	0	SENT_8	[p1l337t759r456b793],
9	efficacy	NN	O	efficacy	nn	10	SENT_8	[p1l471t759r582b793],
10	trials	NNS	O	trial	prep_through	7	SENT_8	[p1l596t759r666b785],
11	so	RB	O	so	advmod	12	SENT_8	[p1l682t768r710b785],
12	far	RB	O	far	advmod	7	SENT_8	[p1l725t759r772b785],
13	.	.	O	.	_	0	SENT_8	[p1l725t759r772b785],

1	In	IN	O	in	_	0	SENT_9	[p1l789t759r820b784],
2	the	DT	O	the	det	7	SENT_9	[p1l835t759r880b785],
3	ﬁrst	NN	O	ﬁrst	nn	7	SENT_9	[p1l242t803r298b829],
4	HIV	NN	MISC	hiv	nn	7	SENT_9	[p1l313t803r382b829],
5	vaccine	NN	O	vaccine	nn	7	SENT_9	[p1l395t803r506b829],
6	efficacy	NN	O	efficacy	nn	7	SENT_9	[p1l522t803r633b837],
7	trial	NN	O	trial	prep_in	8	SENT_9	[p1l647t803r706b829],
8	started	VBD	O	start	_	0	SENT_9	[p1l721t803r821b829],
9	ten	CD	DATE	ten	num	10	SENT_9	[p1l835t808r880b829],
10	years	NNS	DATE	year	npadvmod	11	SENT_9	[p1l242t857r318b882],
11	ago	RB	DATE	ago	advmod	26	SENT_9	[p1l330t857r390b882],
12	,	,	O	,	_	0	SENT_9	[p1l330t857r390b882],
13	recombinant	JJ	O	recombinant	amod	15	SENT_9	[p1l403t848r593b874],
14	gpl20	NN	O	gpl20	nn	15	SENT_9	[p1l604t848r695b882],
15	protein	NN	O	protein	nsubjpass	26	SENT_9	[p1l707t848r822b882],
16	,	,	O	,	_	0	SENT_9	[p1l707t848r822b882],
17	the	DT	O	the	det	19	SENT_9	[p1l835t848r880b874],
18	CD4-binding	JJ	O	cd4-binding	amod	19	SENT_9	[p1l244t892r443b926],
19	subunit	NN	O	subunit	appos	15	SENT_9	[p1l464t892r573b918],
20	of	IN	O	of	_	0	SENT_9	[p1l595t892r627b918],
21	the	DT	O	the	det	23	SENT_9	[p1l643t892r688b918],
22	HIV	NN	MISC	hiv	nn	23	SENT_9	[p1l710t892r780b918],
23	envelope	NN	O	envelope	prep_of	19	SENT_9	[p1l801t901r880b918, p1l242t936r313b970],
24	,	,	O	,	_	0	SENT_9	[p1l801t901r880b918, p1l242t936r313b970],
25	was	VBD	O	be	auxpass	26	SENT_9	[p1l325t945r379b962],
26	used	VBN	O	use	ccomp	8	SENT_9	[p1l392t936r459b962],
27	as	IN	O	as	_	0	SENT_9	[p1l471t945r498b962],
28	vaccine	NN	O	vaccine	nn	30	SENT_9	[p1l510t936r620b962],
29	antigen	NN	O	antigen	nn	30	SENT_9	[p1l634t936r743b970],
30	[	NN	O	[	prep_as	26	SENT_9	[p1l760t936r806b970],
31	1	CD	NUMBER	1	num	32	SENT_9	[p1l760t936r806b970],
32	]	NN	O	]	nsubj	8	SENT_9	[p1l760t936r806b970],
33	.	.	O	.	_	0	SENT_9	[p1l760t936r806b970],

1	The	DT	O	the	det	2	SENT_10	[p1l820t936r880b962],
2	vaccine	NN	O	vaccine	nsubj	8	SENT_10	[p1l242t981r352b1007],
3	neither	CC	O	neither	dep	4	SENT_10	[p1l365t981r470b1007],
4	prevented	VBD	O	prevent	_	0	SENT_10	[p1l480t981r629b1015],
5	HIV	NN	MISC	hiv	nn	6	SENT_10	[p1l640t981r709b1007],
6	acquisition	NN	O	acquisition	dobj	4	SENT_10	[p1l720t981r880b1015],
7	nor	CC	O	nor	_	0	SENT_10	[p1l243t1034r294b1051],
8	reduced	VBD	O	reduce	conj_nor	4	SENT_10	[p1l325t1025r445b1051],
9	the	DT	O	the	det	11	SENT_10	[p1l476t1025r521b1051],
10	viral	JJ	O	viral	amod	11	SENT_10	[p1l552t1025r618b1051],
11	load	NN	O	load	dobj	8	SENT_10	[p1l649t1025r713b1051],
12	in	IN	O	in	_	0	SENT_10	[p1l744t1025r772b1050],
13	those	DT	O	those	det	16	SENT_10	[p1l804t1025r880b1051],
14	acquiring	VBG	O	acquire	amod	16	SENT_10	[p1l243t1069r384b1103],
15	HIV	NN	MISC	hiv	nn	16	SENT_10	[p1l410t1069r479b1095],
16	infection	NN	O	infection	prep_in	8	SENT_10	[p1l505t1069r641b1095],
17	.	.	O	.	_	0	SENT_10	[p1l505t1069r641b1095],

1	Although	IN	O	although	mark	5	SENT_11	[p1l669t1069r808b1103],
2	the	DT	O	the	det	3	SENT_11	[p1l835t1069r880b1095],
3	vaccine	NN	O	vaccine	nsubj	5	SENT_11	[p1l242t1114r352b1140],
4	was	VBD	O	be	cop	5	SENT_11	[p1l370t1123r424b1140],
5	able	JJ	O	able	advcl	15	SENT_11	[p1l443t1114r502b1140],
6	to	TO	O	to	aux	7	SENT_11	[p1l521t1119r548b1140],
7	induce	VB	O	induce	xcomp	5	SENT_11	[p1l567t1114r665b1140],
8	antibodies	NNS	O	antibody	dobj	7	SENT_11	[p1l684t1114r834b1140],
9	to	TO	O	to	_	0	SENT_11	[p1l852t1120r880b1140],
10	gpl20	NN	O	gpl20	prep_to	7	SENT_11	[p1l243t1158r342b1192],
11	,	,	O	,	_	0	SENT_11	[p1l243t1158r342b1192],
12	these	DT	O	these	nsubj	15	SENT_11	[p1l375t1158r449b1184],
13	did	VBD	O	do	aux	15	SENT_11	[p1l482t1158r529b1184],
14	not	RB	O	not	neg	15	SENT_11	[p1l560t1164r608b1184],
15	neutralize	VB	O	neutralize	_	0	SENT_11	[p1l639t1158r785b1184],
16	ﬁeld	NN	O	ﬁeld	nn	17	SENT_11	[p1l817t1158r881b1184],
17	isolates	NNS	O	isolate	dobj	15	SENT_11	[p1l243t1203r347b1229],
18	of	IN	O	of	_	0	SENT_11	[p1l362t1203r394b1229],
19	HIV	NN	O	hiv	prep_of	17	SENT_11	[p1l402t1203r478b1229],
20	.	.	O	.	_	0	SENT_11	[p1l402t1203r478b1229],

1	Differences	NNS	O	difference	nsubjpass	51	SENT_12	[p1l493t1203r660b1229],
2	in	IN	O	in	_	0	SENT_12	[p1l674t1203r701b1228],
3	the	DT	O	the	det	4	SENT_12	[p1l715t1203r759b1229],
4	conformation	NN	O	conformation	prep_in	1	SENT_12	[p1l774t1203r880b1229, p1l243t1247r347b1273],
5	between	IN	O	between	_	0	SENT_12	[p1l373t1247r496b1273],
6	the	DT	O	the	det	9	SENT_12	[p1l521t1247r566b1273],
7	monomeric	JJ	O	monomeric	amod	9	SENT_12	[p1l593t1247r763b1273],
8	gpl20	NN	O	gpl20	nn	9	SENT_12	[p1l789t1247r880b1281],
9	subunit	NN	O	subunit	prep_between	4	SENT_12	[p1l243t1291r353b1317],
10	of	IN	O	of	_	0	SENT_12	[p1l364t1291r396b1317],
11	the	DT	O	the	det	12	SENT_12	[p1l402t1291r447b1317],
12	vaccine	NN	O	vaccine	prep_of	9	SENT_12	[p1l459t1291r569b1317],
13	and	CC	O	and	_	0	SENT_12	[p1l582t1291r637b1317],
14	the	DT	O	the	det	47	SENT_12	[p1l648t1291r693b1317],
15	functionally	RB	O	functionally	advmod	16	SENT_12	[p1l705t1291r881b1325],
16	active	JJ	O	active	amod	47	SENT_12	[p1l243t1336r328b1362],
17	trimeric	JJ	O	trimeric	amod	19	SENT_12	[p1l358t1336r475b1362],
18	envelope	NN	O	envelope	nn	19	SENT_12	[p1l505t1336r636b1370],
19	spike	NN	O	spike	nsubj	42	SENT_12	[p1l666t1336r738b1370],
20	on	IN	O	on	_	0	SENT_12	[p1l769t1345r805b1362],
21	the	DT	O	the	det	22	SENT_12	[p1l835t1336r880b1362],
22	surface	NN	O	surface	prep_on	19	SENT_12	[p1l243t1380r346b1406],
23	of	IN	O	of	_	0	SENT_12	[p1l367t1380r399b1406],
24	virus	NN	O	virus	nn	25	SENT_12	[p1l413t1380r484b1406],
25	particles	NNS	O	particle	prep_of	22	SENT_12	[p1l504t1380r636b1414],
26	,	,	O	,	_	0	SENT_12	[p1l504t1380r636b1414],
27	HIV	NN	O	hiv	nn	28	SENT_12	[p1l658t1380r727b1406],
28	diversity	NN	O	diversity	appos	25	SENT_12	[p1l747t1380r879b1414],
29	,	,	O	,	_	0	SENT_12	[p1l747t1380r879b1414],
30	as	RB	O	as	_	0	SENT_12	[p1l243t1433r271b1450],
31	well	RB	O	well	_	0	SENT_12	[p1l286t1424r346b1450],
32	as	IN	O	as	_	0	SENT_12	[p1l362t1433r390b1450],
33	various	JJ	O	various	amod	36	SENT_12	[p1l405t1424r512b1450],
34	antibody	NN	O	antibody	nn	36	SENT_12	[p1l529t1424r660b1458],
35	escape	NN	O	escape	nn	36	SENT_12	[p1l676t1433r771b1458],
36	mechanisms	NNS	O	mechanism	conj_and	25	SENT_12	[p1l788t1424r880b1450, p1l243t1469r342b1495],
37	of	IN	O	of	_	0	SENT_12	[p1l359t1469r391b1495],
38	the	DT	O	the	det	41	SENT_12	[p1l402t1469r447b1495],
39	HIV	NN	MISC	hiv	nn	41	SENT_12	[p1l464t1469r533b1495],
40	envelope	NN	O	envelope	nn	41	SENT_12	[p1l549t1469r679b1503],
41	(	NN	O	(	prep_of	36	SENT_12	[p1l697t1469r838b1503],
42	reviewed	VBN	O	review	ccomp	16	SENT_12	[p1l697t1469r838b1503],
43	in	IN	O	in	_	0	SENT_12	[p1l853t1469r880b1494],
44	[	NN	O	[	prep_in	42	SENT_12	[p1l247t1513r302b1547],
45	2	CD	NUMBER	2	number	46	SENT_12	[p1l247t1513r302b1547],
46	]	CD	NUMBER	]	num	47	SENT_12	[p1l247t1513r302b1547],
47	)	NN	O	)	conj_and	1	SENT_12	[p1l247t1513r302b1547],
48	,	,	O	,	_	0	SENT_12	[p1l247t1513r302b1547],
49	have	VBP	O	have	aux	51	SENT_12	[p1l324t1513r392b1539],
50	been	VBN	O	be	auxpass	51	SENT_12	[p1l413t1513r483b1539],
51	proposed	VBN	O	propose	_	0	SENT_12	[p1l502t1513r640b1547],
52	to	TO	O	to	aux	53	SENT_12	[p1l659t1519r687b1539],
53	explain	VB	O	explain	xcomp	51	SENT_12	[p1l708t1513r815b1547],
54	the	DT	O	the	det	55	SENT_12	[p1l835t1513r880b1539],
55	inefﬁcacy	NN	O	inefﬁcacy	dobj	53	SENT_12	[p1l243t1557r384b1591],
56	of	IN	O	of	_	0	SENT_12	[p1l410t1557r442b1583],
57	the	DT	O	the	det	60	SENT_12	[p1l463t1557r508b1583],
58	antibody-based	JJ	O	antibody-based	amod	60	SENT_12	[p1l535t1557r763b1591],
59	gpl20	NN	O	gpl20	nn	60	SENT_12	[p1l789t1557r880b1591],
60	vaccine	NN	O	vaccine	prep_of	55	SENT_12	[p1l242t1602r361b1628],
61	.	.	O	.	_	0	SENT_12	[p1l242t1602r361b1628],

1	Given	VBN	O	give	prep	37	SENT_13	[p1l376t1602r465b1628],
2	the	DT	O	the	det	3	SENT_13	[p1l478t1602r522b1628],
3	difficulties	NNS	O	difficulty	dep	1	SENT_13	[p1l536t1602r685b1628],
4	of	IN	O	of	_	0	SENT_13	[p1l699t1602r731b1628],
5	antibodybased	JJ	O	antibodybased	amod	8	SENT_13	[p1l739t1602r880b1636, p1l243t1646r327b1672],
6	HIV	NN	MISC	hiv	nn	8	SENT_13	[p1l360t1646r430b1672],
7	prevention	NN	O	prevention	nn	8	SENT_13	[p1l462t1646r622b1680],
8	strategies	NNS	O	strategy	prep_of	3	SENT_13	[p1l657t1646r800b1680],
9	,	,	O	,	_	0	SENT_13	[p1l657t1646r800b1680],
10	the	DT	O	the	det	14	SENT_13	[p1l835t1646r880b1672],
11	second	JJ	ORDINAL	second	amod	14	SENT_13	[p1l243t1691r344b1717],
12	HIV	NN	MISC	hiv	nn	14	SENT_13	[p1l355t1691r425b1717],
13	efficacy	NN	O	efficacy	nn	14	SENT_13	[p1l436t1691r547b1725],
14	trial	NN	O	trial	nsubj	37	SENT_13	[p1l557t1691r624b1723],
15	,	,	O	,	_	0	SENT_13	[p1l557t1691r624b1723],
16	the	DT	O	the	det	18	SENT_13	[p1l636t1691r681b1717],
17	STEP	NN	O	step	nn	18	SENT_13	[p1l694t1691r783b1717],
18	study	NN	O	study	appos	14	SENT_13	[p1l794t1691r879b1725],
19	,	,	O	,	_	0	SENT_13	[p1l794t1691r879b1725],
20	tested	VBN	O	test	partmod	14	SENT_13	[p1l243t1735r328b1761],
21	whether	IN	O	whether	_	0	SENT_13	[p1l352t1735r474b1761],
22	the	DT	O	the	det	24	SENT_13	[p1l499t1735r544b1761],
23	second	JJ	ORDINAL	second	amod	24	SENT_13	[p1l571t1735r672b1761],
24	arm	NN	O	arm	prep_whether	20	SENT_13	[p1l698t1744r757b1760],
25	of	IN	O	of	_	0	SENT_13	[p1l783t1735r815b1761],
26	the	DT	O	the	det	29	SENT_13	[p1l835t1735r880b1761],
27	adaptive	JJ	O	adaptive	amod	29	SENT_13	[p1l243t1779r368b1813],
28	immune	JJ	O	immune	amod	29	SENT_13	[p1l392t1779r515b1805],
29	response	NN	O	response	prep_of	24	SENT_13	[p1l539t1788r674b1813],
30	,	,	O	,	_	0	SENT_13	[p1l539t1788r674b1813],
31	cytotoxic	JJ	O	cytotoxic	amod	33	SENT_13	[p1l699t1779r833b1813],
32	T	NN	O	t	nn	33	SENT_13	[p1l856t1779r880b1804],
33	cells	NNS	O	cell	appos	29	SENT_13	[p1l243t1824r312b1856],
34	,	,	O	,	_	0	SENT_13	[p1l243t1824r312b1856],
35	would	MD	O	would	aux	37	SENT_13	[p1l326t1824r417b1850],
36	be	VB	O	be	cop	37	SENT_13	[p1l430t1824r464b1850],
37	able	JJ	O	able	_	0	SENT_13	[p1l478t1824r538b1850],
38	to	TO	O	to	aux	39	SENT_13	[p1l552t1829r579b1850],
39	provide	VB	O	provide	xcomp	37	SENT_13	[p1l593t1824r705b1858],
40	protection	NN	O	protection	dobj	39	SENT_13	[p1l718t1824r878b1858],
41	.	.	O	.	_	0	SENT_13	[p1l718t1824r878b1858],

1	To	TO	O	to	aux	2	SENT_14	[p1l243t1868r285b1894],
2	induce	VB	O	induce	purpcl	24	SENT_14	[p1l314t1868r412b1894],
3	cytotoxic	JJ	O	cytotoxic	amod	6	SENT_14	[p1l441t1868r574b1902],
4	T	NN	O	t	nn	6	SENT_14	[p1l602t1868r627b1893],
5	cell	NN	O	cell	nn	6	SENT_14	[p1l655t1868r704b1894],
6	responses	NNS	O	response	dobj	2	SENT_14	[p1l731t1877r879b1902],
7	,	,	O	,	_	0	SENT_14	[p1l731t1877r879b1902],
8	replication-deﬁcient	JJ	O	replication-deﬁcient	amod	10	SENT_14	[p1l243t1912r541b1946],
9	adenoviral	JJ	O	adenoviral	amod	10	SENT_14	[p1l581t1912r737b1938],
10	vectors	NNS	O	vector	nsubjpass	24	SENT_14	[p1l776t1918r880b1938],
11	transfering	VBG	O	transfer	partmod	10	SENT_14	[p1l243t1957r403b1991],
12	the	DT	O	the	det	13	SENT_14	[p1l422t1957r467b1983],
13	gag	NN	O	gag	dobj	11	SENT_14	[p1l484t1966r536b1991],
14	,	,	O	,	_	0	SENT_14	[p1l484t1966r536b1991],
15	pal	NN	O	pal	conj_and	13	SENT_14	[p1l553t1957r602b1991],
16	,	,	O	,	_	0	SENT_14	[p1l553t1957r602b1991],
17	and	CC	O	and	_	0	SENT_14	[p1l623t1957r679b1983],
18	my	PRP$	O	my	poss	20	SENT_14	[p1l698t1957r742b1991],
19	”	NN	O	”	nn	20	SENT_14	[p1l698t1957r742b1991],
20	genes	NNS	O	gene	conj_and	13	SENT_14	[p1l753t1966r833b1991],
21	of	IN	O	of	_	0	SENT_14	[p1l854t1957r886b1983],
22	HIV	NN	MISC	hiv	prep_of	20	SENT_14	[p1l243t2001r312b2027],
23	were	VBD	O	be	auxpass	24	SENT_14	[p1l322t2010r392b2027],
24	used	VBN	O	use	_	0	SENT_14	[p1l404t2001r477b2027],
25	.	.	O	.	_	0	SENT_14	[p1l404t2001r477b2027],

1	Since	IN	O	since	_	0	SENT_15	[p1l492t2001r570b2027],
2	all	PDT	O	all	predet	3	SENT_15	[p1l582t2001r616b2026],
3	the	DT	O	the	prep_since	13	SENT_15	[p1l627t2001r672b2027],
4	three	CD	NUMBER	three	num	6	SENT_15	[p1l683t2001r758b2027],
5	vaccine	NN	O	vaccine	nn	6	SENT_15	[p1l769t2001r880b2027],
6	antigens	NNS	O	antigen	nsubj	13	SENT_15	[p1l243t2045r364b2079],
7	used	VBN	O	use	partmod	6	SENT_15	[p1l376t2045r443b2071],
8	in	IN	O	in	_	0	SENT_15	[p1l454t2045r481b2070],
9	this	DT	O	this	det	10	SENT_15	[p1l493t2045r543b2071],
10	study	NN	O	study	prep_in	7	SENT_15	[p1l555t2045r633b2079],
11	are	VBP	O	be	cop	13	SENT_15	[p1l645t2054r689b2071],
12	intracellular	JJ	O	intracellular	amod	13	SENT_15	[p1l701t2045r881b2071],
13	proteins	NNS	O	protein	ccomp	35	SENT_15	[p1l242t2090r361b2124],
14	that	WDT	O	that	nsubjpass	18	SENT_15	[p1l376t2090r434b2116],
15	are	VBP	O	be	auxpass	18	SENT_15	[p1l448t2099r493b2116],
16	usually	RB	O	usually	advmod	18	SENT_15	[p1l508t2090r611b2124],
17	not	RB	O	not	neg	18	SENT_15	[p1l624t2095r673b2116],
18	expressed	VBN	O	express	rcmod	13	SENT_15	[p1l687t2090r830b2124],
19	on	IN	O	on	_	0	SENT_15	[p1l844t2099r880b2116],
20	the	DT	O	the	det	21	SENT_15	[p1l243t2134r287b2160],
21	surface	NN	O	surface	prep_on	18	SENT_15	[p1l306t2134r408b2160],
22	of	IN	O	of	_	0	SENT_15	[p1l427t2134r458b2160],
23	HIV-infected	JJ	MISC	hiv-infected	amod	24	SENT_15	[p1l470t2134r670b2160],
24	cells	NNS	O	cell	prep_of	21	SENT_15	[p1l686t2134r746b2160],
25	or	CC	O	or	_	0	SENT_15	[p1l765t2143r795b2160],
26	HIV	NN	MISC	hiv	nn	27	SENT_15	[p1l812t2134r881b2160],
27	particles	NNS	O	particle	prep_of	21	SENT_15	[p1l242t2179r374b2213],
28	,	,	O	,	_	0	SENT_15	[p1l242t2179r374b2213],
29	vaccine-induced	JJ	O	vaccine-induced	amod	31	SENT_15	[p1l411t2179r655b2205],
30	HIV-speciﬁc	NN	O	hiv-speciﬁc	nn	31	SENT_15	[p1l691t2179r880b2213],
31	antibodies	NNS	O	antibody	nsubj	35	SENT_15	[p1l243t2223r394b2249],
32	should	MD	O	should	aux	35	SENT_15	[p1l406t2223r503b2249],
33	not	RB	O	not	neg	35	SENT_15	[p1l513t2228r562b2249],
34	be	VB	O	be	cop	35	SENT_15	[p1l572t2223r606b2249],
35	able	JJ	O	able	_	0	SENT_15	[p1l618t2223r677b2249],
36	to	TO	O	to	aux	37	SENT_15	[p1l689t2229r716b2249],
37	contribute	VB	O	contribute	xcomp	35	SENT_15	[p1l728t2223r880b2249],
38	to	TO	O	to	_	0	SENT_15	[p1l243t2272r270b2293],
39	protection	NN	O	protection	prep_to	37	SENT_15	[p1l285t2267r446b2301],
40	.	.	O	.	_	0	SENT_15	[p1l285t2267r446b2301],

1	Thus	RB	O	thus	advmod	7	SENT_16	[p1l463t2267r547b2299],
2	,	,	O	,	_	0	SENT_16	[p1l463t2267r547b2299],
3	the	DT	O	the	det	4	SENT_16	[p1l564t2267r608b2293],
4	study	NN	O	study	nsubjpass	7	SENT_16	[p1l625t2267r703b2301],
5	was	VBD	O	be	auxpass	7	SENT_16	[p1l717t2276r771b2293],
6	specifically	RB	O	specifically	advmod	7	SENT_16	[p1l787t2267r880b2301, p1l243t2312r320b2346],
7	designed	VBN	O	design	_	0	SENT_16	[p1l338t2312r467b2346],
8	to	TO	O	to	aux	9	SENT_16	[p1l485t2317r512b2338],
9	explore	VB	O	explore	xcomp	7	SENT_16	[p1l532t2312r640b2346],
10	the	DT	O	the	det	11	SENT_16	[p1l660t2312r705b2338],
11	efficacy	NN	O	efficacy	dobj	9	SENT_16	[p1l724t2312r836b2346],
12	of	IN	O	of	_	0	SENT_16	[p1l854t2312r886b2338],
13	HIV-speciﬁc	JJ	O	hiv-speciﬁc	amod	14	SENT_16	[p1l243t2356r432b2390],
14	cytotoxic	JJ	O	cytotoxic	amod	16	SENT_16	[p1l450t2356r583b2390],
15	T	NN	O	t	nn	16	SENT_16	[p1l601t2356r625b2381],
16	cells	NNS	O	cell	prep_of	11	SENT_16	[p1l642t2356r710b2382],
17	.	.	O	.	_	0	SENT_16	[p1l642t2356r710b2382],

1	A	DT	O	a	det	2	SENT_17	[p1l729t2356r755b2381],
2	total	NN	O	total	nsubj	16	SENT_17	[p1l771t2356r836b2382],
3	of	IN	O	of	_	0	SENT_17	[p1l854t2356r886b2382],
4	3,000	CD	NUMBER	3,000	num	5	SENT_17	[p1l244t2400r325b2432],
5	volunteers	NNS	O	volunteer	prep_of	2	SENT_17	[p1l354t2400r507b2426],
6	with	IN	O	with	_	0	SENT_17	[p1l537t2400r601b2426],
7	a	DT	O	a	det	9	SENT_17	[p1l632t2409r648b2425],
8	high	JJ	O	high	amod	9	SENT_17	[p1l677t2400r742b2434],
9	risk	NN	O	risk	prep_with	5	SENT_17	[p1l772t2400r824b2426],
10	of	IN	O	of	_	0	SENT_17	[p1l854t2400r886b2426],
11	acquiring	VBG	O	acquire	prepc_of	9	SENT_17	[p1l243t2445r384b2479],
12	HIV	NN	MISC	hiv	nn	13	SENT_17	[p1l403t2445r472b2471],
13	infection	NN	O	infection	dobj	11	SENT_17	[p1l490t2445r619b2471],
14	were	VBD	O	be	_	0	SENT_17	[p1l637t2454r707b2471],
15	either	CC	O	either	preconj	14	SENT_17	[p1l728t2445r812b2471],
16	immunized	VBD	O	immunize	conj_or	14	SENT_17	[p1l831t2445r880b2470, p1l243t2489r372b2515],
17	three	CD	NUMBER	three	num	18	SENT_17	[p1l386t2489r461b2515],
18	times	NNS	O	time	dobj	16	SENT_17	[p1l477t2489r554b2515],
19	intramuscularly	RB	O	intramuscularly	advmod	16	SENT_17	[p1l569t2489r803b2523],
20	with	IN	O	with	_	0	SENT_17	[p1l816t2489r880b2515],
21	replication-deﬁcient	JJ	O	replication-deﬁcient	amod	23	SENT_17	[p1l243t2533r541b2567],
22	adenoviral	JJ	O	adenoviral	amod	23	SENT_17	[p1l581t2533r737b2559],
23	vectors	NNS	O	vector	prep_with	16	SENT_17	[p1l776t2539r880b2559],
24	transfering	VBG	O	transfer	partmod	23	SENT_17	[p1l243t2578r403b2612],
25	the	DT	O	the	det	26	SENT_17	[p1l422t2578r467b2604],
26	gag	NN	O	gag	dobj	24	SENT_17	[p1l484t2587r536b2612],
27	,	,	O	,	_	0	SENT_17	[p1l484t2587r536b2612],
28	pal	NN	O	pal	dobj	24	SENT_17	[p1l553t2578r602b2612],
29	,	,	O	,	_	0	SENT_17	[p1l553t2578r602b2612],
30	and	CC	O	and	_	0	SENT_17	[p1l623t2578r679b2604],
31	my	PRP$	O	my	poss	33	SENT_17	[p1l698t2578r742b2612],
32	”	NN	O	”	nn	33	SENT_17	[p1l698t2578r742b2612],
33	genes	NNS	O	gene	conj_and	26	SENT_17	[p1l753t2587r833b2612],
34	of	IN	O	of	_	0	SENT_17	[p1l854t2578r886b2604],
35	HIV	NN	MISC	hiv	prep_of	33	SENT_17	[p1l243t2622r320b2654],
36	,	,	O	,	_	0	SENT_17	[p1l243t2622r320b2654],
37	or	CC	O	or	_	0	SENT_17	[p1l338t2631r368b2648],
38	received	VBD	O	receive	conj_or	14	SENT_17	[p1l384t2622r508b2648],
39	a	DT	O	a	det	40	SENT_17	[p1l524t2631r540b2647],
40	placebo	NN	O	placebo	dobj	38	SENT_17	[p1l555t2622r678b2656],
41	.	.	O	.	_	0	SENT_17	[p1l555t2622r678b2656],

1	As	IN	O	as	mark	2	SENT_18	[p1l695t2622r732b2648],
2	observed	VBN	O	observe	advcl	18	SENT_18	[p1l749t2622r881b2648],
3	in	IN	O	in	_	0	SENT_18	[p1l243t2667r270b2692],
4	non-human	JJ	O	non-human	amod	6	SENT_18	[p1l286t2667r461b2693],
5	primate	JJ	O	primate	amod	6	SENT_18	[p1l477t2667r592b2701],
6	studies	NNS	O	study	prep_in	2	SENT_18	[p1l609t2667r707b2693],
7	and	CC	O	and	_	0	SENT_18	[p1l724t2667r779b2693],
8	previous	JJ	O	previous	amod	9	SENT_18	[p1l794t2667r880b2701, p1l243t2720r291b2737],
9	phase	NN	O	phase	prep_in	2	SENT_18	[p1l309t2711r393b2745],
10	I	PRP	O	I	dep	9	SENT_18	[p1l411t2711r423b2736],
11	clinical	JJ	O	clinical	amod	12	SENT_18	[p1l441t2711r545b2737],
12	trials	NNS	O	trial	dep	9	SENT_18	[p1l562t2711r641b2743],
13	,	,	O	,	_	0	SENT_18	[p1l562t2711r641b2743],
14	the	DT	O	the	det	17	SENT_18	[p1l661t2711r705b2737],
15	adenoviral	JJ	O	adenoviral	amod	17	SENT_18	[p1l724t2711r881b2737],
16	vector	NN	O	vector	nn	17	SENT_18	[p1l242t2760r334b2781],
17	vaccine	NN	O	vaccine	nsubj	18	SENT_18	[p1l353t2755r464b2781],
18	induced	VBD	O	induce	_	0	SENT_18	[p1l484t2755r603b2781],
19	substantial	JJ	O	substantial	amod	24	SENT_18	[p1l623t2755r780b2781],
20	HIVspeciﬁc	NN	O	hivspeciﬁc	nn	24	SENT_18	[p1l800t2755r880b2781, p1l243t2800r350b2834],
21	cytotoxic	JJ	O	cytotoxic	amod	24	SENT_18	[p1l365t2800r498b2834],
22	T	NN	O	t	nn	24	SENT_18	[p1l512t2800r537b2825],
23	cell	NN	O	cell	nn	24	SENT_18	[p1l551t2800r600b2826],
24	responses	NNS	O	response	nsubj	30	SENT_18	[p1l614t2809r754b2834],
25	in	IN	O	in	_	0	SENT_18	[p1l768t2800r796b2825],
26	most	JJS	O	most	prep_in	24	SENT_18	[p1l810t2805r881b2826],
27	of	IN	O	of	_	0	SENT_18	[p1l243t2844r275b2870],
28	the	DT	O	the	det	29	SENT_18	[p1l301t2844r346b2870],
29	vaccinees	NNS	O	vaccinee	prep_of	26	SENT_18	[p1l376t2844r516b2870],
30	[	VBP	O	[	ccomp	18	SENT_18	[p1l552t2844r598b2878],
31	3	CD	NUMBER	3	num	32	SENT_18	[p1l552t2844r598b2878],
32	]	NN	O	]	dobj	30	SENT_18	[p1l552t2844r598b2878],
33	.	.	O	.	_	0	SENT_18	[p1l552t2844r598b2878],

1	However	RB	O	however	advmod	22	SENT_19	[p1l631t2844r774b2876],
2	,	,	O	,	_	0	SENT_19	[p1l631t2844r774b2876],
3	at	IN	O	at	ccomp	22	SENT_19	[p1l807t2850r834b2870],
4	a	DT	O	a	det	7	SENT_19	[p1l865t2853r881b2869],
5	planned	VBN	O	plan	amod	7	SENT_19	[p1l242t2889r363b2923],
6	interim	NN	O	interim	nn	7	SENT_19	[p1l385t2889r493b2915],
7	analysis	NN	O	analysis	pobj	3	SENT_19	[p1l516t2889r637b2923],
8	,	,	O	,	_	0	SENT_19	[p1l516t2889r637b2923],
9	19	CD	NUMBER	19	num	10	SENT_19	[p1l666t2889r696b2915],
10	individuals	NNS	O	individual	nsubj	22	SENT_19	[p1l720t2889r880b2915],
11	in	IN	O	in	_	0	SENT_19	[p1l243t2933r270b2958],
12	the	DT	O	the	det	14	SENT_19	[p1l287t2933r332b2959],
13	vaccine	NN	O	vaccine	nn	14	SENT_19	[p1l348t2933r459b2959],
14	arm	NN	O	arm	prep_in	10	SENT_19	[p1l476t2942r535b2958],
15	and	CC	O	and	_	0	SENT_19	[p1l552t2933r608b2959],
16	ll	NN	O	ll	nn	17	SENT_19	[p1l628t2933r655b2958],
17	individuals	NNS	O	individual	conj_and	10	SENT_19	[p1l676t2933r836b2959],
18	of	IN	O	of	_	0	SENT_19	[p1l854t2933r886b2959],
19	the	DT	O	the	det	21	SENT_19	[p1l243t2977r287b3003],
20	placebo	NN	O	placebo	nn	21	SENT_19	[p1l306t2977r421b3011],
21	arm	NN	O	arm	prep_of	17	SENT_19	[p1l440t2986r499b3002],
22	acquired	VBD	O	acquire	_	0	SENT_19	[p1l517t2977r647b3011],
23	HIV	NN	MISC	hiv	nn	24	SENT_19	[p1l665t2977r734b3003],
24	infection	NN	O	infection	dobj	22	SENT_19	[p1l752t2977r880b3003],
25	during	IN	O	during	_	0	SENT_19	[p1l243t3022r341b3056],
26	a	DT	O	a	det	27	SENT_19	[p1l359t3031r374b3047],
27	follow-up	NN	O	follow-up	prep_during	22	SENT_19	[p1l391t3022r530b3056],
28	of	IN	O	of	_	0	SENT_19	[p1l549t3022r581b3048],
29	approximately	RB	O	approximately	quantmod	30	SENT_19	[p1l594t3022r809b3056],
30	620	CD	NUMBER	620	prep_of	27	SENT_19	[p1l826t3022r880b3049],

1	p	NN	O	p	nn	3	SENT_20	[p1l242t3124r316b3183],
2	p	NN	O	p	nn	3	SENT_20	[p1l242t3124r316b3183],
3	PLoS	NN	O	plo	nsubj	4	SENT_20	[p1l344t3144r408b3167],
4	Pathogens	VBD	O	pathogen	_	0	SENT_20	[p1l423t3143r567b3174],
5	|	CD	NUMBER	|	num	6	SENT_20	[p1l587t3142r590b3175],
6	www	NN	O	www	dobj	4	SENT_20	[p1l610t3143r949b3174],
7	.	.	O	.	_	0	SENT_20	[p1l610t3143r949b3174],

1	p	NN	O	p	nn	4	SENT_21	[p1l610t3143r949b3174],
2	|	CD	NUMBER	|	num	4	SENT_21	[p1l610t3143r949b3174],
3	ospathogens.org	NN	O	ospathogens.org	nn	4	SENT_21	[p1l610t3143r949b3174],
4	person	NN	O	person	nn	5	SENT_21	[p1l956t724r1056b749],
5	years	NNS	DURATION	year	nsubj	9	SENT_21	[p1l1067t724r1143b749],
6	in	IN	O	in	_	0	SENT_21	[p1l1157t715r1184b740],
7	both	DT	O	both	det	8	SENT_21	[p1l1197t715r1264b741],
8	groups	NNS	O	group	prep_in	5	SENT_21	[p1l1277t724r1376b749],
9	[	VBP	O	[	_	0	SENT_21	[p1l1394t715r1440b749],
10	4	CD	NUMBER	4	number	11	SENT_21	[p1l1394t715r1440b749],
11	]	CD	NUMBER	]	dobj	9	SENT_21	[p1l1394t715r1440b749],
12	.	.	O	.	_	0	SENT_21	[p1l1394t715r1440b749],

1	Incidences	NNS	O	incidence	nsubj	18	SENT_22	[p1l1455t715r1594b741, p1l957t768r984b785],
2	of	IN	O	of	_	0	SENT_22	[p1l999t759r1031b785],
3	3.07	CD	NUMBER	3.07	prep_of	1	SENT_22	[p1l1042t759r1103b785],
4	and	CC	O	and	_	0	SENT_22	[p1l1120t759r1175b785],
5	1.77	CD	NUMBER	1.77	conj_and	3	SENT_22	[p1l1194t759r1251b785],
6	per	IN	O	per	_	0	SENT_22	[p1l1267t768r1316b793],
7	100	CD	NUMBER	100	num	8	SENT_22	[p1l1335t759r1385b785],
8	volunteers	NNS	O	volunteer	prep_per	3	SENT_22	[p1l1399t759r1552b785],
9	in	IN	O	in	_	0	SENT_22	[p1l1567t759r1595b784],
10	the	DT	O	the	det	14	SENT_22	[p1l957t803r1002b829],
11	vaccine	NN	O	vaccine	nn	14	SENT_22	[p1l1023t803r1134b829],
12	and	CC	O	and	_	0	SENT_22	[p1l1158t803r1213b829],
13	placebo	NN	O	placebo	conj_and	11	SENT_22	[p1l1234t803r1349b837],
14	group	NN	O	group	prep_in	8	SENT_22	[p1l1372t812r1467b837],
15	,	,	O	,	_	0	SENT_22	[p1l1372t812r1467b837],
16	respectively	RB	O	respectively	advmod	18	SENT_22	[p1l1490t812r1594b837, p1l957t848r1043b882],
17	,	,	O	,	_	0	SENT_22	[p1l1490t812r1594b837, p1l957t848r1043b882],
18	indicate	VBP	O	indicate	_	0	SENT_22	[p1l1056t848r1172b874],
19	that	IN	O	that	complm	21	SENT_22	[p1l1184t848r1242b874],
20	there	EX	O	there	expl	21	SENT_22	[p1l1253t848r1327b874],
21	was	VBD	O	be	ccomp	18	SENT_22	[p1l1339t857r1393b874],
22	no	DT	O	no	det	24	SENT_22	[p1l1405t857r1441b874],
23	beneficial	JJ	O	beneficial	amod	24	SENT_22	[p1l1453t848r1595b874],
24	effect	NN	O	effect	nsubj	21	SENT_22	[p1l957t892r1036b918],
25	of	IN	O	of	_	0	SENT_22	[p1l1049t892r1081b918],
26	the	DT	O	the	det	27	SENT_22	[p1l1090t892r1135b918],
27	vaccine	NN	O	vaccine	prep_of	24	SENT_22	[p1l1149t892r1260b918],
28	on	IN	O	on	_	0	SENT_22	[p1l1275t901r1311b918],
29	HIV	NN	MISC	hiv	nn	30	SENT_22	[p1l1326t892r1395b918],
30	acquisition	NN	O	acquisition	prep_on	27	SENT_22	[p1l1409t892r1576b926],
31	.	.	O	.	_	0	SENT_22	[p1l1409t892r1576b926],

1	The	DT	O	the	det	4	SENT_23	[p1l994t937r1054b963],
2	HIV	NN	MISC	hiv	nn	4	SENT_23	[p1l1074t937r1143b963],
3	virus	NN	O	virus	nn	4	SENT_23	[p1l1160t937r1231b963],
4	particle	NN	O	particle	nsubj	5	SENT_23	[p1l1249t937r1359b971],
5	transmitted	VBD	O	transmit	_	0	SENT_23	[p1l1378t937r1549b963],
6	to	TO	O	to	_	0	SENT_23	[p1l1566t943r1594b963],
7	an	DT	O	a	det	8	SENT_23	[p1l957t991r993b1007],
8	individual	NN	O	individual	prep_to	5	SENT_23	[p1l1012t982r1161b1008],
9	can	MD	O	can	aux	12	SENT_23	[p1l1180t988r1282b1008],
10	not	RB	O	not	neg	12	SENT_23	[p1l1180t988r1282b1008],
11	be	VB	O	be	auxpass	12	SENT_23	[p1l1300t982r1334b1008],
12	targeted	VBN	O	target	rcmod	8	SENT_23	[p1l1354t982r1476b1016],
13	by	IN	O	by	_	0	SENT_23	[p1l1494t982r1530b1016],
14	the	DT	O	the	det	15	SENT_23	[p1l1549t982r1594b1008],
15	vaccinees	NNS	O	vaccinee	agent	12	SENT_23	[p1l956t1026r1104b1052],
16	’	VBP	O	’	dep	15	SENT_23	[p1l956t1026r1104b1052],
17	cytotoxic	JJ	O	cytotoxic	amod	19	SENT_23	[p1l1122t1026r1255b1060],
18	T	NN	O	t	nn	19	SENT_23	[p1l1272t1026r1296b1051],
19	cells	NNS	O	cell	dobj	16	SENT_23	[p1l1313t1026r1382b1058],
20	,	,	O	,	_	0	SENT_23	[p1l1313t1026r1382b1058],
21	because	IN	O	because	mark	23	SENT_23	[p1l1399t1026r1515b1052],
22	they	PRP	O	they	nsubj	23	SENT_23	[p1l1532t1026r1595b1060],
23	require	VBP	O	require	advcl	5	SENT_23	[p1l957t1071r1063b1105],
24	presentation	NN	O	presentation	dobj	23	SENT_23	[p1l1078t1071r1262b1105],
25	of	IN	O	of	_	0	SENT_23	[p1l1279t1071r1311b1097],
26	HIV-derived	JJ	O	hiv-derived	amod	27	SENT_23	[p1l1322t1071r1514b1097],
27	peptides	NNS	O	peptide	prep_of	24	SENT_23	[p1l1528t1080r1594b1105, p1l957t1115r1023b1141],
28	on	IN	O	on	_	0	SENT_23	[p1l1050t1124r1087b1141],
29	autologous	JJ	O	autologous	amod	31	SENT_23	[p1l1113t1115r1273b1149],
30	MHC-I	NN	O	mhc-i	nn	31	SENT_23	[p1l1299t1115r1414b1141],
31	molecules	NNS	O	molecule	prep_on	27	SENT_23	[p1l1439t1115r1592b1141],
32	.	.	O	.	_	0	SENT_23	[p1l1439t1115r1592b1141],

1	When	WRB	O	when	advmod	2	SENT_24	[p1l956t1159r1047b1185],
2	looking	VBG	O	look	advcl	34	SENT_24	[p1l1058t1159r1168b1193],
3	at	IN	O	at	_	0	SENT_24	[p1l1180t1165r1207b1185],
4	the	DT	O	the	det	6	SENT_24	[p1l1218t1159r1263b1185],
5	different	JJ	O	different	amod	6	SENT_24	[p1l1276t1159r1401b1185],
6	stages	NNS	O	stage	prep_at	2	SENT_24	[p1l1412t1164r1497b1193],
7	in	IN	O	in	_	0	SENT_24	[p1l1509t1159r1537b1184],
8	the	DT	O	the	det	9	SENT_24	[p1l1549t1159r1594b1185],
9	establishment	NN	O	establishment	prep_in	6	SENT_24	[p1l957t1204r1160b1230],
10	of	IN	O	of	_	0	SENT_24	[p1l1177t1204r1209b1230],
11	HIV	NN	MISC	hiv	nn	12	SENT_24	[p1l1220t1204r1290b1230],
12	infection	NN	O	infection	prep_of	9	SENT_24	[p1l1306t1204r1434b1230],
13	after	IN	O	after	_	0	SENT_24	[p1l1452t1204r1518b1230],
14	mucosal	JJ	O	mucosal	amod	15	SENT_24	[p1l1535t1213r1594b1230, p1l957t1248r1029b1274],
15	exposure	NN	O	exposure	prep_after	2	SENT_24	[p1l1041t1257r1172b1282],
16	(	CD	NUMBER	(	num	17	SENT_24	[p1l1186t1248r1288b1282],
17	Figure	NN	O	figure	dep	2	SENT_24	[p1l1186t1248r1288b1282],
18	1	CD	NUMBER	1	num	19	SENT_24	[p1l1306t1248r1335b1282],
19	)	NN	O	)	dep	17	SENT_24	[p1l1306t1248r1335b1282],
20	,	,	O	,	_	0	SENT_24	[p1l1306t1248r1335b1282],
21	the	DT	O	the	det	23	SENT_24	[p1l1348t1248r1393b1274],
22	earliest	JJS	O	earliest	amod	23	SENT_24	[p1l1406t1248r1510b1274],
23	stage	NN	O	stage	nsubj	34	SENT_24	[p1l1522t1253r1594b1282],
24	cytotoxic	JJ	O	cytotoxic	amod	26	SENT_24	[p1l957t1293r1091b1327],
25	T	NN	O	t	nn	26	SENT_24	[p1l1106t1293r1131b1318],
26	cells	NNS	O	cell	nsubj	28	SENT_24	[p1l1147t1293r1207b1319],
27	could	MD	O	could	aux	28	SENT_24	[p1l1223t1293r1305b1319],
28	exert	VB	O	exert	rcmod	23	SENT_24	[p1l1320t1298r1394b1319],
29	their	PRP$	O	they	poss	31	SENT_24	[p1l1409t1293r1478b1319],
30	beneﬁcial	JJ	O	beneﬁcial	amod	31	SENT_24	[p1l1493t1293r1594b1319, p1l957t1337r1007b1363],
31	effect	NN	O	effect	dobj	28	SENT_24	[p1l1026t1337r1104b1363],
32	is	VBZ	O	be	cop	34	SENT_24	[p1l1122t1337r1142b1363],
33	the	DT	O	the	det	34	SENT_24	[p1l1160t1337r1205b1363],
34	killing	NN	O	killing	_	0	SENT_24	[p1l1223t1337r1314b1371],
35	of	IN	O	of	_	0	SENT_24	[p1l1332t1337r1364b1363],
36	the	DT	O	the	det	39	SENT_24	[p1l1377t1337r1422b1363],
37	first	JJ	ORDINAL	first	amod	39	SENT_24	[p1l1440t1337r1496b1363],
38	HIVinfected	JJ	O	hivinfected	amod	39	SENT_24	[p1l1514t1337r1594b1363, p1l957t1381r1074b1407],
39	cell	NN	O	cell	prep_of	34	SENT_24	[p1l1097t1381r1153b1413],
40	,	,	O	,	_	0	SENT_24	[p1l1097t1381r1153b1413],
41	presumably	RB	O	presumably	advmod	34	SENT_24	[p1l1177t1381r1351b1415],
42	in	IN	O	in	_	0	SENT_24	[p1l1374t1381r1401b1406],
43	the	DT	O	the	det	45	SENT_24	[p1l1424t1381r1469b1407],
44	lamina	NN	O	lamina	nn	45	SENT_24	[p1l1493t1381r1595b1406],
45	propria	NN	O	proprium	prep_in	34	SENT_24	[p1l956t1426r1067b1460],
46	of	IN	O	of	_	0	SENT_24	[p1l1081t1426r1113b1452],
47	the	DT	O	the	det	49	SENT_24	[p1l1122t1426r1166b1452],
48	exposed	VBN	O	expose	amod	49	SENT_24	[p1l1182t1426r1301b1460],
49	mucosa	NN	O	mucosa	prep_of	45	SENT_24	[p1l1314t1435r1433b1452],
50	.	.	O	.	_	0	SENT_24	[p1l1314t1435r1433b1452],

1	However	RB	O	however	advmod	17	SENT_25	[p1l1450t1426r1593b1458],
2	,	,	O	,	_	0	SENT_25	[p1l1450t1426r1593b1458],
3	given	VBN	O	give	prep	17	SENT_25	[p1l957t1470r1035b1504],
4	the	DT	O	the	det	6	SENT_25	[p1l1056t1470r1101b1496],
5	low	JJ	O	low	amod	6	SENT_25	[p1l1122t1470r1175b1496],
6	density	NN	O	density	dep	3	SENT_25	[p1l1195t1470r1300b1504],
7	of	IN	O	of	_	0	SENT_25	[p1l1320t1470r1352b1496],
8	T	NN	O	t	nn	9	SENT_25	[p1l1368t1470r1392b1495],
9	cells	NNS	O	cell	prep_of	6	SENT_25	[p1l1413t1470r1474b1496],
10	in	IN	O	in	_	0	SENT_25	[p1l1495t1470r1523b1495],
11	this	DT	O	this	det	12	SENT_25	[p1l1544t1470r1594b1496],
12	compartment	NN	O	compartment	prep_in	9	SENT_25	[p1l957t1520r1166b1549],
13	,	,	O	,	_	0	SENT_25	[p1l957t1520r1166b1549],
14	it	PRP	O	it	nsubj	17	SENT_25	[p1l1179t1515r1199b1541],
15	seems	VBZ	O	seem	cop	17	SENT_25	[p1l1210t1524r1295b1541],
16	highly	RB	O	highly	advmod	17	SENT_25	[p1l1307t1515r1399b1549],
17	unlikely	JJ	O	unlikely	_	0	SENT_25	[p1l1409t1515r1526b1549],
18	that	IN	O	that	_	0	SENT_25	[p1l1537t1515r1595b1541],
19	an	DT	O	a	det	24	SENT_25	[p1l957t1568r993b1584],
20	HIV-speciﬁc	JJ	O	hiv-speciﬁc	amod	21	SENT_25	[p1l1010t1559r1199b1593],
21	cytotoxic	JJ	O	cytotoxic	amod	24	SENT_25	[p1l1216t1559r1350b1593],
22	T	NN	O	t	nn	24	SENT_25	[p1l1367t1559r1392b1584],
23	cell	NN	O	cell	nn	24	SENT_25	[p1l1409t1559r1458b1585],
24	encounters	NNS	O	encounter	prep_that	17	SENT_25	[p1l1475t1568r1594b1585, p1l957t1609r1008b1630],
25	this	DT	O	this	det	28	SENT_25	[p1l1019t1604r1070b1630],
26	single	JJ	O	single	amod	28	SENT_25	[p1l1081t1604r1163b1638],
27	HIV-infected	JJ	MISC	hiv-infected	amod	28	SENT_25	[p1l1174t1604r1373b1630],
28	cell	NN	O	cell	dep	24	SENT_25	[p1l1384t1604r1439b1630],
29	.	.	O	.	_	0	SENT_25	[p1l1384t1604r1439b1630],

1	Rather	RB	O	rather	advmod	6	SENT_26	[p1l1452t1604r1564b1636],
2	,	,	O	,	_	0	SENT_26	[p1l1452t1604r1564b1636],
3	it	PRP	O	it	nsubjpass	6	SENT_26	[p1l1576t1604r1595b1630],
4	can	MD	O	can	aux	6	SENT_26	[p1l957t1657r1009b1674],
5	be	VB	O	be	auxpass	6	SENT_26	[p1l1020t1648r1054b1674],
6	assumed	VBN	O	assume	_	0	SENT_26	[p1l1067t1648r1193b1674],
7	that	IN	O	that	complm	25	SENT_26	[p1l1205t1648r1263b1674],
8	additional	JJ	O	additional	amod	10	SENT_26	[p1l1275t1648r1424b1674],
9	replication	NN	O	replication	nn	10	SENT_26	[p1l1436t1648r1594b1682],
10	cycles	NNS	O	cycle	nsubj	25	SENT_26	[p1l957t1693r1042b1727],
11	and	CC	O	and	_	0	SENT_26	[p1l1065t1693r1120b1719],
12	local	JJ	O	local	amod	13	SENT_26	[p1l1142t1693r1211b1719],
13	spread	NN	O	spread	conj_and	10	SENT_26	[p1l1234t1693r1331b1727],
14	of	IN	O	of	_	0	SENT_26	[p1l1353t1693r1385b1719],
15	the	DT	O	the	det	16	SENT_26	[p1l1403t1693r1447b1719],
16	virus	NN	O	virus	prep_of	13	SENT_26	[p1l1470t1693r1541b1719],
17	or	CC	O	or	_	0	SENT_26	[p1l1564t1702r1595b1719],
18	virus-infected	JJ	O	virus-infected	amod	19	SENT_26	[p1l956t1737r1158b1763],
19	cells	NNS	O	cell	prep_of	13	SENT_26	[p1l1174t1737r1235b1763],
20	to	TO	O	to	_	0	SENT_26	[p1l1252t1742r1279b1763],
21	the	DT	O	the	det	24	SENT_26	[p1l1297t1737r1341b1763],
22	draining	VBG	O	drain	amod	24	SENT_26	[p1l1359t1737r1485b1771],
23	lymph	NN	O	lymph	nn	24	SENT_26	[p1l1500t1737r1594b1771],
24	nodes	NNS	O	node	prep_to	19	SENT_26	[p1l957t1781r1042b1807],
25	occur	VBP	O	occur	ccomp	6	SENT_26	[p1l1055t1790r1137b1807],
26	prior	RB	O	prior	advmod	25	SENT_26	[p1l1149t1781r1223b1815],
27	to	TO	O	to	aux	28	SENT_26	[p1l1235t1786r1262b1807],
28	encounter	VB	O	encounter	dep	26	SENT_26	[p1l1276t1787r1425b1807],
29	with	IN	O	with	_	0	SENT_26	[p1l1437t1781r1501b1807],
30	HIVspeciﬁc	NN	O	hivspeciﬁc	nn	32	SENT_26	[p1l1514t1781r1594b1807, p1l957t1826r1064b1860],
31	T	NN	O	t	nn	32	SENT_26	[p1l1077t1826r1101b1851],
32	cells	NNS	O	cell	prep_with	28	SENT_26	[p1l1114t1826r1182b1852],
33	.	.	O	.	_	0	SENT_26	[p1l1114t1826r1182b1852],

1	Subsequent	JJ	O	subsequent	amod	2	SENT_27	[p1l1198t1826r1369b1860],
2	activation	NN	O	activation	nsubj	13	SENT_27	[p1l1382t1826r1527b1852],
3	and	CC	O	and	_	0	SENT_27	[p1l1540t1826r1595b1852],
4	expansion	NN	O	expansion	conj_and	2	SENT_27	[p1l957t1870r1107b1904],
5	of	IN	O	of	_	0	SENT_27	[p1l1135t1870r1167b1896],
6	the	DT	O	the	det	9	SENT_27	[p1l1190t1870r1234b1896],
7	HIV-speciﬁc	JJ	MISC	hiv-speciﬁc	amod	9	SENT_27	[p1l1264t1870r1453b1904],
8	T	NN	O	t	nn	9	SENT_27	[p1l1481t1870r1505b1895],
9	cells	NNS	O	cell	prep_of	2	SENT_27	[p1l1534t1870r1594b1896],
10	might	MD	O	might	aux	13	SENT_27	[p1l957t1915r1043b1949],
11	be	VB	O	be	cop	13	SENT_27	[p1l1070t1915r1104b1941],
12	too	RB	O	too	advmod	13	SENT_27	[p1l1132t1920r1178b1941],
13	slow	JJ	O	slow	_	0	SENT_27	[p1l1207t1915r1271b1941],
14	to	TO	O	to	aux	15	SENT_27	[p1l1297t1920r1325b1941],
15	prevent	VB	O	prevent	xcomp	13	SENT_27	[p1l1352t1921r1465b1949],
16	further	JJ	O	further	amod	17	SENT_27	[p1l1492t1915r1595b1941],
17	spread	NN	O	spread	dobj	15	SENT_27	[p1l957t1959r1055b1993],
18	of	IN	O	of	_	0	SENT_27	[p1l1079t1959r1111b1985],
19	the	DT	O	the	det	20	SENT_27	[p1l1130t1959r1175b1985],
20	virus	NN	O	virus	prep_of	17	SENT_27	[p1l1199t1959r1278b1985],
21	.	.	O	.	_	0	SENT_27	[p1l1199t1959r1278b1985],

1	Thus	RB	O	thus	advmod	19	SENT_28	[p1l1304t1959r1389b1991],
2	,	,	O	,	_	0	SENT_28	[p1l1304t1959r1389b1991],
3	rather	RB	O	rather	prep	19	SENT_28	[p1l1414t1959r1505b1985],
4	then	RB	O	then	advmod	5	SENT_28	[p1l1529t1959r1594b1985],
5	preventing	VBG	O	prevent	dep	3	SENT_28	[p1l956t2003r1117b2037],
6	HIV	NN	MISC	hiv	nn	7	SENT_28	[p1l1135t2003r1205b2029],
7	infection	NN	O	infection	dobj	5	SENT_28	[p1l1224t2003r1361b2035],
8	,	,	O	,	_	0	SENT_28	[p1l1224t2003r1361b2035],
9	the	DT	O	the	det	10	SENT_28	[p1l1382t2003r1426b2029],
10	beneﬁt	NN	O	beneﬁt	nsubj	19	SENT_28	[p1l1446t2003r1548b2029],
11	of	IN	O	of	_	0	SENT_28	[p1l1568t2003r1600b2029],
12	the	DT	O	the	det	15	SENT_28	[p1l957t2048r1002b2074],
13	cytotoxic	JJ	O	cytotoxic	amod	15	SENT_28	[p1l1037t2048r1171b2082],
14	T	NN	O	t	nn	15	SENT_28	[p1l1205t2048r1230b2073],
15	cells	NNS	O	cell	prep_of	10	SENT_28	[p1l1264t2048r1325b2074],
16	might	MD	O	might	aux	19	SENT_28	[p1l1360t2048r1446b2082],
17	be	VB	O	be	cop	19	SENT_28	[p1l1480t2048r1514b2074],
18	the	DT	O	the	det	19	SENT_28	[p1l1549t2048r1594b2074],
19	reduction	NN	O	reduction	_	0	SENT_28	[p1l957t2092r1099b2118],
20	of	IN	O	of	_	0	SENT_28	[p1l1127t2092r1159b2118],
21	viral	JJ	O	viral	amod	22	SENT_28	[p1l1181t2092r1247b2118],
22	load	NN	O	load	prep_of	19	SENT_28	[p1l1275t2092r1346b2118],
23	.	.	O	.	_	0	SENT_28	[p1l1275t2092r1346b2118],

1	However	RB	O	however	advmod	11	SENT_29	[p1l1376t2092r1520b2124],
2	,	,	O	,	_	0	SENT_29	[p1l1376t2092r1520b2124],
3	the	DT	O	the	det	5	SENT_29	[p1l1549t2092r1594b2118],
4	interim	JJ	O	interim	amod	5	SENT_29	[p1l957t2137r1065b2163],
5	analysis	NN	O	analysis	nsubj	11	SENT_29	[p1l1085t2137r1198b2171],
6	of	IN	O	of	_	0	SENT_29	[p1l1219t2137r1251b2163],
7	the	DT	O	the	det	9	SENT_29	[p1l1266t2137r1311b2163],
8	STEP	NN	O	step	nn	9	SENT_29	[p1l1333t2137r1421b2163],
9	study	NN	O	study	prep_of	5	SENT_29	[p1l1441t2137r1519b2171],
10	also	RB	O	also	advmod	11	SENT_29	[p1l1539t2137r1594b2163],
11	failed	VBD	O	fail	_	0	SENT_29	[p1l956t2181r1038b2207],
12	to	TO	O	to	aux	13	SENT_29	[p1l1056t2186r1083b2207],
13	provide	VB	O	provide	xcomp	11	SENT_29	[p1l1102t2181r1214b2215],
14	any	DT	O	any	det	15	SENT_29	[p1l1234t2190r1288b2215],
15	evidence	NN	O	evidence	iobj	13	SENT_29	[p1l1306t2181r1434b2207],
16	for	IN	O	for	_	0	SENT_29	[p1l1453t2181r1495b2207],
17	lower	JJR	O	lower	amod	19	SENT_29	[p1l1513t2181r1595b2207],
18	viral	JJ	O	viral	amod	19	SENT_29	[p1l956t2225r1022b2251],
19	loads	NNS	O	load	prep_for	15	SENT_29	[p1l1050t2225r1126b2251],
20	in	IN	O	in	_	0	SENT_29	[p1l1155t2225r1183b2250],
21	the	DT	O	the	det	23	SENT_29	[p1l1212t2225r1257b2251],
22	vaccine	NN	O	vaccine	nn	23	SENT_29	[p1l1286t2225r1396b2251],
23	group	NN	O	group	prep_in	19	SENT_29	[p1l1426t2234r1513b2259],
24	[	CD	NUMBER	[	num	26	SENT_29	[p1l1546t2225r1592b2259],
25	4	CD	NUMBER	4	num	26	SENT_29	[p1l1546t2225r1592b2259],
26	]	NN	O	]	dobj	13	SENT_29	[p1l1546t2225r1592b2259],
27	.	.	O	.	_	0	SENT_29	[p1l1546t2225r1592b2259],

1	Therefore	RB	O	therefore	advmod	19	SENT_30	[p1l957t2270r1114b2302],
2	,	,	O	,	_	0	SENT_30	[p1l957t2270r1114b2302],
3	neither	DT	O	neither	det	11	SENT_30	[p1l1179t2270r1284b2296],
4	non-neutralizing	JJ	O	non-neutralizing	amod	11	SENT_30	[p1l1348t2270r1595b2304],
5	gp120-speciﬁc	NN	O	gp120-speciﬁc	nn	6	SENT_30	[p1l957t2314r1169b2348],
6	antibodies	NNS	O	antibody	nn	11	SENT_30	[p1l1181t2314r1331b2340],
7	nor	CC	O	nor	_	0	SENT_30	[p1l1343t2323r1394b2340],
8	HIV-speciﬁc	JJ	O	hiv-speciﬁc	nn	11	SENT_30	[p1l1405t2314r1594b2348],
9	cytotoxic	JJ	O	cytotoxic	amod	11	SENT_30	[p1l957t2359r1091b2393],
10	T	NN	O	t	nn	11	SENT_30	[p1l1101t2359r1126b2384],
11	cells	NNS	O	cell	nsubj	19	SENT_30	[p1l1136t2359r1197b2385],
12	induced	VBN	O	induce	partmod	11	SENT_30	[p1l1207t2359r1326b2385],
13	by	IN	O	by	_	0	SENT_30	[p1l1336t2359r1372b2393],
14	the	DT	O	the	det	17	SENT_30	[p1l1382t2359r1426b2385],
15	adenoviral	JJ	O	adenoviral	amod	17	SENT_30	[p1l1438t2359r1595b2385],
16	vector	NN	O	vector	nn	17	SENT_30	[p1l956t2408r1048b2429],
17	vaccine	NN	O	vaccine	agent	12	SENT_30	[p1l1065t2403r1176b2429],
18	were	VBD	O	be	cop	19	SENT_30	[p1l1195t2412r1265b2429],
19	sufficient	JJ	O	sufficient	_	0	SENT_30	[p1l1285t2403r1417b2429],
20	to	TO	O	to	aux	21	SENT_30	[p1l1435t2409r1463b2429],
21	provide	VB	O	provide	xcomp	19	SENT_30	[p1l1481t2403r1594b2437],
22	protection	NN	O	protection	dobj	21	SENT_30	[p1l956t2447r1116b2481],
23	.	.	O	.	_	0	SENT_30	[p1l956t2447r1116b2481],

1	The	DT	O	the	det	2	SENT_31	[p1l1708t714r1768b740],
2	incidence	NN	O	incidence	nsubj	10	SENT_31	[p1l1784t714r1924b740],
3	of	IN	O	of	_	0	SENT_31	[p1l1940t714r1971b740],
4	HIV	NN	MISC	hiv	nn	5	SENT_31	[p1l1981t714r2051b740],
5	infections	NNS	O	infection	prep_of	2	SENT_31	[p1l2065t714r2205b740],
6	in	IN	O	in	_	0	SENT_31	[p1l2221t714r2248b739],
7	the	DT	O	the	det	9	SENT_31	[p1l2263t714r2308b740],
8	vaccine	NN	O	vaccine	nn	9	SENT_31	[p1l1670t757r1780b783],
9	group	NN	O	group	prep_in	5	SENT_31	[p1l1793t766r1879b791],
10	seemed	VBD	O	seem	_	0	SENT_31	[p1l1892t757r2001b783],
11	to	TO	O	to	aux	12	SENT_31	[p1l2012t762r2039b783],
12	be	VB	O	be	xcomp	10	SENT_31	[p1l2051t757r2085b783],
13	higher	JJR	O	higher	dep	14	SENT_31	[p1l2097t757r2192b791],
14	than	IN	O	than	advmod	12	SENT_31	[p1l2203t757r2269b783],
15	in	IN	O	in	_	0	SENT_31	[p1l2281t757r2308b782],
16	the	DT	O	the	det	18	SENT_31	[p1l1671t801r1715b827],
17	placebo	NN	O	placebo	nn	18	SENT_31	[p1l1729t801r1844b835],
18	group	NN	O	group	prep_in	12	SENT_31	[p1l1858t810r1953b835],
19	.	.	O	.	_	0	SENT_31	[p1l1858t810r1953b835],

1	This	DT	O	this	nsubj	2	SENT_32	[p1l1969t801r2034b827],
2	raised	VBD	O	raise	_	0	SENT_32	[p1l2048t801r2136b827],
3	the	DT	O	the	det	5	SENT_32	[p1l2149t801r2194b827],
4	critical	JJ	O	critical	amod	5	SENT_32	[p1l2209t801r2309b827],
5	question	NN	O	question	dobj	2	SENT_32	[p1l1671t844r1795b878],
6	of	IN	O	of	_	0	SENT_32	[p1l1816t844r1848b870],
7	whether	IN	O	whether	complm	10	SENT_32	[p1l1862t844r1984b870],
8	vaccination	NN	O	vaccination	nsubj	10	SENT_32	[p1l2002t844r2174b870],
9	actually	RB	O	actually	advmod	10	SENT_32	[p1l2194t844r2309b878],
10	enhances	VBZ	O	enhance	prepc_of	5	SENT_32	[p1l1671t888r1807b914],
11	the	DT	O	the	det	12	SENT_32	[p1l1827t888r1872b914],
12	frequency	NN	O	frequency	dobj	10	SENT_32	[p1l1892t888r2040b922],
13	of	IN	O	of	_	0	SENT_32	[p1l2060t888r2091b914],
14	HIV	NN	MISC	hiv	nn	15	SENT_32	[p1l2107t888r2176b914],
15	acquisition	NN	O	acquisition	prep_of	12	SENT_32	[p1l2195t888r2308b922, p1l1671t932r1735b958],
16	.	.	O	.	_	0	SENT_32	[p1l2195t888r2308b922, p1l1671t932r1735b958],

1	Post-hoc	NN	O	post-hoc	nn	2	SENT_33	[p1l1760t932r1887b958],
2	analyses	NNS	O	analysis	nsubj	6	SENT_33	[p1l1909t932r2029b966],
3	of	IN	O	of	_	0	SENT_33	[p1l2052t932r2084b958],
4	different	JJ	O	different	amod	5	SENT_33	[p1l2101t932r2226b958],
5	subgroups	NNS	O	subgroup	prep_of	2	SENT_33	[p1l2248t932r2308b958, p1l1671t984r1770b1009],
6	indicated	VBD	O	indicate	_	0	SENT_33	[p1l1796t975r1933b1001],
7	that	IN	O	that	complm	26	SENT_33	[p1l1959t975r2017b1001],
8	the	DT	O	the	det	9	SENT_33	[p1l2043t975r2087b1001],
9	incidence	NN	O	incidence	nsubj	26	SENT_33	[p1l2114t975r2254b1001],
10	of	IN	O	of	_	0	SENT_33	[p1l2282t975r2314b1001],
11	HIV	NN	MISC	hiv	nn	12	SENT_33	[p1l1671t1019r1740b1045],
12	infections	NNS	O	infection	prep_of	9	SENT_33	[p1l1765t1019r1905b1045],
13	in	IN	O	in	_	0	SENT_33	[p1l1931t1019r1958b1044],
14	volunteers	NNS	O	volunteer	prep_in	12	SENT_33	[p1l1982t1019r2135b1045],
15	with	IN	O	with	_	0	SENT_33	[p1l2159t1019r2224b1045],
16	preexisting	VBG	O	preexist	prepc_with	14	SENT_33	[p1l2248t1028r2308b1053, p1l1671t1062r1784b1096],
17	humoral	JJ	O	humoral	amod	18	SENT_33	[p1l1799t1062r1926b1088],
18	immunity	NN	O	immunity	dobj	16	SENT_33	[p1l1942t1062r2087b1096],
19	to	TO	O	to	_	0	SENT_33	[p1l2102t1067r2129b1088],
20	adenovirus	NN	O	adenovirus	prep_to	16	SENT_33	[p1l2147t1062r2308b1088],
21	prior	RB	O	prior	_	0	SENT_33	[p1l1670t1106r1744b1140],
22	to	TO	O	to	_	0	SENT_33	[p1l1760t1112r1788b1132],
23	immunization	NN	O	immunization	prep_prior_to	20	SENT_33	[p1l1805t1106r2014b1132],
24	was	VBD	O	be	cop	26	SENT_33	[p1l2029t1115r2083b1132],
25	2.3-fold	JJ	O	2.3-fold	amod	26	SENT_33	[p1l2102t1106r2215b1133],
26	(	NN	O	(	ccomp	6	SENT_33	[p1l2232t1106r2306b1140],
27	95	CD	PERCENT	95	number	28	SENT_33	[p1l2232t1106r2306b1140],
28	%	NN	PERCENT	%	amod	30	SENT_33	[p1l2232t1106r2306b1140],
29	conﬁdence	NN	O	conﬁdence	nn	30	SENT_33	[p1l1671t1149r1830b1175],
30	interval	NN	O	interval	npadvmod	35	SENT_33	[p1l1844t1149r1956b1175],
31	1.1	CD	NUMBER	1.1	number	34	SENT_33	[p1l1973t1149r2010b1175],
32	to	TO	O	to	dep	34	SENT_33	[p1l2027t1155r2054b1175],
33	4.7	CD	NUMBER	4.7	number	34	SENT_33	[p1l2068t1149r2120b1183],
34	)	CD	NUMBER	)	num	30	SENT_33	[p1l2068t1149r2120b1183],
35	higher	JJR	O	higher	amod	26	SENT_33	[p1l2134t1149r2229b1183],
36	than	IN	O	than	prep	35	SENT_33	[p1l2242t1149r2308b1175],
37	in	IN	O	in	pcomp	36	SENT_33	[p1l1671t1193r1698b1218],
38	the	DT	O	the	det	44	SENT_33	[p1l1712t1193r1757b1219],
39	respective	JJ	O	respective	amod	44	SENT_33	[p1l1771t1193r1916b1227],
40	placebo	NN	O	placebo	nn	44	SENT_33	[p1l1930t1193r2045b1227],
41	subgroup	NN	O	subgroup	nn	44	SENT_33	[p1l2060t1193r2197b1227],
42	[	NN	O	[	nn	44	SENT_33	[p1l2215t1193r2261b1227],
43	4	CD	NUMBER	4	num	44	SENT_33	[p1l2215t1193r2261b1227],
44	]	NN	O	]	pobj	37	SENT_33	[p1l2215t1193r2261b1227],
45	.	.	O	.	_	0	SENT_33	[p1l2215t1193r2261b1227],

1	In	IN	O	in	_	0	SENT_34	[p1l2277t1193r2309b1218],
2	contrast	NN	O	contrast	prep_in	5	SENT_34	[p1l1671t1242r1797b1269],
3	,	,	O	,	_	0	SENT_34	[p1l1671t1242r1797b1269],
4	there	EX	O	there	expl	5	SENT_34	[p1l1819t1237r1894b1263],
5	was	VBD	O	be	_	0	SENT_34	[p1l1914t1246r1969b1263],
6	no	DT	O	no	det	7	SENT_34	[p1l1990t1246r2026b1263],
7	difference	NN	O	difference	nsubj	5	SENT_34	[p1l2048t1237r2193b1263],
8	in	IN	O	in	_	0	SENT_34	[p1l2214t1237r2242b1262],
9	the	DT	O	the	det	10	SENT_34	[p1l2263t1237r2308b1263],
10	incidence	NN	O	incidence	prep_in	7	SENT_34	[p1l1671t1280r1811b1306],
11	of	IN	O	of	_	0	SENT_34	[p1l1833t1280r1865b1306],
12	HIV	NN	MISC	hiv	nn	13	SENT_34	[p1l1880t1280r1950b1306],
13	infection	NN	O	infection	prep_of	10	SENT_34	[p1l1970t1280r2098b1306],
14	between	IN	O	between	_	0	SENT_34	[p1l2119t1280r2242b1306],
15	the	DT	O	the	det	16	SENT_34	[p1l2263t1280r2308b1306],
16	vaccine	NN	O	vaccine	prep_between	13	SENT_34	[p1l1670t1324r1780b1350],
17	and	CC	O	and	_	0	SENT_34	[p1l1805t1324r1860b1350],
18	the	DT	O	the	det	20	SENT_34	[p1l1883t1324r1928b1350],
19	placebo	NN	O	placebo	nn	20	SENT_34	[p1l1951t1324r2066b1358],
20	groups	NNS	O	group	conj_and	13	SENT_34	[p1l2089t1333r2189b1358],
21	in	IN	O	in	_	0	SENT_34	[p1l2212t1324r2240b1349],
22	the	DT	O	the	det	23	SENT_34	[p1l2263t1324r2308b1350],
23	absence	NN	O	absence	prep_in	20	SENT_34	[p1l1671t1367r1786b1393],
24	of	IN	O	of	_	0	SENT_34	[p1l1823t1367r1855b1393],
25	pre-existing	JJ	O	pre-existing	amod	26	SENT_34	[p1l1884t1367r2059b1401],
26	antibodies	NNS	O	antibody	prep_of	23	SENT_34	[p1l2094t1367r2245b1393],
27	to	TO	O	to	_	0	SENT_34	[p1l2280t1373r2308b1393],
28	adenovirus	NN	O	adenovirus	prep_to	5	SENT_34	[p1l1671t1411r1840b1437],
29	.	.	O	.	_	0	SENT_34	[p1l1671t1411r1840b1437],

1	An	DT	O	a	det	3	SENT_35	[p1l1860t1411r1904b1436],
2	initial	JJ	O	initial	amod	3	SENT_35	[p1l1923t1411r2007b1437],
3	comparison	NN	O	comparison	nsubj	23	SENT_35	[p1l2025t1411r2199b1445],
4	of	IN	O	of	_	0	SENT_35	[p1l2218t1411r2250b1437],
5	the	DT	O	the	det	6	SENT_35	[p1l2263t1411r2308b1437],
6	distribution	NN	O	distribution	prep_of	3	SENT_35	[p1l1671t1455r1842b1481],
7	of	IN	O	of	_	0	SENT_35	[p1l1860t1455r1892b1481],
8	risk	NN	O	risk	nn	9	SENT_35	[p1l1905t1455r1957b1481],
9	factors	NNS	O	factor	prep_of	6	SENT_35	[p1l1973t1455r2071b1481],
10	in	IN	O	in	_	0	SENT_35	[p1l2089t1455r2117b1480],
11	the	DT	O	the	det	15	SENT_35	[p1l2135t1455r2179b1481],
12	vaccine	NN	O	vaccine	nn	15	SENT_35	[p1l2197t1455r2308b1481],
13	and	CC	O	and	_	0	SENT_35	[p1l1671t1498r1727b1524],
14	placebo	NN	O	placebo	nn	15	SENT_35	[p1l1739t1498r1854b1532],
15	subgroups	NNS	O	subgroup	prep_in	9	SENT_35	[p1l1869t1498r2019b1532],
16	with	IN	O	with	_	0	SENT_35	[p1l2032t1498r2097b1524],
17	high	JJ	O	high	amod	18	SENT_35	[p1l2110t1498r2175b1532],
18	levels	NNS	O	level	prep_with	15	SENT_35	[p1l2188t1498r2267b1524],
19	of	IN	O	of	_	0	SENT_35	[p1l2282t1498r2314b1524],
20	pre-existing	JJ	O	pre-existing	amod	22	SENT_35	[p1l1670t1542r1845b1576],
21	adenoviral	JJ	O	adenoviral	amod	22	SENT_35	[p1l1858t1542r2014b1568],
22	immunity	NN	O	immunity	prep_of	18	SENT_35	[p1l2027t1542r2172b1576],
23	revealed	VBD	O	reveal	_	0	SENT_35	[p1l2184t1542r2309b1568],
24	a	DT	O	a	det	26	SENT_35	[p1l1671t1594r1687b1610],
25	good	JJ	O	good	amod	26	SENT_35	[p1l1699t1585r1772b1619],
26	match	NN	O	match	nsubj	49	SENT_35	[p1l1784t1585r1876b1611],
27	of	IN	O	of	_	0	SENT_35	[p1l1889t1585r1921b1611],
28	baseline	NN	O	baseline	nn	29	SENT_35	[p1l1928t1585r2046b1611],
29	variables	NNS	O	variable	prep_of	26	SENT_35	[p1l2058t1585r2189b1611],
30	such	JJ	O	such	_	0	SENT_35	[p1l2202t1585r2268b1611],
31	as	IN	O	as	_	0	SENT_35	[p1l2281t1594r2308b1611],
32	location	NN	O	location	prep_such_as	29	SENT_35	[p1l1670t1629r1797b1661],
33	,	,	O	,	_	0	SENT_35	[p1l1670t1629r1797b1661],
34	race	NN	O	race	prep_such_as	29	SENT_35	[p1l1813t1638r1883b1661],
35	,	,	O	,	_	0	SENT_35	[p1l1813t1638r1883b1661],
36	age	NN	O	age	prep_such_as	29	SENT_35	[p1l1900t1638r1957b1663],
37	,	,	O	,	_	0	SENT_35	[p1l1900t1638r1957b1663],
38	risk	NN	O	risk	nn	39	SENT_35	[p1l1974t1629r2025b1655],
39	behavior	NN	O	behavior	prep_such_as	29	SENT_35	[p1l2039t1629r2178b1661],
40	,	,	O	,	_	0	SENT_35	[p1l2039t1629r2178b1661],
41	circumcision	NN	O	circumcision	prep_such_as	29	SENT_35	[p1l2194t1629r2308b1655, p1l1671t1673r1763b1705],
42	,	,	O	,	_	0	SENT_35	[p1l2194t1629r2308b1655, p1l1671t1673r1763b1705],
43	and	CC	O	and	_	0	SENT_35	[p1l1785t1673r1840b1699],
44	history	NN	O	history	prep_such_as	29	SENT_35	[p1l1859t1673r1961b1707],
45	of	IN	O	of	_	0	SENT_35	[p1l1981t1673r2013b1699],
46	sexual	JJ	O	sexual	amod	48	SENT_35	[p1l2028t1673r2119b1699],
47	transmitted	JJ	O	transmitted	amod	48	SENT_35	[p1l2139t1673r2309b1699],
48	diseases	NNS	O	disease	prep_of	44	SENT_35	[p1l1671t1716r1785b1742],
49	[	VBP	O	[	ccomp	23	SENT_35	[p1l1813t1716r1859b1750],
50	5	CD	NUMBER	5	number	51	SENT_35	[p1l1813t1716r1859b1750],
51	]	CD	NUMBER	]	dobj	49	SENT_35	[p1l1813t1716r1859b1750],
52	.	.	O	.	_	0	SENT_35	[p1l1813t1716r1859b1750],

1	If	IN	O	if	mark	3	SENT_36	[p1l1885t1716r1912b1741],
2	this	DT	O	this	nsubj	3	SENT_36	[p1l1930t1716r1980b1742],
3	holds	VBZ	O	hold	advcl	21	SENT_36	[p1l2004t1716r2082b1742],
4	up	RP	O	up	prt	3	SENT_36	[p1l2105t1725r2142b1750],
5	for	IN	O	for	_	0	SENT_36	[p1l2166t1716r2208b1742],
6	other	JJ	O	other	amod	8	SENT_36	[p1l2231t1716r2309b1742],
7	confounding	JJ	O	confounding	amod	8	SENT_36	[p1l1671t1760r1859b1794],
8	factors	NNS	O	factor	prep_for	3	SENT_36	[p1l1880t1760r1986b1792],
9	,	,	O	,	_	0	SENT_36	[p1l1880t1760r1986b1792],
10	the	DT	O	the	det	12	SENT_36	[p1l2010t1760r2055b1786],
11	enhanced	VBN	O	enhance	amod	12	SENT_36	[p1l2078t1760r2222b1786],
12	incidence	NN	O	incidence	nsubj	21	SENT_36	[p1l2244t1760r2308b1786, p1l1671t1803r1756b1829],
13	of	IN	O	of	_	0	SENT_36	[p1l1770t1803r1802b1829],
14	HIV	NN	MISC	hiv	nn	15	SENT_36	[p1l1810t1803r1880b1829],
15	infections	NNS	O	infection	prep_of	12	SENT_36	[p1l1892t1803r2033b1829],
16	in	IN	O	in	_	0	SENT_36	[p1l2046t1803r2073b1828],
17	this	DT	O	this	prep_in	15	SENT_36	[p1l2086t1803r2137b1829],
18	vaccinated	VBN	O	vaccinate	partmod	17	SENT_36	[p1l2149t1803r2309b1829],
19	subgroup	NN	O	subgroup	dobj	18	SENT_36	[p1l1671t1847r1808b1881],
20	might	MD	O	might	aux	21	SENT_36	[p1l1827t1847r1914b1881],
21	have	VB	O	have	_	0	SENT_36	[p1l1932t1847r2000b1873],
22	severe	JJ	O	severe	amod	23	SENT_36	[p1l2020t1856r2109b1873],
23	implications	NNS	O	implication	dobj	21	SENT_36	[p1l2128t1847r2308b1881],
24	for	IN	O	for	_	0	SENT_36	[p1l1670t1890r1712b1916],
25	all	DT	O	all	det	29	SENT_36	[p1l1731t1890r1764b1915],
26	subsequent	JJ	O	subsequent	amod	29	SENT_36	[p1l1783t1890r1947b1924],
27	HIV	NN	MISC	hiv	nn	29	SENT_36	[p1l1965t1890r2034b1916],
28	vaccine	NN	O	vaccine	nn	29	SENT_36	[p1l2051t1890r2162b1916],
29	trials	NNS	O	trial	prep_for	21	SENT_36	[p1l2181t1890r2260b1922],
30	,	,	O	,	_	0	SENT_36	[p1l2181t1890r2260b1922],
31	as	RB	O	as	_	0	SENT_36	[p1l2281t1899r2308b1916],
32	well	RB	O	well	_	0	SENT_36	[p1l1670t1934r1729b1960],
33	as	IN	O	as	_	0	SENT_36	[p1l1742t1943r1770b1960],
34	for	IN	O	for	_	0	SENT_36	[p1l1783t1934r1825b1960],
35	vaccine	NN	O	vaccine	nn	39	SENT_36	[p1l1836t1934r1947b1960],
36	and	CC	O	and	_	0	SENT_36	[p1l1961t1934r2017b1960],
37	gene	NN	O	gene	nn	39	SENT_36	[p1l2029t1943r2097b1968],
38	therapy	NN	O	therapy	nn	39	SENT_36	[p1l2111t1934r2225b1968],
39	trials	NNS	O	trial	conj_and	29	SENT_36	[p1l2237t1934r2308b1960],
40	using	VBG	O	use	xcomp	21	SENT_36	[p1l1670t1978r1749b2012],
41	adenoviral	JJ	O	adenoviral	amod	42	SENT_36	[p1l1771t1978r1928b2004],
42	vectors	NNS	O	vector	dobj	40	SENT_36	[p1l1949t1984r2061b2004],
43	.	.	O	.	_	0	SENT_36	[p1l1949t1984r2061b2004],

1	It	PRP	O	it	nsubj	4	SENT_37	[p1l2086t1978r2109b2004],
2	is	VBZ	O	be	cop	4	SENT_37	[p1l2131t1978r2151b2004],
3	therefore	RB	O	therefore	advmod	4	SENT_37	[p1l2174t1978r2308b2004],
4	important	JJ	O	important	_	0	SENT_37	[p1l1671t2021r1820b2055],
5	to	TO	O	to	aux	6	SENT_37	[p1l1836t2027r1863b2047],
6	explore	VB	O	explore	xcomp	4	SENT_37	[p1l1880t2021r1988b2055],
7	how	WRB	O	how	advmod	12	SENT_37	[p1l2005t2021r2068b2047],
8	such	JJ	O	such	amod	10	SENT_37	[p1l2084t2021r2150b2047],
9	a	DT	O	a	det	10	SENT_37	[p1l2167t2030r2182b2046],
10	vaccine	NN	O	vaccine	nsubj	12	SENT_37	[p1l2197t2021r2308b2047],
11	could	MD	O	could	aux	12	SENT_37	[p1l1671t2065r1752b2091],
12	increase	VB	O	increase	ccomp	6	SENT_37	[p1l1773t2065r1892b2091],
13	the	DT	O	the	det	14	SENT_37	[p1l1914t2065r1958b2091],
14	susceptibility	NN	O	susceptibility	dobj	12	SENT_37	[p1l1980t2065r2171b2099],
15	to	TO	O	to	_	0	SENT_37	[p1l2191t2071r2218b2091],
16	HIV	NN	MISC	hiv	nn	17	SENT_37	[p1l2240t2065r2309b2091],
17	infection	NN	O	infection	prep_to	12	SENT_37	[p1l1671t2108r1807b2134],
18	.	.	O	.	_	0	SENT_37	[p1l1671t2108r1807b2134],

1	Theoretically	RB	O	theoretically	advmod	7	SENT_38	[p1l1841t2108r2046b2142],
2	,	,	O	,	_	0	SENT_38	[p1l1841t2108r2046b2142],
3	this	DT	O	this	nsubj	15	SENT_38	[p1l2079t2108r2130b2134],
4	could	MD	O	could	aux	7	SENT_38	[p1l2162t2108r2243b2134],
5	be	VB	O	be	cop	7	SENT_38	[p1l2274t2108r2308b2134],
6	either	CC	O	either	advmod	7	SENT_38	[p1l1671t2152r1756b2178],
7	due	JJ	O	due	_	0	SENT_38	[p1l1782t2152r1834b2178],
8	to	TO	O	to	_	0	SENT_38	[p1l1861t2157r1888b2178],
9	an	DT	O	a	det	13	SENT_38	[p1l1915t2161r1950b2177],
10	excessive	JJ	O	excessive	amod	13	SENT_38	[p1l1977t2152r2108b2178],
11	adenovirusspeciﬁc	JJ	O	adenovirusspeciﬁc	amod	13	SENT_38	[p1l2135t2152r2308b2178, p1l1671t2196r1778b2230],
12	immune	JJ	O	immune	amod	13	SENT_38	[p1l1800t2196r1922b2222],
13	reaction	NN	O	reaction	prep_to	7	SENT_38	[p1l1944t2196r2065b2222],
14	or	CC	O	or	_	0	SENT_38	[p1l2087t2205r2118b2222],
15	due	JJ	O	due	conj_or	7	SENT_38	[p1l2139t2196r2191b2222],
16	to	TO	O	to	_	0	SENT_38	[p1l2214t2202r2241b2222],
17	the	DT	O	the	det	18	SENT_38	[p1l2263t2196r2308b2222],
18	induction	NN	O	induction	prep_to	15	SENT_38	[p1l1671t2239r1812b2265],
19	of	IN	O	of	_	0	SENT_38	[p1l1849t2239r1881b2265],
20	detrimental	JJ	O	detrimental	amod	21	SENT_38	[p1l1912t2239r2083b2265],
21	HIV-speciﬁc	JJ	MISC	hiv-speciﬁc	amod	23	SENT_38	[p1l2119t2239r2308b2273],
22	immune	JJ	O	immune	amod	23	SENT_38	[p1l1671t2283r1793b2309],
23	responses	NNS	O	response	prep_of	18	SENT_38	[p1l1808t2292r1955b2317],
24	.	.	O	.	_	0	SENT_38	[p1l1808t2292r1955b2317],

1	Injection	NN	O	injection	nsubj	8	SENT_39	[p1l1708t2326r1840b2360],
2	of	IN	O	of	_	0	SENT_39	[p1l1858t2326r1890b2352],
3	the	DT	O	the	det	6	SENT_39	[p1l1902t2326r1947b2352],
4	adenoviral	JJ	O	adenoviral	amod	6	SENT_39	[p1l1966t2326r2122b2352],
5	vector	NN	O	vector	nn	6	SENT_39	[p1l2138t2332r2231b2352],
6	particle	NN	O	particle	prep_of	1	SENT_39	[p1l2247t2335r2308b2360, p1l1671t2370r1730b2396],
7	can	MD	O	can	aux	8	SENT_39	[p1l1759t2379r1811b2396],
8	induce	VB	O	induce	_	0	SENT_39	[p1l1839t2370r1937b2396],
9	an	DT	O	a	det	12	SENT_39	[p1l1967t2379r2002b2395],
10	immediate	JJ	O	immediate	amod	12	SENT_39	[p1l2030t2370r2187b2396],
11	innate	JJ	O	innate	amod	12	SENT_39	[p1l2216t2370r2308b2396],
12	response	NN	O	response	dobj	8	SENT_39	[p1l1671t2423r1797b2448],
13	leading	VBG	O	lead	partmod	12	SENT_39	[p1l1811t2414r1920b2448],
14	to	TO	O	to	_	0	SENT_39	[p1l1932t2419r1959b2440],
15	increased	VBN	O	increase	prepc_to	13	SENT_39	[p1l1973t2414r2113b2440],
16	inﬂammatory	JJ	O	inﬂammatory	amod	18	SENT_39	[p1l2126t2414r2308b2440, p1l1671t2466r1701b2491],
17	cytokine	NN	O	cytokine	nn	18	SENT_39	[p1l1726t2457r1848b2491],
18	levels	NNS	O	level	dobj	15	SENT_39	[p1l1874t2457r1952b2483],
19	in	IN	O	in	_	0	SENT_39	[p1l1978t2457r2006b2482],
20	the	DT	O	the	det	21	SENT_39	[p1l2031t2457r2076b2483],
21	blood	NN	O	blood	prep_in	15	SENT_39	[p1l2101t2457r2193b2489],
22	,	,	O	,	_	0	SENT_39	[p1l2101t2457r2193b2489],
23	which	WDT	O	which	dep	15	SENT_39	[p1l2219t2457r2309b2483],

1	Citation	NNP	O	Citation	_	0	SENT_40	[p1l957t2614r1074b2635],
2	:	:	O	:	_	0	SENT_40	[p1l957t2614r1074b2635],
3	Uberla	NNP	O	Uberla	nn	4	SENT_40	[p1l1087t2610r1163b2635],
4	K	NNP	O	K	nsubj	5	SENT_40	[p1l1177t2615r1190b2635],
5	(	VBD	O	(	dep	1	SENT_40	[p1l1201t2615r1274b2639],
6	2008	CD	DATE	2008	num	8	SENT_40	[p1l1201t2615r1274b2639],
7	)	CD	NUMBER	)	num	8	SENT_40	[p1l1201t2615r1274b2639],
8	HIV	NN	O	hiv	dobj	5	SENT_40	[p1l1287t2615r1327b2635],
9	Vaccine	NNP	O	Vaccine	nn	10	SENT_40	[p1l1337t2615r1430b2635],
10	Development	NNP	O	Development	dep	8	SENT_40	[p1l1442t2614r1606b2641],
11	in	IN	O	in	_	0	SENT_40	[p1l1618t2615r1637b2635],
12	the	DT	O	the	det	13	SENT_40	[p1l1649t2614r1688b2635],
13	Aftermath	NN	O	aftermath	prep_in	5	SENT_40	[p1l1699t2614r1820b2635],
14	of	IN	O	of	_	0	SENT_40	[p1l1833t2614r1857b2635],
15	the	DT	O	the	det	17	SENT_40	[p1l1866t2614r1905b2635],
16	STEP	NN	O	step	nn	17	SENT_40	[p1l1917t2615r1973b2635],
17	Study	NN	O	study	prep_of	13	SENT_40	[p1l1985t2614r2059b2641],
18	:	:	O	:	_	0	SENT_40	[p1l1985t2614r2059b2641],
19	Re-Focus	VB	O	re-focus	parataxis	5	SENT_40	[p1l2072t2615r2178b2635],
20	on	IN	O	on	_	0	SENT_40	[p1l2190t2620r2219b2635],
21	Occult	NNP	O	Occult	nn	23	SENT_40	[p1l2231t2614r2308b2635],
22	HIV	NN	O	hiv	nn	23	SENT_40	[p1l958t2648r998b2668],
23	Infection	NN	O	infection	prep_on	19	SENT_40	[p1l1010t2647r1126b2668],
24	?	.	O	?	_	0	SENT_40	[p1l1010t2647r1126b2668],

1	PLoS	NN	O	plo	nn	2	SENT_41	[p1l1139t2648r1195b2668],
2	Pathog	NN	O	pathog	_	0	SENT_41	[p1l1208t2647r1292b2674],
3	4	CD	NUMBER	4	num	4	SENT_41	[p1l1304t2648r1355b2672],
4	(	NN	O	(	dep	2	SENT_41	[p1l1304t2648r1355b2672],
5	8	CD	NUMBER	8	num	6	SENT_41	[p1l1304t2648r1355b2672],
6	)	NN	O	)	dep	2	SENT_41	[p1l1304t2648r1355b2672],
7	:	:	O	:	_	0	SENT_41	[p1l1304t2648r1355b2672],
8	eIOOOI14	NN	O	eioooi14	dep	2	SENT_41	[p1l1366t2649r1489b2668],
9	.	.	O	.	_	0	SENT_41	[p1l1366t2649r1489b2668],

1	doi	FW	O	doi	_	0	SENT_42	[p1l1501t2647r1873b2674],
2	:	:	O	:	_	0	SENT_42	[p1l1501t2647r1873b2674],
3	IO	NN	O	io	dep	1	SENT_42	[p1l1501t2647r1873b2674],
4	.	.	O	.	_	0	SENT_42	[p1l1501t2647r1873b2674],

1	I371/journa	NN	O	i371/journa	_	0	SENT_43	[p1l1501t2647r1873b2674],
2	|	NN	O	|	dep	1	SENT_43	[p1l1501t2647r1873b2674],
3	.	.	O	.	_	0	SENT_43	[p1l1501t2647r1873b2674],

1	ppat	NN	O	ppat	_	0	SENT_44	[p1l1501t2647r1873b2674],
2	.1000	CD	NUMBER	.1000	num	1	SENT_44	[p1l1501t2647r1873b2674],
3	I	PRP	O	I	dep	1	SENT_44	[p1l1501t2647r1873b2674],
4	14	CD	NUMBER	14	dep	1	SENT_44	[p1l1882t2649r1908b2668],

1	Editor	NNP	O	Editor	_	0	SENT_45	[p1l958t2699r1048b2720],
2	:	:	O	:	_	0	SENT_45	[p1l958t2699r1048b2720],
3	Marianne	NNP	PERSON	Marianne	nn	4	SENT_45	[p1l1061t2700r1172b2720],
4	Manchester	NNP	PERSON	Manchester	dep	1	SENT_45	[p1l1184t2699r1330b2724],
5	,	,	O	,	_	0	SENT_45	[p1l1184t2699r1330b2724],
6	The	DT	O	the	det	9	SENT_45	[p1l1340t2699r1385b2720],
7	Scripps	NNP	ORGANIZATION	Scripps	nn	9	SENT_45	[p1l1396t2700r1483b2726],
8	Research	NNP	ORGANIZATION	Research	nn	9	SENT_45	[p1l1495t2699r1600b2720],
9	Institute	NNP	ORGANIZATION	Institute	appos	4	SENT_45	[p1l1614t2700r1717b2724],
10	,	,	O	,	_	0	SENT_45	[p1l1614t2700r1717b2724],
11	United	NNP	LOCATION	United	nn	12	SENT_45	[p1l1731t2699r1809b2720],
12	States	NNPS	LOCATION	States	appos	4	SENT_45	[p1l1821t2700r1893b2720],
13	of	IN	LOCATION	of	_	0	SENT_45	[p1l1904t2699r1929b2720],
14	America	NNP	LOCATION	America	prep_of	12	SENT_45	[p1l1938t2700r2036b2720],

1	Published	VBN	O	publish	_	0	SENT_46	[p1l958t2752r1093b2773],
2	August	NNP	DATE	August	tmod	1	SENT_46	[p1l1105t2753r1191b2779],
3	29	CD	DATE	29	num	2	SENT_46	[p1l1203t2754r1237b2777],
4	,	,	DATE	,	_	0	SENT_46	[p1l1203t2754r1237b2777],
5	2008	CD	DATE	2008	num	6	SENT_46	[p1l1249t2754r1306b2773],
6	Copyright	NN	O	copyright	dobj	1	SENT_46	[p1l957t2803r1103b2831],
7	:	:	O	:	_	0	SENT_46	[p1l957t2803r1103b2831],
8	©	CD	NUMBER	©	num	11	SENT_46	[p1l1121t2804r1141b2824],
9	2008	CD	DATE	2008	num	11	SENT_46	[p1l1158t2805r1216b2824],
10	Klaus	NNP	PERSON	Klaus	nn	11	SENT_46	[p1l1229t2803r1289b2824],
11	Uberla	NNP	PERSON	Uberla	dep	6	SENT_46	[p1l1303t2800r1386b2824],
12	.	.	O	.	_	0	SENT_46	[p1l1303t2800r1386b2824],

1	This	DT	O	this	nsubj	7	SENT_47	[p1l1397t2803r1445b2824],
2	is	VBZ	O	be	cop	7	SENT_47	[p1l1457t2804r1473b2824],
3	an	DT	O	a	det	7	SENT_47	[p1l1485t2809r1512b2824],
4	open	JJ	O	open	amod	7	SENT_47	[p1l1525t2809r1673b2830],
5	—	NN	O	—	nn	7	SENT_47	[p1l1525t2809r1673b2830],
6	access	NN	O	access	nn	7	SENT_47	[p1l1525t2809r1673b2830],
7	article	NN	O	article	_	0	SENT_47	[p1l1685t2803r1757b2824],
8	distributed	VBN	O	distribute	partmod	7	SENT_47	[p1l1769t2803r1900b2824],
9	under	IN	O	under	_	0	SENT_47	[p1l1914t2803r1984b2824],
10	the	DT	O	the	det	11	SENT_47	[p1l1995t2803r2034b2824],
11	terms	NNS	O	term	prep_under	8	SENT_47	[p1l2045t2807r2113b2824],
12	of	IN	O	of	_	0	SENT_47	[p1l2125t2803r2150b2824],
13	the	DT	O	the	det	17	SENT_47	[p1l2159t2803r2198b2824],
14	Creative	NNP	O	Creative	nn	17	SENT_47	[p1l2210t2804r2308b2824],
15	Commons	NNPS	O	Commons	nn	17	SENT_47	[p1l957t2838r1080b2858],
16	Attribution	NNP	O	Attribution	nn	17	SENT_47	[p1l1091t2837r1222b2858],
17	License	NNP	O	License	prep_of	11	SENT_47	[p1l1236t2838r1328b2862],
18	,	,	O	,	_	0	SENT_47	[p1l1236t2838r1328b2862],
19	which	WDT	O	which	nsubj	20	SENT_47	[p1l1339t2837r1410b2858],
20	permits	VBZ	O	permit	rcmod	11	SENT_47	[p1l1423t2838r1512b2864],
21	unrestricted	JJ	O	unrestricted	amod	22	SENT_47	[p1l1524t2837r1668b2858],
22	use	NN	O	use	dobj	20	SENT_47	[p1l1680t2843r1725b2862],
23	,	,	O	,	_	0	SENT_47	[p1l1680t2843r1725b2862],
24	distribution	NN	O	distribution	dobj	20	SENT_47	[p1l1737t2837r1882b2862],
25	,	,	O	,	_	0	SENT_47	[p1l1737t2837r1882b2862],
26	and	CC	O	and	_	0	SENT_47	[p1l1893t2837r1937b2858],
27	reproduction	NN	O	reproduction	conj_and	22	SENT_47	[p1l1949t2837r2106b2864],
28	in	IN	O	in	_	0	SENT_47	[p1l2118t2838r2137b2858],
29	any	DT	O	any	det	30	SENT_47	[p1l2149t2843r2192b2864],
30	medium	NN	O	medium	prep_in	27	SENT_47	[p1l2203t2837r2308b2862],
31	,	,	O	,	_	0	SENT_47	[p1l2203t2837r2308b2862],
32	provided	VBD	O	provide	prep	20	SENT_47	[p1l958t2870r1064b2897],
33	the	DT	O	the	det	35	SENT_47	[p1l1076t2870r1115b2891],
34	original	JJ	O	original	amod	35	SENT_47	[p1l1126t2870r1215b2897],
35	author	NN	O	author	nsubjpass	39	SENT_47	[p1l1228t2870r1308b2891],
36	and	CC	O	and	_	0	SENT_47	[p1l1319t2870r1362b2891],
37	source	NN	O	source	nsubjpass	39	SENT_47	[p1l1375t2876r1454b2891],
38	are	VBP	O	be	auxpass	39	SENT_47	[p1l1465t2876r1501b2891],
39	credited	VBN	O	credit	dep	32	SENT_47	[p1l1513t2870r1617b2891],
40	.	.	O	.	_	0	SENT_47	[p1l1513t2870r1617b2891],

1	Funding	NNP	O	Funding	_	0	SENT_48	[p1l958t2922r1080b2949],
2	:	:	O	:	_	0	SENT_48	[p1l958t2922r1080b2949],
3	This	DT	O	this	det	4	SENT_48	[p1l1090t2922r1138b2943],
4	work	NN	O	work	nsubjpass	6	SENT_48	[p1l1149t2922r1209b2943],
5	was	VBD	O	be	auxpass	6	SENT_48	[p1l1220t2928r1265b2943],
6	supported	VBN	O	support	dep	1	SENT_48	[p1l1277t2922r1401b2949],
7	by	IN	O	by	_	0	SENT_48	[p1l1414t2922r1442b2949],
8	the	DT	O	the	det	10	SENT_48	[p1l1453t2922r1492b2943],
9	EUROPRISE	NNP	O	EUROPRISE	nn	10	SENT_48	[p1l1504t2923r1637b2943],
10	Network	NNP	O	Network	agent	6	SENT_48	[p1l1650t2922r1751b2943],
11	of	IN	O	of	_	0	SENT_48	[p1l1762t2922r1787b2943],
12	Excellence	NNP	O	Excellence	prep_of	10	SENT_48	[p1l1798t2922r1927b2943],
13	.	.	O	.	_	0	SENT_48	[p1l1798t2922r1927b2943],

1	Competing	VBG	O	compete	amod	2	SENT_49	[p1l957t2974r1110b3001],
2	Interests	NNS	O	interest	_	0	SENT_49	[p1l1123t2975r1249b2995],
3	:	:	O	:	_	0	SENT_49	[p1l1123t2975r1249b2995],
4	The	DT	O	the	det	5	SENT_49	[p1l1260t2974r1304b2995],
5	authors	NNS	O	author	nsubj	7	SENT_49	[p1l1316t2974r1406b2995],
6	have	VBP	O	have	aux	7	SENT_49	[p1l1419t2974r1475b2995],
7	declared	VBN	O	declare	dep	2	SENT_49	[p1l1486t2974r1588b2995],
8	that	IN	O	that	complm	12	SENT_49	[p1l1600t2974r1649b2995],
9	no	DT	O	no	det	11	SENT_49	[p1l1661t2980r1690b2995],
10	competing	VBG	O	compete	amod	11	SENT_49	[p1l1702t2975r1832b3001],
11	interests	NNS	O	interest	nsubj	12	SENT_49	[p1l1845t2975r1946b2995],
12	exist	VBP	O	exist	ccomp	7	SENT_49	[p1l1958t2975r2018b2995],
13	.	.	O	.	_	0	SENT_49	[p1l1958t2975r2018b2995],

1	*	NN	O	*	nn	2	SENT_50	[p1l957t3027r967b3037],
2	E	NN	O	e	_	0	SENT_50	[p1l980t3026r1057b3047],
3	—	CD	NUMBER	—	dep	2	SENT_50	[p1l980t3026r1057b3047],
4	mai	FW	O	mai	nn	5	SENT_50	[p1l980t3026r1057b3047],
5	|	FW	O	|	dep	2	SENT_50	[p1l980t3026r1057b3047],
6	:	:	O	:	_	0	SENT_50	[p1l980t3026r1057b3047],
7	k	NN	O	k	dep	2	SENT_50	[p1l1070t3026r1327b3047],
8	|	CD	NUMBER	|	num	9	SENT_50	[p1l1070t3026r1327b3047],
9	aus	NN	O	aus	dep	7	SENT_50	[p1l1070t3026r1327b3047],
10	.	.	O	.	_	0	SENT_50	[p1l1070t3026r1327b3047],

1	ueber	NN	O	ueber	_	0	SENT_51	[p1l1070t3026r1327b3047],
2	|	SYM	O	|	dep	3	SENT_51	[p1l1070t3026r1327b3047],
3	a@rub.de	IN	O	a@rub.de	dep	1	SENT_51	[p1l1070t3026r1327b3047],

1	August	NNP	DATE	August	_	0	SENT_52	[p1l1631t3144r1729b3174],
2	2008	CD	DATE	2008	num	4	SENT_52	[p1l1742t3145r1807b3167],
3	|	NNP	O	|	nn	4	SENT_52	[p1l1828t3142r1830b3175],
4	Volume	NN	O	volume	dep	1	SENT_52	[p1l1850t3143r1955b3167],
5	4	CD	NUMBER	4	number	6	SENT_52	[p1l1973t3145r1989b3167],
6	|	CD	NUMBER	|	dep	4	SENT_52	[p1l2009t3142r2011b3175],
7	Issue	NN	O	issue	nn	10	SENT_52	[p1l2033t3144r2099b3167],
8	8	CD	NUMBER	8	num	10	SENT_52	[p1l2117t3145r2132b3167],
9	|	NN	O	|	nn	10	SENT_52	[p1l2152t3142r2155b3175],
10	e1000114	NN	O	e1000114	dep	1	SENT_52	[p1l2175t3145r2309b3167],

1	Lamina	NN	O	lamina	nn	3	SENT_53	[p2l242t703r276b851],
2	propria	NN	O	proprium	nn	3	SENT_53	[p2l294t707r338b849],
3	occult	NN	O	occult	nsubj	7	SENT_53	[p2l1205t861r1239b983],
4	abortive	JJ	O	abortive	amod	6	SENT_53	[p2l1199t529r1233b693],
5	Lymph	NNP	O	Lymph	nn	6	SENT_53	[p2l242t1135r286b1267],
6	node	NN	O	node	dep	3	SENT_53	[p2l294t1151r328b1249],
7	established	VBD	O	establish	_	0	SENT_53	[p2l1197t1275r1233b1507],

1	Y	NN	O	y	_	0	SENT_54	[p2l548t1483r598b1581],
2	at	IN	O	at	_	0	SENT_54	[p2l634t1513r686b1559],
3	6	CD	NUMBER	6	num	4	SENT_54	[p2l718t1463r810b1575],
4	*	NN	O	*	prep_at	1	SENT_54	[p2l718t1463r810b1575],
5	:	:	O	:	_	0	SENT_54	[p2l718t1463r810b1575],

1	Blood	NN	O	blood	nn	2	SENT_55	[p2l242t1425r276b1537],
2	vessel	NN	O	vessel	_	0	SENT_55	[p2l294t1417r328b1547],

1	Lt.	NNP	O	Lt.	_	0	SENT_56	[p2l598t1457r640b1495],

1	Figure	NNP	O	Figure	_	0	SENT_57	[p2l244t1658r343b1689],
2	1	CD	NUMBER	1	dep	1	SENT_57	[p2l356t1660r381b1682],
3	.	.	O	.	_	0	SENT_57	[p2l356t1660r381b1682],

1	Model	NNP	O	Model	nsubj	11	SENT_58	[p2l393t1658r490b1682],
2	of	IN	O	of	_	0	SENT_58	[p2l502t1658r534b1682],
3	the	DT	O	the	det	5	SENT_58	[p2l543t1658r594b1682],
4	Early	JJ	O	early	amod	5	SENT_58	[p2l605t1658r683b1689],
5	Stages	NNS	O	stage	prep_of	1	SENT_58	[p2l693t1659r797b1689],
6	of	IN	O	of	_	0	SENT_58	[p2l808t1658r840b1682],
7	Mucosal	JJ	O	mucosal	amod	9	SENT_58	[p2l851t1658r979b1682],
8	HIV	NN	O	hiv	nn	9	SENT_58	[p2l992t1659r1047b1682],
9	Infection	NN	O	infection	prep_of	5	SENT_58	[p2l1059t1658r1196b1682],
10	(	CD	NUMBER	(	dep	9	SENT_58	[p2l1209t1658r1360b1686],
11	Modified	VBN	O	modify	_	0	SENT_58	[p2l1209t1658r1360b1686],
12	from	IN	O	from	_	0	SENT_58	[p2l1371t1658r1446b1682],
13	[	CD	NUMBER	[	number	14	SENT_58	[p2l1459t1659r1523b1686],
14	11	CD	NUMBER	11	num	16	SENT_58	[p2l1459t1659r1523b1686],
15	]	NN	O	]	nn	16	SENT_58	[p2l1459t1659r1523b1686],
16	)	NN	O	)	prep_from	11	SENT_58	[p2l1459t1659r1523b1686],
17	and	CC	O	and	_	0	SENT_58	[p2l1535t1658r1593b1682],
18	Vaccine-Induced	JJ	O	vaccine-induced	amod	19	SENT_58	[p2l243t1695r503b1719],
19	Enhancement	NN	O	enhancement	prep_from	11	SENT_58	[p2l519t1695r733b1719],
20	of	IN	O	of	_	0	SENT_58	[p2l747t1695r779b1719],
21	Infection	NN	O	infection	prep_of	16	SENT_58	[p2l792t1695r939b1719],
22	.	.	O	.	_	0	SENT_58	[p2l792t1695r939b1719],

1	Free	JJ	O	free	amod	2	SENT_59	[p2l954t1696r1011b1719],
2	virus	NN	O	virus	nsubj	3	SENT_59	[p2l1023t1696r1087b1719],
3	crosses	VBZ	O	cross	_	0	SENT_59	[p2l1101t1702r1199b1719],
4	the	DT	O	the	det	6	SENT_59	[p2l1211t1695r1256b1719],
5	epithelial	JJ	O	epithelial	amod	6	SENT_59	[p2l1270t1695r1394b1726],
6	barrier	NN	O	barrier	nsubj	18	SENT_59	[p2l1409t1695r1498b1719],
7	of	IN	O	of	_	0	SENT_59	[p2l1511t1695r1539b1719],
8	the	DT	O	the	det	9	SENT_59	[p2l1550t1695r1594b1719],
9	mucosa	NN	O	mucosa	conj_or	9	SENT_59	[p2l244t1739r348b1756],
10	through	IN	O	through	_	0	SENT_59	[p2l367t1732r478b1763],
11	breaks	NNS	O	break	prep_through	9	SENT_59	[p2l498t1732r586b1756],
12	or	CC	O	or	_	0	SENT_59	[p2l605t1739r632b1756],
13	by	IN	O	by	_	0	SENT_59	[p2l651t1732r683b1763],
14	transport	NN	O	transport	prep_by	9	SENT_59	[p2l700t1736r827b1763],
15	on	IN	O	on	_	0	SENT_59	[p2l846t1739r879b1756],
16	dendritic	JJ	O	dendritic	amod	17	SENT_59	[p2l898t1732r1020b1756],
17	cells	NNS	O	cell	prep_on	14	SENT_59	[p2l1039t1732r1096b1756],
18	(	VBP	O	(	ccomp	3	SENT_59	[p2l1116t1733r1180b1760],
19	DC	NN	O	dc	nn	20	SENT_59	[p2l1116t1733r1180b1760],
20	)	NN	O	)	dobj	18	SENT_59	[p2l1116t1733r1180b1760],
21	,	,	O	,	_	0	SENT_59	[p2l1116t1733r1180b1760],
22	transcytosis	NN	O	transcytosis	conj_or	20	SENT_59	[p2l1198t1733r1365b1763],
23	,	,	O	,	_	0	SENT_59	[p2l1198t1733r1365b1763],
24	or	CC	O	or	_	0	SENT_59	[p2l1384t1739r1412b1756],
25	infection	NN	O	infection	conj_or	20	SENT_59	[p2l1430t1732r1549b1756],
26	of	IN	O	of	_	0	SENT_59	[p2l1568t1732r1596b1756],
27	intraepithelial	JJ	O	intraepithelial	amod	28	SENT_59	[p2l244t1770r431b1801],
28	DC	NN	ORGANIZATION	dc	prep_of	25	SENT_59	[p2l444t1771r488b1798],
29	,	,	O	,	_	0	SENT_59	[p2l444t1771r488b1798],
30	macrophages	NNS	O	macrophage	conj_or	28	SENT_59	[p2l500t1770r692b1801],
31	,	,	O	,	_	0	SENT_59	[p2l500t1770r692b1801],
32	or	CC	O	or	_	0	SENT_59	[p2l703t1777r730b1794],
33	CD4	NN	O	cd4	nn	36	SENT_59	[p2l740t1771r815b1794],
34	+	CC	O	+	_	0	SENT_59	[p2l740t1771r815b1794],
35	T	NN	O	t	conj_+	33	SENT_59	[p2l823t1771r840b1794],
36	cells	NNS	O	cell	prep_of	25	SENT_59	[p2l849t1770r914b1794],
37	.	.	O	.	_	0	SENT_59	[p2l849t1770r914b1794],

1	Initially	RB	O	initially	advmod	5	SENT_60	[p2l925t1770r1028b1801],
2	,	,	O	,	_	0	SENT_60	[p2l925t1770r1028b1801],
3	this	DT	O	this	nsubj	5	SENT_60	[p2l1037t1770r1086b1794],
4	will	MD	O	will	aux	5	SENT_60	[p2l1096t1770r1140b1794],
5	lead	VB	O	lead	_	0	SENT_60	[p2l1153t1770r1207b1794],
6	to	TO	O	to	_	0	SENT_60	[p2l1218t1774r1246b1794],
7	a	DT	O	a	det	17	SENT_60	[p2l1256t1777r1269b1794],
8	single	JJ	O	single	amod	17	SENT_60	[p2l1280t1770r1360b1801],
9	H	NN	O	h	nn	17	SENT_60	[p2l1371t1770r1538b1794],
10	|	CD	NUMBER	|	num	11	SENT_60	[p2l1371t1770r1538b1794],
11	V	NN	O	v	dep	17	SENT_60	[p2l1371t1770r1538b1794],
12	—	RB	O	—	dep	11	SENT_60	[p2l1371t1770r1538b1794],
13	infected	JJ	O	infected	amod	17	SENT_60	[p2l1371t1770r1538b1794],
14	cell	NN	O	cell	nn	17	SENT_60	[p2l1550t1770r1593b1794],
15	(	NN	O	(	nn	17	SENT_60	[p2l244t1808r276b1835],
16	1	CD	NUMBER	1	num	17	SENT_60	[p2l244t1808r276b1835],
17	)	NN	O	)	prep_to	5	SENT_60	[p2l244t1808r276b1835],
18	located	JJ	O	located	amod	17	SENT_60	[p2l288t1807r387b1831],
19	in	IN	O	in	_	0	SENT_60	[p2l398t1808r420b1831],
20	the	DT	O	the	det	22	SENT_60	[p2l431t1807r475b1831],
21	lamina	NN	O	lamina	nn	22	SENT_60	[p2l487t1807r576b1831],
22	propria	NN	O	proprium	prep_in	18	SENT_60	[p2l587t1808r692b1838],
23	.	.	O	.	_	0	SENT_60	[p2l587t1808r692b1838],

1	Further	JJ	O	further	amod	2	SENT_61	[p2l704t1807r803b1831],
2	spread	NN	O	spread	nsubjpass	5	SENT_61	[p2l812t1807r903b1838],
3	can	MD	O	can	aux	5	SENT_61	[p2l914t1814r960b1831],
4	be	VB	O	be	auxpass	5	SENT_61	[p2l972t1807r1005b1831],
5	blocked	VBN	O	block	_	0	SENT_61	[p2l1016t1807r1122b1831],
6	by	IN	O	by	_	0	SENT_61	[p2l1134t1807r1166b1838],
7	infection	NN	O	infection	agent	5	SENT_61	[p2l1177t1807r1295b1831],
8	of	IN	O	of	_	0	SENT_61	[p2l1306t1807r1334b1831],
9	the	DT	O	the	det	11	SENT_61	[p2l1341t1807r1386b1831],
10	ﬁrst	NN	O	ﬁrst	nn	11	SENT_61	[p2l1395t1807r1446b1831],
11	cell	NN	O	cell	prep_of	7	SENT_61	[p2l1456t1807r1499b1831],
12	with	IN	O	with	_	0	SENT_61	[p2l1510t1807r1569b1831],
13	a	DT	O	a	det	16	SENT_61	[p2l1580t1814r1593b1831],
14	replication-deficient	JJ	O	replication-deficient	amod	16	SENT_61	[p2l244t1844r519b1875],
15	virus	NN	O	virus	nn	16	SENT_61	[p2l533t1845r597b1868],
16	mutant	NN	O	mutant	nsubj	34	SENT_61	[p2l614t1848r720b1872],
17	,	,	O	,	_	0	SENT_61	[p2l614t1848r720b1872],
18	integration	NN	O	integration	appos	16	SENT_61	[p2l736t1845r886b1875],
19	into	IN	O	into	_	0	SENT_61	[p2l902t1845r955b1868],
20	a	DT	O	a	det	24	SENT_61	[p2l970t1851r983b1868],
21	transcriptionally	RB	O	transcriptionally	advmod	22	SENT_61	[p2l998t1844r1221b1875],
22	silent	JJ	O	silent	amod	24	SENT_61	[p2l1235t1844r1307b1868],
23	genomic	JJ	O	genomic	amod	24	SENT_61	[p2l1322t1845r1442b1875],
24	region	NN	O	region	prep_into	18	SENT_61	[p2l1458t1845r1552b1875],
25	,	,	O	,	_	0	SENT_61	[p2l1458t1845r1552b1875],
26	or	CC	O	or	_	0	SENT_61	[p2l1567t1851r1595b1868],
27	absence	NN	O	absence	prep_into	18	SENT_61	[p2l243t1882r355b1906],
28	of	IN	O	of	_	0	SENT_61	[p2l367t1882r395b1906],
29	susceptible	JJ	O	susceptible	amod	32	SENT_61	[p2l404t1882r558b1913],
30	secondary	JJ	O	secondary	amod	32	SENT_61	[p2l570t1882r710b1913],
31	target	NN	O	target	nn	32	SENT_61	[p2l720t1886r803b1913],
32	cells	NNS	O	cell	prep_of	27	SENT_61	[p2l813t1882r877b1910],
33	,	,	O	,	_	0	SENT_61	[p2l813t1882r877b1910],
34	leading	VBG	O	lead	prepc_with	5	SENT_61	[p2l890t1882r989b1913],
35	to	TO	O	to	_	0	SENT_61	[p2l1001t1886r1028b1906],
36	abortive	JJ	O	abortive	amod	37	SENT_61	[p2l1040t1882r1153b1906],
37	infection	NN	O	infection	prep_to	34	SENT_61	[p2l1165t1882r1283b1906],
38	once	IN	DATE	once	mark	42	SENT_61	[p2l1295t1889r1361b1906],
39	the	DT	O	the	det	41	SENT_61	[p2l1371t1882r1416b1906],
40	infected	JJ	O	infected	amod	41	SENT_61	[p2l1428t1882r1537b1906],
41	cell	NN	O	cell	nsubj	42	SENT_61	[p2l1550t1882r1593b1906],
42	dies	VBZ	O	die	advcl	34	SENT_61	[p2l243t1919r304b1943],
43	.	.	O	.	_	0	SENT_61	[p2l243t1919r304b1943],

1	If	IN	O	if	mark	5	SENT_62	[p2l321t1919r337b1943],
2	the	DT	O	the	det	3	SENT_62	[p2l349t1919r394b1943],
3	virus	NN	O	virus	nsubjpass	5	SENT_62	[p2l409t1920r473b1943],
4	is	VBZ	O	be	auxpass	5	SENT_62	[p2l489t1920r507b1943],
5	transmitted	VBN	O	transmit	advcl	17	SENT_62	[p2l521t1919r680b1943],
6	to	TO	O	to	_	0	SENT_62	[p2l696t1923r724b1943],
7	secondary	JJ	O	secondary	amod	9	SENT_62	[p2l740t1919r880b1950],
8	target	NN	O	target	nn	9	SENT_62	[p2l894t1923r977b1950],
9	cells	NNS	O	cell	prep_to	5	SENT_62	[p2l992t1919r1049b1943],
10	(	VBP	O	(	rcmod	9	SENT_62	[p2l1066t1920r1105b1947],
11	2	CD	NUMBER	2	number	12	SENT_62	[p2l1066t1920r1105b1947],
12	)	CD	NUMBER	)	dobj	10	SENT_62	[p2l1066t1920r1105b1947],
13	,	,	O	,	_	0	SENT_62	[p2l1066t1920r1105b1947],
14	occult	NN	O	occult	nn	15	SENT_62	[p2l1120t1919r1204b1943],
15	infections	NNS	O	infection	nsubj	17	SENT_62	[p2l1219t1919r1352b1943],
16	can	MD	O	can	aux	17	SENT_62	[p2l1367t1926r1413b1943],
17	occur	VB	O	occur	_	0	SENT_62	[p2l1429t1926r1505b1943],
18	if	IN	O	if	mark	25	SENT_62	[p2l1520t1919r1537b1943],
19	the	DT	O	the	det	21	SENT_62	[p2l1550t1919r1594b1943],
20	reproductive	JJ	O	reproductive	amod	21	SENT_62	[p2l244t1956r419b1987],
21	rate	NN	O	rate	nsubj	25	SENT_62	[p2l431t1960r482b1980],
22	of	IN	O	of	_	0	SENT_62	[p2l493t1956r521b1980],
23	H	NN	O	h	prep_of	21	SENT_62	[p2l531t1956r698b1980],
24	|	CD	NUMBER	|	num	23	SENT_62	[p2l531t1956r698b1980],
25	V	NN	O	v	advcl	17	SENT_62	[p2l531t1956r698b1980],
26	—	RB	O	—	advmod	27	SENT_62	[p2l531t1956r698b1980],
27	infected	JJ	O	infected	amod	28	SENT_62	[p2l531t1956r698b1980],
28	cells	NNS	O	cell	nsubjpass	30	SENT_62	[p2l710t1956r767b1980],
29	is	VBZ	O	be	auxpass	30	SENT_62	[p2l779t1957r796b1980],
30	reduced	VBN	O	reduce	ccomp	25	SENT_62	[p2l808t1956r919b1980],
31	to	TO	O	to	_	0	SENT_62	[p2l930t1960r957b1980],
32	less	JJR	O	less	mwe	33	SENT_62	[p2l970t1956r1017b1980],
33	than	IN	O	than	quantmod	34	SENT_62	[p2l1027t1956r1088b1980],
34	one	CD	NUMBER	one	prep_to	30	SENT_62	[p2l1100t1963r1158b1980],
35	.	.	O	.	_	0	SENT_62	[p2l1100t1963r1158b1980],

1	These	DT	O	these	det	4	SENT_63	[p2l1167t1956r1248b1980],
2	occult	NN	O	occult	nn	4	SENT_63	[p2l1258t1956r1342b1980],
3	HIV	NN	O	hiv	nn	4	SENT_63	[p2l1353t1957r1399b1980],
4	infections	NNS	O	infection	nsubjpass	21	SENT_63	[p2l1410t1956r1542b1980],
5	are	VBP	O	be	auxpass	6	SENT_63	[p2l1553t1963r1594b1980],
6	reported	VBN	O	report	_	0	SENT_63	[p2l244t1994r361b2025],
7	to	TO	O	to	aux	9	SENT_63	[p2l375t1998r403b2018],
8	be	VB	O	be	auxpass	9	SENT_63	[p2l418t1994r451b2018],
9	associated	VBN	O	associate	xcomp	6	SENT_63	[p2l464t1994r606b2018],
10	with	IN	O	with	_	0	SENT_63	[p2l620t1994r679b2018],
11	detectable	JJ	O	detectable	amod	12	SENT_63	[p2l694t1994r840b2018],
12	levels	NNS	O	level	prep_with	9	SENT_63	[p2l855t1994r928b2018],
13	of	IN	O	of	_	0	SENT_63	[p2l942t1994r970b2018],
14	HIV-speciﬁc	JJ	O	hiv-speciﬁc	amod	17	SENT_63	[p2l983t1994r1141b2025],
15	cellular	JJ	O	cellular	amod	17	SENT_63	[p2l1155t1994r1253b2018],
16	immune	JJ	O	immune	amod	17	SENT_63	[p2l1266t1995r1380b2018],
17	responses	NNS	O	response	prep_of	12	SENT_63	[p2l1394t2001r1529b2025],
18	and	CC	O	and	_	0	SENT_63	[p2l1543t1994r1593b2018],
19	can	MD	O	can	aux	21	SENT_63	[p2l243t2038r289b2055],
20	be	VB	O	be	auxpass	21	SENT_63	[p2l307t2031r340b2055],
21	defined	VBN	O	define	conj_and	6	SENT_63	[p2l356t2031r459b2055],
22	by	IN	O	by	_	0	SENT_63	[p2l477t2031r510b2062],
23	transient	JJ	O	transient	amod	24	SENT_63	[p2l524t2032r646b2055],
24	detection	NN	O	detection	agent	21	SENT_63	[p2l662t2031r792b2055],
25	of	IN	O	of	_	0	SENT_63	[p2l809t2031r837b2055],
26	virus	NN	O	virus	prep_of	24	SENT_63	[p2l850t2032r914b2055],
27	in	IN	O	in	_	0	SENT_63	[p2l932t2032r953b2055],
28	the	DT	O	the	det	29	SENT_63	[p2l970t2031r1015b2055],
29	absence	NN	O	absence	prep_in	21	SENT_63	[p2l1031t2031r1143b2055],
30	of	IN	O	of	_	0	SENT_63	[p2l1160t2031r1188b2055],
31	subsequent	JJ	O	subsequent	amod	32	SENT_63	[p2l1202t2031r1363b2062],
32	seroconversion	NN	O	seroconversion	prep_of	29	SENT_63	[p2l1379t2032r1594b2055],
33	.	.	O	.	_	0	SENT_63	[p2l1379t2032r1594b2055],

1	Transient	JJ	O	transient	amod	2	SENT_64	[p2l242t2070r369b2093],
2	viremia	NN	O	viremia	nsubj	3	SENT_64	[p2l382t2070r482b2093],
3	suggests	VBZ	O	suggest	_	0	SENT_64	[p2l497t2073r617b2100],
4	that	IN	O	that	complm	9	SENT_64	[p2l630t2069r686b2093],
5	occult	NN	O	occult	nn	6	SENT_64	[p2l699t2069r783b2093],
6	infections	NNS	O	infection	nsubj	9	SENT_64	[p2l797t2069r929b2093],
7	can	MD	O	can	aux	9	SENT_64	[p2l943t2076r989b2093],
8	still	RB	O	still	advmod	9	SENT_64	[p2l1004t2069r1048b2093],
9	occur	VB	O	occur	ccomp	3	SENT_64	[p2l1063t2076r1139b2093],
10	after	IN	O	after	_	0	SENT_64	[p2l1152t2069r1215b2093],
11	spread	NN	O	spread	prep_after	9	SENT_64	[p2l1228t2069r1319b2100],
12	of	IN	O	of	_	0	SENT_64	[p2l1334t2069r1362b2093],
13	the	DT	O	the	det	14	SENT_64	[p2l1373t2069r1418b2093],
14	virus	NN	O	virus	prep_of	11	SENT_64	[p2l1431t2070r1495b2093],
15	to	TO	O	to	_	0	SENT_64	[p2l1508t2073r1536b2093],
16	the	DT	O	the	det	19	SENT_64	[p2l1550t2069r1594b2093],
17	regional	JJ	O	regional	amod	19	SENT_64	[p2l244t2106r353b2137],
18	lymph	NN	O	lymph	nn	19	SENT_64	[p2l369t2106r453b2137],
19	node	NN	O	node	prep_to	9	SENT_64	[p2l469t2106r538b2130],
20	(	CD	NUMBER	(	number	21	SENT_64	[p2l552t2107r592b2134],
21	3	CD	NUMBER	3	num	22	SENT_64	[p2l552t2107r592b2134],
22	)	NN	O	)	dep	19	SENT_64	[p2l552t2107r592b2134],
23	.	.	O	.	_	0	SENT_64	[p2l552t2107r592b2134],

1	As	IN	O	as	mark	33	SENT_65	[p2l605t2107r637b2130],
2	outlined	VBN	O	outline	csubj	33	SENT_65	[p2l651t2106r764b2130],
3	in	IN	O	in	_	0	SENT_65	[p2l779t2107r801b2130],
4	the	DT	O	the	det	5	SENT_65	[p2l815t2106r860b2130],
5	text	NN	O	text	prep_in	2	SENT_65	[p2l873t2110r932b2134],
6	,	,	O	,	_	0	SENT_65	[p2l873t2110r932b2134],
7	enhancement	NN	O	enhancement	appos	5	SENT_65	[p2l946t2106r1137b2130],
8	of	IN	O	of	_	0	SENT_65	[p2l1150t2106r1178b2130],
9	the	DT	O	the	det	10	SENT_65	[p2l1189t2106r1234b2130],
10	incidence	NN	O	incidence	prep_of	7	SENT_65	[p2l1248t2106r1379b2130],
11	of	IN	O	of	prep	10	SENT_65	[p2l1392t2106r1420b2130],
12	established	VBN	O	establish	partmod	29	SENT_65	[p2l1432t2106r1594b2134],
13	,	,	O	,	_	0	SENT_65	[p2l1432t2106r1594b2134],
14	seropositive	JJ	O	seropositive	amod	16	SENT_65	[p2l243t2144r409b2174],
15	HIV	NN	MISC	hiv	nn	16	SENT_65	[p2l424t2144r470b2167],
16	infections	NNS	O	infection	nsubjpass	29	SENT_65	[p2l484t2143r617b2167],
17	in	IN	O	in	_	0	SENT_65	[p2l632t2144r653b2167],
18	a	DT	O	a	det	19	SENT_65	[p2l669t2150r682b2167],
19	subgroup	NN	O	subgroup	prep_in	16	SENT_65	[p2l697t2143r830b2174],
20	of	IN	O	of	_	0	SENT_65	[p2l845t2143r873b2167],
21	vaccinated	VBN	O	vaccinate	prepc_of	19	SENT_65	[p2l884t2143r1031b2167],
22	volunteers	NNS	O	volunteer	dobj	21	SENT_65	[p2l1046t2143r1190b2167],
23	of	IN	O	of	_	0	SENT_65	[p2l1205t2143r1233b2167],
24	the	DT	O	the	det	26	SENT_65	[p2l1244t2143r1289b2167],
25	STEP	NN	O	step	nn	26	SENT_65	[p2l1303t2144r1368b2167],
26	study	NN	O	study	prep_of	22	SENT_65	[p2l1382t2143r1457b2174],
27	could	MD	O	could	aux	29	SENT_65	[p2l1471t2143r1545b2167],
28	be	VB	O	be	auxpass	29	SENT_65	[p2l1562t2143r1594b2167],
29	explained	VBN	O	explain	dep	11	SENT_65	[p2l243t2181r375b2212],
30	by	IN	O	by	_	0	SENT_65	[p2l390t2181r422b2212],
31	vaccine	NN	O	vaccine	nn	32	SENT_65	[p2l433t2181r665b2209],
32	—	NN	O	—	agent	29	SENT_65	[p2l433t2181r665b2209],
33	induced	VBD	O	induce	advcl	38	SENT_65	[p2l433t2181r665b2209],
34	,	,	O	,	_	0	SENT_65	[p2l433t2181r665b2209],
35	HIV-specific	JJ	O	hiv-specific	amod	37	SENT_65	[p2l679t2181r837b2212],
36	enhancer	NN	O	enhancer	nn	37	SENT_65	[p2l850t2181r978b2205],
37	cells	NNS	O	cell	nsubj	38	SENT_65	[p2l990t2181r1047b2205],
38	(	VBP	O	(	dep	50	SENT_65	[p2l1061t2182r1111b2209],
39	EC	NNP	ORGANIZATION	EC	dobj	38	SENT_65	[p2l1061t2182r1111b2209],
40	)	CD	NUMBER	)	num	39	SENT_65	[p2l1061t2182r1111b2209],
41	promoting	VBG	O	promote	partmod	39	SENT_65	[p2l1126t2182r1271b2212],
42	virus	NN	O	virus	dobj	41	SENT_65	[p2l1284t2182r1348b2205],
43	spread	VBN	O	spread	partmod	42	SENT_65	[p2l1361t2181r1451b2212],
44	by	IN	O	by	_	0	SENT_65	[p2l1466t2181r1498b2212],
45	acting	VBG	O	act	agent	43	SENT_65	[p2l1510t2182r1593b2212],
46	on	IN	O	on	_	0	SENT_65	[p2l243t2225r276b2242],
47	secondary	JJ	O	secondary	amod	49	SENT_65	[p2l288t2218r428b2249],
48	target	NN	O	target	nn	49	SENT_65	[p2l436t2222r519b2249],
49	cells	NNS	O	cell	prep_on	45	SENT_65	[p2l529t2218r586b2242],
50	(	VBP	O	(	_	0	SENT_65	[p2l597t2219r629b2246],
51	2	CD	NUMBER	2	number	52	SENT_65	[p2l597t2219r629b2246],
52	)	CD	NUMBER	)	num	54	SENT_65	[p2l597t2219r629b2246],
53	and/or	IN	O	and/or	quantmod	54	SENT_65	[p2l640t2218r731b2243],
54	a	DT	O	a	npadvmod	55	SENT_65	[p2l740t2225r753b2242],
55	localized	JJ	O	localized	amod	56	SENT_65	[p2l765t2218r882b2242],
56	nidus	NN	O	nidus	dobj	50	SENT_65	[p2l894t2218r967b2242],
57	of	IN	O	of	_	0	SENT_65	[p2l977t2218r1005b2242],
58	infection	NN	O	infection	prep_of	56	SENT_65	[p2l1013t2218r1132b2242],
59	in	IN	O	in	_	0	SENT_65	[p2l1143t2219r1165b2242],
60	the	DT	O	the	det	63	SENT_65	[p2l1175t2218r1220b2242],
61	draining	VBG	O	drain	amod	63	SENT_65	[p2l1230t2218r1342b2249],
62	lymph	NN	O	lymph	nn	63	SENT_65	[p2l1354t2218r1438b2249],
63	node	NN	O	node	prep_in	58	SENT_65	[p2l1450t2218r1519b2242],
64	(	CD	NUMBER	(	num	66	SENT_65	[p2l1529t2219r1569b2246],
65	3	CD	NUMBER	3	amod	66	SENT_65	[p2l1529t2219r1569b2246],
66	)	NN	O	)	nsubj	50	SENT_65	[p2l1529t2219r1569b2246],
67	.	.	O	.	_	0	SENT_65	[p2l1529t2219r1569b2246],

1	If	IN	O	if	mark	6	SENT_66	[p2l1580t2218r1596b2242],
2	the	DT	O	the	det	4	SENT_66	[p2l242t2256r287b2280],
3	enhancer	NN	O	enhancer	nn	4	SENT_66	[p2l299t2256r427b2280],
4	cells	NNS	O	cell	nsubj	6	SENT_66	[p2l437t2256r495b2280],
5	indeed	RB	O	indeed	advmod	6	SENT_66	[p2l508t2256r600b2280],
6	increase	VBP	O	increase	advcl	25	SENT_66	[p2l613t2257r724b2280],
7	the	DT	O	the	det	8	SENT_66	[p2l735t2256r780b2280],
8	number	NN	O	number	dobj	6	SENT_66	[p2l792t2256r900b2280],
9	of	IN	O	of	_	0	SENT_66	[p2l911t2256r939b2280],
10	established	JJ	O	established	amod	12	SENT_66	[p2l948t2256r1103b2280],
11	HIV	NN	MISC	hiv	nn	12	SENT_66	[p2l1117t2257r1162b2280],
12	infections	NNS	O	infection	prep_of	8	SENT_66	[p2l1174t2256r1306b2280],
13	by	IN	O	by	_	0	SENT_66	[p2l1319t2256r1351b2287],
14	acting	VBG	O	act	prepc_by	6	SENT_66	[p2l1362t2257r1445b2287],
15	at	IN	O	at	_	0	SENT_66	[p2l1458t2260r1483b2280],
16	stage	NN	O	stage	prep_at	14	SENT_66	[p2l1495t2260r1568b2287],
17	2	CD	NUMBER	2	num	16	SENT_66	[p2l1580t2258r1594b2280],
18	or	CC	O	or	_	0	SENT_66	[p2l243t2300r271b2317],
19	3	CD	NUMBER	3	num	16	SENT_66	[p2l287t2295r308b2321],
20	,	,	O	,	_	0	SENT_66	[p2l287t2295r308b2321],
21	early	RB	O	early	advmod	23	SENT_66	[p2l325t2293r390b2324],
22	HIV	NN	O	hiv	nn	23	SENT_66	[p2l408t2294r453b2317],
23	infections	NNS	O	infection	nsubj	25	SENT_66	[p2l470t2293r603b2317],
24	must	MD	O	must	aux	25	SENT_66	[p2l620t2297r688b2317],
25	resolve	VB	O	resolve	_	0	SENT_66	[p2l706t2293r801b2317],
26	spontaneously	RB	O	spontaneously	advmod	25	SENT_66	[p2l818t2293r1020b2324],
27	in	IN	O	in	_	0	SENT_66	[p2l1037t2294r1058b2317],
28	the	DT	O	the	det	29	SENT_66	[p2l1076t2293r1120b2317],
29	absence	NN	O	absence	prep_in	25	SENT_66	[p2l1137t2293r1249b2317],
30	of	IN	O	of	_	0	SENT_66	[p2l1266t2293r1294b2317],
31	the	DT	O	the	det	33	SENT_66	[p2l1308t2293r1353b2317],
32	vaccine	NN	O	vaccine	nn	33	SENT_66	[p2l1369t2293r1593b2317],
33	—	NN	O	—	prep_of	29	SENT_66	[p2l1369t2293r1593b2317],
34	induced	VBD	O	induce	partmod	33	SENT_66	[p2l1369t2293r1593b2317],
35	enhancer	NN	O	enhancer	nn	36	SENT_66	[p2l243t2330r371b2354],
36	cells	NNS	O	cell	dobj	34	SENT_66	[p2l383t2330r448b2354],
37	.	.	O	.	_	0	SENT_66	[p2l383t2330r448b2354],

1	An	DT	O	a	det	4	SENT_67	[p2l460t2331r495b2354],
2	approximate	JJ	O	approximate	amod	4	SENT_67	[p2l509t2331r684b2361],
3	2-fold	JJ	O	2-fold	amod	4	SENT_67	[p2l697t2330r775b2354],
4	increase	NN	O	increase	nsubj	22	SENT_67	[p2l789t2331r900b2354],
5	in	IN	O	in	_	0	SENT_67	[p2l913t2331r935b2354],
6	the	DT	O	the	det	7	SENT_67	[p2l948t2330r993b2354],
7	incidence	NN	O	incidence	prep_in	4	SENT_67	[p2l1006t2330r1136b2354],
8	of	IN	O	of	_	0	SENT_67	[p2l1149t2330r1177b2354],
9	seropositive	JJ	O	seropositive	amod	11	SENT_67	[p2l1188t2331r1353b2361],
10	HIV	NN	MISC	hiv	nn	11	SENT_67	[p2l1367t2331r1413b2354],
11	infections	NNS	O	infection	prep_of	7	SENT_67	[p2l1425t2330r1557b2354],
12	in	IN	O	in	_	0	SENT_67	[p2l1571t2331r1593b2354],
13	the	DT	O	the	det	15	SENT_67	[p2l242t2367r287b2391],
14	vaccine	NN	O	vaccine	nn	15	SENT_67	[p2l298t2368r401b2391],
15	subgroup	NN	O	subgroup	prep_in	11	SENT_67	[p2l414t2367r547b2398],
16	compared	VBN	O	compare	_	0	SENT_67	[p2l559t2367r697b2398],
17	to	TO	O	to	prepc_compared_to	15	SENT_67	[p2l710t2371r737b2391],
18	the	DT	O	the	det	20	SENT_67	[p2l749t2367r794b2391],
19	placebo	NN	O	placebo	nn	20	SENT_67	[p2l807t2367r915b2398],
20	subgroup	NN	O	subgroup	pobj	15	SENT_67	[p2l927t2367r1060b2398],
21	therefore	RB	O	therefore	advmod	22	SENT_67	[p2l1072t2367r1199b2391],
22	suggests	VBZ	O	suggest	_	0	SENT_67	[p2l1212t2371r1332b2398],
23	that	IN	O	that	complm	29	SENT_67	[p2l1343t2367r1399b2391],
24	less	JJR	O	less	quantmod	26	SENT_67	[p2l1412t2367r1459b2391],
25	than	IN	O	than	quantmod	26	SENT_67	[p2l1470t2367r1531b2391],
26	half	NN	O	half	nsubj	29	SENT_67	[p2l1546t2367r1596b2391],
27	of	IN	O	of	_	0	SENT_67	[p2l243t2405r271b2429],
28	all	DT	O	all	prep_of	26	SENT_67	[p2l282t2405r310b2429],
29	stage	NN	O	stage	ccomp	22	SENT_67	[p2l325t2409r398b2436],
30	2	CD	NUMBER	2	num	33	SENT_67	[p2l411t2407r425b2429],
31	or	CC	O	or	_	0	SENT_67	[p2l438t2412r466b2429],
32	3	CD	NUMBER	3	conj_or	30	SENT_67	[p2l479t2407r492b2429],
33	infections	NNS	O	infection	dobj	29	SENT_67	[p2l507t2405r639b2429],
34	in	IN	O	in	_	0	SENT_67	[p2l653t2406r675b2429],
35	the	DT	O	the	det	38	SENT_67	[p2l689t2405r734b2429],
36	placebo	NN	O	placebo	nn	38	SENT_67	[p2l748t2405r855b2436],
37	subgroup	NN	O	subgroup	nn	38	SENT_67	[p2l869t2405r1002b2436],
38	progress	NN	O	progress	prep_in	33	SENT_67	[p2l1016t2412r1133b2436],
39	to	TO	O	to	_	0	SENT_67	[p2l1145t2409r1173b2429],
40	established	VBN	O	establish	amod	41	SENT_67	[p2l1186t2405r1341b2429],
41	infections	NNS	O	infection	prep_to	38	SENT_67	[p2l1355t2405r1495b2429],
42	.	.	O	.	_	0	SENT_67	[p2l1355t2405r1495b2429],

1	doi	FW	O	doi	_	0	SENT_68	[p2l243t2442r777b2473],
2	:10.1371	CD	NUMBER	:10.1371	dep	1	SENT_68	[p2l243t2442r777b2473],
3	/	:	O	/	punct	5	SENT_68	[p2l243t2442r777b2473],
4	journa	NN	O	journa	nn	5	SENT_68	[p2l243t2442r777b2473],
5	|	NN	O	|	dep	2	SENT_68	[p2l243t2442r777b2473],
6	.	.	O	.	_	0	SENT_68	[p2l243t2442r777b2473],

1	ppat	NN	O	ppat	_	0	SENT_69	[p2l243t2442r777b2473],
2	.1000114	CD	NUMBER	.1000114	dep	1	SENT_69	[p2l243t2442r777b2473],
3	.	.	O	.	_	0	SENT_69	[p2l243t2442r777b2473],

1	g001	NN	O	g001	_	0	SENT_70	[p2l243t2442r777b2473],

1	return	NN	O	return	_	0	SENT_71	[p2l243t2543r335b2563],
2	to	TO	O	to	_	0	SENT_71	[p2l348t2543r375b2563],
3	baseline	NN	O	baseline	nn	4	SENT_71	[p2l388t2537r506b2563],
4	levels	NNS	O	level	prep_to	1	SENT_71	[p2l519t2537r597b2563],
5	within	IN	O	within	_	0	SENT_71	[p2l609t2537r703b2563],
6	3	CD	DURATION	3	number	8	SENT_71	[p2l717t2537r732b2563],
7	to	TO	DURATION	to	dep	8	SENT_71	[p2l745t2543r773b2563],
8	7	CD	DURATION	7	num	9	SENT_71	[p2l788t2538r801b2563],
9	days	NNS	NUMBER	day	prep_within	1	SENT_71	[p2l816t2537r880b2571],
10	[	RB	O	[	advmod	12	SENT_71	[p2l247t2581r293b2615],
11	6	CD	NUMBER	6	num	12	SENT_71	[p2l247t2581r293b2615],
12	]	NN	O	]	rcmod	9	SENT_71	[p2l247t2581r293b2615],
13	.	.	O	.	_	0	SENT_71	[p2l247t2581r293b2615],

1	However	RB	O	however	advmod	33	SENT_72	[p2l318t2581r462b2613],
2	,	,	O	,	_	0	SENT_72	[p2l318t2581r462b2613],
3	since	IN	O	since	mark	16	SENT_72	[p2l486t2581r557b2607],
4	the	DT	O	the	det	7	SENT_72	[p2l581t2581r626b2607],
5	increased	VBN	O	increase	amod	7	SENT_72	[p2l649t2581r789b2607],
6	HIV	NN	MISC	hiv	nn	7	SENT_72	[p2l812t2581r881b2607],
7	incidence	NN	O	incidence	nsubj	16	SENT_72	[p2l243t2626r383b2652],
8	in	IN	O	in	_	0	SENT_72	[p2l406t2626r433b2651],
9	the	DT	O	the	det	11	SENT_72	[p2l456t2626r500b2652],
10	vaccine	NN	O	vaccine	nn	11	SENT_72	[p2l522t2626r633b2652],
11	subgroup	NN	O	subgroup	prep_in	7	SENT_72	[p2l657t2626r794b2660],
12	with	IN	O	with	_	0	SENT_72	[p2l816t2626r880b2652],
13	pre-existing	JJ	O	pre-existing	amod	15	SENT_72	[p2l242t2670r417b2704],
14	adenoviral	JJ	O	adenoviral	amod	15	SENT_72	[p2l429t2670r585b2696],
15	immunity	NN	O	immunity	prep_with	11	SENT_72	[p2l598t2670r743b2704],
16	seems	VBZ	O	seem	advcl	33	SENT_72	[p2l755t2679r840b2696],
17	to	TO	O	to	aux	18	SENT_72	[p2l852t2676r880b2696],
18	persist	VB	O	persist	xcomp	16	SENT_72	[p2l242t2713r336b2747],
19	for	IN	O	for	_	0	SENT_72	[p2l369t2713r411b2739],
20	at	IN	DURATION	at	advmod	23	SENT_72	[p2l445t2719r471b2739],
21	least	JJS	DURATION	least	pobj	20	SENT_72	[p2l504t2713r570b2739],
22	a	DT	DURATION	a	det	23	SENT_72	[p2l603t2722r619b2738],
23	year	NN	DURATION	year	prep_for	18	SENT_72	[p2l651t2722r716b2747],
24	[	RB	O	[	advmod	26	SENT_72	[p2l753t2713r800b2747],
25	4	CD	NUMBER	4	num	26	SENT_72	[p2l753t2713r800b2747],
26	]	NN	O	]	rcmod	23	SENT_72	[p2l753t2713r800b2747],
27	,	,	O	,	_	0	SENT_72	[p2l753t2713r800b2747],
28	the	DT	O	the	det	31	SENT_72	[p2l835t2713r880b2739],
29	immediate	JJ	O	immediate	amod	31	SENT_72	[p2l243t2758r399b2784],
30	innate	JJ	O	innate	amod	31	SENT_72	[p2l420t2758r511b2784],
31	response	NN	O	response	nsubj	33	SENT_72	[p2l531t2767r658b2792],
32	is	VBZ	O	be	cop	33	SENT_72	[p2l678t2758r698b2784],
33	unlikely	JJ	O	unlikely	_	0	SENT_72	[p2l717t2758r834b2792],
34	to	TO	O	to	aux	36	SENT_72	[p2l852t2764r880b2784],
35	be	VB	O	be	cop	36	SENT_72	[p2l243t2802r276b2828],
36	responsible	JJ	O	responsible	xcomp	33	SENT_72	[p2l289t2802r453b2836],
37	for	IN	O	for	_	0	SENT_72	[p2l466t2802r508b2828],
38	the	DT	O	the	det	40	SENT_72	[p2l519t2802r564b2828],
39	observed	VBN	O	observe	amod	40	SENT_72	[p2l577t2802r709b2828],
40	increase	NN	O	increase	prep_for	36	SENT_72	[p2l721t2802r840b2828],
41	in	IN	O	in	_	0	SENT_72	[p2l853t2802r880b2827],
42	susceptibility	NN	O	susceptibility	prep_in	40	SENT_72	[p2l243t2846r433b2880],
43	to	TO	O	to	_	0	SENT_72	[p2l462t2852r490b2872],
44	HIV	NN	MISC	hiv	nn	45	SENT_72	[p2l521t2846r590b2872],
45	infection	NN	O	infection	prep_to	36	SENT_72	[p2l619t2846r748b2872],
46	in	IN	O	in	_	0	SENT_72	[p2l778t2846r805b2871],
47	the	DT	O	the	det	49	SENT_72	[p2l835t2846r880b2872],
48	vaccine	NN	O	vaccine	nn	49	SENT_72	[p2l242t2890r352b2916],
49	subgroup	NN	O	subgroup	prep_in	45	SENT_72	[p2l368t2890r514b2924],
50	.	.	O	.	_	0	SENT_72	[p2l368t2890r514b2924],

1	Injection	NN	O	injection	nsubj	13	SENT_73	[p2l530t2890r662b2924],
2	of	IN	O	of	_	0	SENT_73	[p2l677t2890r709b2916],
3	the	DT	O	the	det	5	SENT_73	[p2l718t2890r763b2916],
4	adenoviral	JJ	O	adenoviral	amod	5	SENT_73	[p2l779t2890r880b2916, p2l242t2934r308b2960],
5	particle	NN	O	particle	prep_of	1	SENT_73	[p2l331t2934r442b2968],
6	into	IN	O	into	_	0	SENT_73	[p2l467t2934r523b2960],
7	individuals	NNS	O	individual	prep_into	5	SENT_73	[p2l548t2934r708b2960],
8	with	IN	O	with	_	0	SENT_73	[p2l732t2934r797b2960],
9	preexisting	VBG	O	preexist	prepc_with	7	SENT_73	[p2l820t2943r880b2968, p2l243t2978r356b3012],
10	adenoviral	JJ	O	adenoviral	amod	11	SENT_73	[p2l370t2978r526b3004],
11	immunity	NN	O	immunity	dobj	9	SENT_73	[p2l541t2978r686b3012],
12	also	RB	O	also	advmod	9	SENT_73	[p2l700t2978r755b3004],
13	raises	VBZ	O	raise	_	0	SENT_73	[p2l770t2978r850b3004],
14	a	DT	O	a	det	16	SENT_73	[p2l865t2987r881b3003],
15	recall	NN	O	recall	nn	16	SENT_73	[p2l243t3022r323b3048],
16	response	NN	O	response	dobj	13	SENT_73	[p2l350t3031r486b3056],
17	,	,	O	,	_	0	SENT_73	[p2l350t3031r486b3056],
18	including	VBG	O	include	_	0	SENT_73	[p2l515t3022r654b3056],
19	activation	NN	O	activation	prep_including	16	SENT_73	[p2l681t3022r826b3048],
20	of	IN	O	of	prep	19	SENT_73	[p2l854t3022r886b3048],

1	Y	NN	O	y	nn	2	SENT_74	[p2l242t3124r316b3183],
2	PLoS	NN	O	plo	nsubj	3	SENT_74	[p2l344t3144r408b3167],
3	Pathogens	VBD	O	pathogen	_	0	SENT_74	[p2l423t3143r567b3174],
4	|	CD	NUMBER	|	num	5	SENT_74	[p2l587t3142r590b3175],
5	www	NN	O	www	dobj	3	SENT_74	[p2l610t3143r949b3174],
6	.	.	O	.	_	0	SENT_74	[p2l610t3143r949b3174],

1	p	NN	O	p	nn	3	SENT_75	[p2l610t3143r949b3174],
2	|	CD	NUMBER	|	num	3	SENT_75	[p2l610t3143r949b3174],
3	ospathogens.org	NN	O	ospathogens.org	_	0	SENT_75	[p2l610t3143r949b3174],
4	adenovirus-specific	JJ	O	adenovirus-specific	amod	5	SENT_75	[p2l957t2537r1239b2571],
5	CD4	NN	O	cd4	dep	3	SENT_75	[p2l1260t2537r1352b2563],
6	+	CC	O	+	_	0	SENT_75	[p2l1260t2537r1352b2563],
7	T	NN	O	t	nn	8	SENT_75	[p2l1371t2537r1396b2562],
8	cells	NNS	O	cell	dep	3	SENT_75	[p2l1416t2537r1484b2563],
9	.	.	O	.	_	0	SENT_75	[p2l1416t2537r1484b2563],

1	These	DT	O	these	nsubj	2	SENT_76	[p2l1505t2537r1594b2563],
2	activated	VBN	O	activate	_	0	SENT_76	[p2l957t2581r1091b2607],
3	CD4	NN	O	cd4	nn	6	SENT_76	[p2l1115t2581r1207b2607],
4	+	CC	O	+	_	0	SENT_76	[p2l1115t2581r1207b2607],
5	T	NN	O	t	conj_+	3	SENT_76	[p2l1231t2581r1255b2606],
6	cells	NNS	O	cell	dobj	2	SENT_76	[p2l1279t2581r1339b2607],
7	could	MD	O	could	aux	8	SENT_76	[p2l1364t2581r1445b2607],
8	serve	VB	O	serve	rcmod	6	SENT_76	[p2l1469t2590r1541b2607],
9	as	IN	O	as	_	0	SENT_76	[p2l1567t2590r1594b2607],
10	additional	JJ	O	additional	amod	12	SENT_76	[p2l957t2626r1106b2652],
11	target	NN	O	target	nn	12	SENT_76	[p2l1133t2631r1219b2660],
12	cells	NNS	O	cell	prep_as	8	SENT_76	[p2l1245t2626r1305b2652],
13	for	IN	O	for	_	0	SENT_76	[p2l1331t2626r1373b2652],
14	HIV	NN	O	hiv	prep_for	12	SENT_76	[p2l1400t2626r1469b2652],
15	in	IN	O	in	_	0	SENT_76	[p2l1495t2626r1522b2651],
16	the	DT	O	the	det	18	SENT_76	[p2l1549t2626r1594b2652],
17	lamina	NN	O	lamina	nn	18	SENT_76	[p2l956t2670r1059b2695],
18	propria	NN	O	proprium	prep_in	8	SENT_76	[p2l1086t2670r1197b2704],
19	and	CC	O	and	_	0	SENT_76	[p2l1225t2670r1281b2696],
20	therefore	RB	O	therefore	advmod	21	SENT_76	[p2l1308t2670r1441b2696],
21	enhance	VBP	O	enhance	conj_and	8	SENT_76	[p2l1471t2670r1594b2696],
22	the	DT	O	the	det	23	SENT_76	[p2l957t2713r1002b2739],
23	risk	NN	O	risk	dobj	21	SENT_76	[p2l1016t2713r1068b2739],
24	of	IN	O	of	_	0	SENT_76	[p2l1082t2713r1114b2739],
25	HIV	NN	MISC	hiv	nn	26	SENT_76	[p2l1122t2713r1192b2739],
26	infection	NN	O	infection	prep_of	23	SENT_76	[p2l1205t2713r1341b2739],
27	.	.	O	.	_	0	SENT_76	[p2l1205t2713r1341b2739],

1	However	RB	O	however	advmod	20	SENT_77	[p2l1357t2713r1501b2745],
2	,	,	O	,	_	0	SENT_77	[p2l1357t2713r1501b2745],
3	given	VBN	O	give	prep	20	SENT_77	[p2l1516t2713r1594b2747],
4	the	DT	O	the	det	6	SENT_77	[p2l957t2758r1002b2784],
5	vast	JJ	O	vast	amod	6	SENT_77	[p2l1014t2763r1072b2784],
6	amount	NN	O	amount	dep	3	SENT_77	[p2l1084t2763r1199b2784],
7	of	IN	O	of	_	0	SENT_77	[p2l1212t2758r1243b2784],
8	antigens	NNS	O	antigen	prep_of	6	SENT_77	[p2l1251t2758r1373b2792],
9	and	CC	O	and	_	0	SENT_77	[p2l1386t2758r1441b2784],
10	infections	NNS	O	infection	prep_of	6	SENT_77	[p2l1453t2758r1594b2784],
11	humans	NNS	O	human	nsubjpass	14	SENT_77	[p2l957t2802r1074b2828],
12	are	VBP	O	be	auxpass	14	SENT_77	[p2l1097t2811r1142b2828],
13	continuously	RB	O	continuously	advmod	14	SENT_77	[p2l1164t2802r1354b2836],
14	exposed	VBN	O	expose	rcmod	6	SENT_77	[p2l1376t2802r1495b2836],
15	to	TO	O	to	prep	14	SENT_77	[p2l1516t2808r1552b2834],
16	,	,	O	,	_	0	SENT_77	[p2l1516t2808r1552b2834],
17	it	PRP	O	it	nsubj	20	SENT_77	[p2l1576t2802r1595b2828],
18	seems	VBZ	O	seem	cop	20	SENT_77	[p2l957t2855r1042b2872],
19	highly	RB	O	highly	advmod	20	SENT_77	[p2l1063t2846r1155b2880],
20	unlikely	JJ	O	unlikely	_	0	SENT_77	[p2l1174t2846r1291b2880],
21	that	IN	O	that	complm	30	SENT_77	[p2l1310t2846r1368b2872],
22	intramuscular	JJ	O	intramuscular	amod	23	SENT_77	[p2l1387t2846r1595b2872],
23	injection	NN	O	injection	nsubj	30	SENT_77	[p2l957t2890r1085b2924],
24	of	IN	O	of	_	0	SENT_77	[p2l1109t2890r1141b2916],
25	the	DT	O	the	det	27	SENT_77	[p2l1159t2890r1204b2916],
26	adenoviral	JJ	O	adenoviral	amod	27	SENT_77	[p2l1229t2890r1385b2916],
27	particle	NN	O	particle	prep_of	23	SENT_77	[p2l1408t2890r1518b2924],
28	can	MD	O	can	aux	30	SENT_77	[p2l1543t2899r1594b2916],
29	notably	RB	O	notably	advmod	30	SENT_77	[p2l957t2934r1069b2968],
30	raise	VB	O	raise	ccomp	20	SENT_77	[p2l1090t2934r1156b2960],
31	the	DT	O	the	det	32	SENT_77	[p2l1179t2934r1224b2960],
32	number	NN	O	number	dobj	30	SENT_77	[p2l1247t2934r1364b2960],
33	of	IN	O	of	_	0	SENT_77	[p2l1386t2934r1418b2960],
34	susceptible	JJ	O	susceptible	amod	35	SENT_77	[p2l1435t2934r1593b2968],
35	CD4	NN	O	cd4	prep_of	32	SENT_77	[p2l958t2978r1050b3004],
36	+	CC	O	+	_	0	SENT_77	[p2l958t2978r1050b3004],
37	T	NN	O	t	nn	38	SENT_77	[p2l1063t2978r1087b3003],
38	cells	NNS	O	cell	dobj	30	SENT_77	[p2l1100t2978r1161b3004],
39	in	IN	O	in	_	0	SENT_77	[p2l1174t2978r1202b3003],
40	the	DT	O	the	det	45	SENT_77	[p2l1215t2978r1260b3004],
41	rectal	JJ	O	rectal	amod	45	SENT_77	[p2l1273t2978r1355b3004],
42	or	CC	O	or	_	0	SENT_77	[p2l1368t2987r1399b3004],
43	male	JJ	O	male	conj_or	41	SENT_77	[p2l1411t2978r1482b3004],
44	genital	JJ	O	genital	amod	45	SENT_77	[p2l1496t2978r1595b3012],
45	mucosa	NN	O	mucosa	prep_in	38	SENT_77	[p2l957t3031r1070b3048],
46	above	IN	O	above	_	0	SENT_77	[p2l1099t3022r1185b3048],
47	their	PRP$	O	they	poss	50	SENT_77	[p2l1215t3022r1284b3048],
48	pre-existing	JJ	O	pre-existing	amod	50	SENT_77	[p2l1311t3022r1486b3056],
49	background	NN	O	background	nn	50	SENT_77	[p2l1514t3022r1594b3048, p2l1671t256r1778b290],
50	level	NN	O	level	prep_above	45	SENT_77	[p2l1807t256r1874b282],
51	for	IN	O	for	_	0	SENT_77	[p2l1903t256r1944b282],
52	an	DT	O	a	det	54	SENT_77	[p2l1974t265r2009b281],
53	extended	JJ	O	extended	amod	54	SENT_77	[p2l2040t256r2175b282],
54	period	NN	O	period	prep_for	30	SENT_77	[p2l2203t256r2306b290],
55	.	.	O	.	_	0	SENT_77	[p2l2203t256r2306b290],

1	Another	DT	O	another	det	2	SENT_78	[p2l1670t300r1794b326],
2	argument	NN	O	argument	nsubj	6	SENT_78	[p2l1810t305r1953b334],
3	against	IN	O	against	_	0	SENT_78	[p2l1969t300r2072b334],
4	this	DT	O	this	det	5	SENT_78	[p2l2087t300r2138b326],
5	hypothesis	NN	O	hypothesis	prep_against	2	SENT_78	[p2l2153t300r2308b334],
6	is	VBZ	O	be	_	0	SENT_78	[p2l1671t343r1691b369],
7	that	IN	O	that	complm	21	SENT_78	[p2l1721t343r1779b369],
8	the	DT	O	the	det	9	SENT_78	[p2l1809t343r1854b369],
9	percentage	NN	O	percentage	nsubj	21	SENT_78	[p2l1884t348r2046b377],
10	of	IN	O	of	_	0	SENT_78	[p2l2078t343r2110b369],
11	adenovirusspeciﬁc	JJ	O	adenovirusspeciﬁc	amod	12	SENT_78	[p2l2135t343r2308b369, p2l1671t387r1778b421],
12	CD4	NN	O	cd4	prep_of	9	SENT_78	[p2l1799t387r1892b413],
13	+	CC	O	+	_	0	SENT_78	[p2l1799t387r1892b413],
14	T	NN	O	t	nn	15	SENT_78	[p2l1912t387r1936b412],
15	cells	NNS	O	cell	conj_+	12	SENT_78	[p2l1957t387r2017b413],
16	in	IN	O	in	_	0	SENT_78	[p2l2038t387r2065b412],
17	the	DT	O	the	det	18	SENT_78	[p2l2085t387r2130b413],
18	blood	NN	O	blood	prep_in	15	SENT_78	[p2l2151t387r2235b413],
19	was	VBD	O	be	cop	21	SENT_78	[p2l2254t396r2308b413],
20	actually	RB	O	actually	advmod	21	SENT_78	[p2l1671t431r1786b465],
21	lower	JJR	O	lower	ccomp	6	SENT_78	[p2l1811t431r1894b457],
22	in	IN	O	in	_	0	SENT_78	[p2l1920t431r1947b456],
23	the	DT	O	the	det	24	SENT_78	[p2l1974t431r2018b457],
24	group	NN	O	group	prep_in	21	SENT_78	[p2l2045t440r2132b465],
25	with	IN	O	with	_	0	SENT_78	[p2l2158t431r2222b457],
26	preexisting	VBG	O	preexist	prepc_with	21	SENT_78	[p2l2248t440r2308b465, p2l1671t475r1784b509],
27	immunity	NN	O	immunity	dobj	26	SENT_78	[p2l1797t475r1942b509],
28	to	TO	O	to	_	0	SENT_78	[p2l1955t480r1982b501],
29	adenovirus	NN	O	adenovirus	nn	30	SENT_78	[p2l1998t475r2159b501],
30	[	NN	O	[	prep_to	26	SENT_78	[p2l2178t475r2224b509],
31	3	CD	NUMBER	3	num	32	SENT_78	[p2l2178t475r2224b509],
32	]	NN	O	]	dep	30	SENT_78	[p2l2178t475r2224b509],
33	.	.	O	.	_	0	SENT_78	[p2l2178t475r2224b509],

1	Thus	RB	O	thus	advmod	6	SENT_79	[p2l1708t520r1793b552],
2	,	,	O	,	_	0	SENT_79	[p2l1708t520r1793b552],
3	it	PRP	O	it	nsubj	6	SENT_79	[p2l1805t520r1824b546],
4	seems	VBZ	O	seem	cop	6	SENT_79	[p2l1834t529r1919b546],
5	more	RBR	O	more	advmod	6	SENT_79	[p2l1931t529r2007b546],
6	plausible	JJ	O	plausible	_	0	SENT_79	[p2l2018t520r2148b554],
7	that	IN	O	that	complm	15	SENT_79	[p2l2160t520r2218b546],
8	HIVinfected	JJ	O	hivinfected	amod	9	SENT_79	[p2l2228t520r2308b546, p2l1671t564r1788b590],
9	cells	NNS	O	cell	nsubj	15	SENT_79	[p2l1807t564r1867b590],
10	or	CC	O	or	_	0	SENT_79	[p2l1888t573r1918b590],
11	HIV	NN	MISC	hiv	nn	14	SENT_79	[p2l1937t564r2007b590],
12	antigen	NN	O	antigen	nn	14	SENT_79	[p2l2026t564r2135b598],
13	presenting	NN	O	presenting	nn	14	SENT_79	[p2l2154t564r2309b598],
14	cells	NNS	O	cell	conj_or	9	SENT_79	[p2l1671t608r1731b634],
15	(	VBP	O	(	ccomp	6	SENT_79	[p2l1749t608r1842b642],
16	stages	NNS	O	stage	nsubj	24	SENT_79	[p2l1749t608r1842b642],
17	2	CD	NUMBER	2	num	16	SENT_79	[p2l1860t608r1874b635],
18	and	CC	O	and	_	0	SENT_79	[p2l1893t608r1948b634],
19	3	CD	NUMBER	3	conj_and	16	SENT_79	[p2l1965t608r1979b634],
20	in	IN	O	in	_	0	SENT_79	[p2l1997t608r2024b633],
21	Figure	NNP	O	Figure	prep_in	16	SENT_79	[p2l2041t608r2135b642],
22	l	NN	O	l	tmod	24	SENT_79	[p2l2157t608r2177b642],
23	)	CD	NUMBER	)	nsubj	24	SENT_79	[p2l2157t608r2177b642],
24	activate	VBP	O	activate	ccomp	15	SENT_79	[p2l2195t608r2307b634],
25	vaccine	NN	O	vaccine	nn	26	SENT_79	[p2l1670t652r1921b684],
26	—	NN	O	—	nsubj	27	SENT_79	[p2l1670t652r1921b684],
27	induced	VBD	O	induce	ccomp	24	SENT_79	[p2l1670t652r1921b684],
28	,	,	O	,	_	0	SENT_79	[p2l1670t652r1921b684],
29	HIV-speciﬁc	JJ	O	hiv-speciﬁc	dep	27	SENT_79	[p2l1943t652r2132b686],
30	T	NN	O	t	nn	31	SENT_79	[p2l2153t652r2178b677],
31	cells	NNS	O	cell	dep	29	SENT_79	[p2l2199t652r2259b678],
32	in	IN	O	in	_	0	SENT_79	[p2l2281t652r2308b677],
33	the	DT	O	the	det	35	SENT_79	[p2l1671t696r1715b722],
34	lamina	NN	O	lamina	nn	35	SENT_79	[p2l1729t696r1831b721],
35	propria	NN	O	proprium	prep_in	31	SENT_79	[p2l1843t696r1954b730],
36	of	IN	O	of	_	0	SENT_79	[p2l1967t696r1999b722],
37	the	DT	O	the	det	39	SENT_79	[p2l2006t696r2051b722],
38	exposed	VBN	O	expose	amod	39	SENT_79	[p2l2065t696r2184b730],
39	mucosa	NN	O	mucosa	prep_of	35	SENT_79	[p2l2196t705r2309b722],
40	or	CC	O	or	_	0	SENT_79	[p2l1671t749r1702b766],
41	in	IN	O	in	_	0	SENT_79	[p2l1726t740r1754b765],
42	its	PRP$	O	its	poss	45	SENT_79	[p2l1778t740r1809b766],
43	draining	VBG	O	drain	amod	45	SENT_79	[p2l1833t740r1959b774],
44	lymph	NN	O	lymph	nn	45	SENT_79	[p2l1982t740r2076b774],
45	node	NN	O	node	conj_or	35	SENT_79	[p2l2101t740r2181b766],
46	.	.	O	.	_	0	SENT_79	[p2l2101t740r2181b766],

1	In	IN	O	in	_	0	SENT_80	[p2l2207t740r2239b765],
2	the	DT	O	the	det	3	SENT_80	[p2l2263t740r2308b766],
3	absence	NN	O	absence	prep_in	19	SENT_80	[p2l1671t784r1786b810],
4	of	IN	O	of	_	0	SENT_80	[p2l1823t784r1855b810],
5	effective	JJ	O	effective	amod	8	SENT_80	[p2l1885t784r2005b810],
6	antiviral	JJ	O	antiviral	amod	8	SENT_80	[p2l2041t784r2163b810],
7	effector	NN	O	effector	nn	8	SENT_80	[p2l2198t784r2309b810],
8	mechanisms	NNS	O	mechanism	prep_of	3	SENT_80	[p2l1670t827r1861b859],
9	,	,	O	,	_	0	SENT_80	[p2l1670t827r1861b859],
10	these	DT	O	these	det	15	SENT_80	[p2l1879t827r1952b853],
11	activated	VBN	O	activate	amod	15	SENT_80	[p2l1970t827r2103b853],
12	HIV-speciﬁc	NN	O	hiv-speciﬁc	nn	15	SENT_80	[p2l2119t827r2308b861],
13	“	NN	O	“	nn	15	SENT_80	[p2l1672t871r1844b897],
14	enhancer	NN	O	enhancer	nn	15	SENT_80	[p2l1672t871r1844b897],
15	”	NN	O	”	appos	8	SENT_80	[p2l1672t871r1844b897],
16	T	NN	O	t	nn	17	SENT_80	[p2l1872t871r1896b896],
17	cells	NNS	O	cell	nsubj	19	SENT_80	[p2l1922t871r1983b897],
18	could	MD	O	could	aux	19	SENT_80	[p2l2009t871r2090b897],
19	favour	VB	O	favour	_	0	SENT_80	[p2l2115t871r2211b897],
20	early	JJ	O	early	amod	21	SENT_80	[p2l2237t871r2309b905],
21	spread	NN	O	spread	dobj	19	SENT_80	[p2l1671t915r1768b949],
22	of	IN	O	of	_	0	SENT_80	[p2l1782t915r1814b941],
23	the	DT	O	the	det	25	SENT_80	[p2l1822t915r1866b941],
24	HIV	NN	MISC	hiv	nn	25	SENT_80	[p2l1880t915r1950b941],
25	infection	NN	O	infection	prep_of	21	SENT_80	[p2l1962t915r2098b941],
26	.	.	O	.	_	0	SENT_80	[p2l1962t915r2098b941],

1	Whether	IN	O	whether	complm	7	SENT_81	[p2l2113t915r2245b941],
2	this	DT	O	this	nsubjpass	18	SENT_81	[p2l2257t915r2308b941],
3	is	VBZ	O	be	auxpass	7	SENT_81	[p2l1671t959r1691b985],
4	only	RB	O	only	advmod	7	SENT_81	[p2l1711t959r1775b993],
5	a	DT	O	a	det	6	SENT_81	[p2l1794t968r1810b984],
6	risk	NN	O	risk	pobj	4	SENT_81	[p2l1829t959r1881b985],
7	associated	VBN	O	associate	csubj	24	SENT_81	[p2l1900t959r2049b985],
8	with	IN	O	with	_	0	SENT_81	[p2l2067t959r2132b985],
9	adenoviral	JJ	O	adenoviral	amod	11	SENT_81	[p2l2152t959r2309b985],
10	vector	NN	O	vector	nn	11	SENT_81	[p2l1670t1008r1762b1029],
11	vaccines	NNS	O	vaccine	prep_with	7	SENT_81	[p2l1774t1003r1898b1029],
12	encoding	VBG	O	encode	xcomp	7	SENT_81	[p2l1912t1003r2048b1037],
13	HIV	NN	MISC	hiv	nn	14	SENT_81	[p2l2060t1003r2130b1029],
14	antigens	NNS	O	antigen	dobj	12	SENT_81	[p2l2143t1003r2264b1037],
15	or	CC	O	or	_	0	SENT_81	[p2l2278t1012r2309b1029],
16	is	VBZ	O	be	auxpass	18	SENT_81	[p2l1671t1047r1691b1073],
17	also	RB	O	also	advmod	18	SENT_81	[p2l1711t1047r1766b1073],
18	shared	VBN	O	share	csubj	24	SENT_81	[p2l1787t1047r1885b1073],
19	by	IN	O	by	_	0	SENT_81	[p2l1904t1047r1940b1081],
20	other	JJ	O	other	amod	22	SENT_81	[p2l1960t1047r2037b1073],
21	HIV	NN	MISC	hiv	nn	22	SENT_81	[p2l2057t1047r2126b1073],
22	vaccines	NNS	O	vaccine	agent	18	SENT_81	[p2l2144t1047r2268b1073],
23	is	VBZ	O	be	cop	24	SENT_81	[p2l2288t1047r2308b1073],
24	unclear	JJ	O	unclear	_	0	SENT_81	[p2l1670t1090r1788b1116],
25	.	.	O	.	_	0	SENT_81	[p2l1670t1090r1788b1116],

1	However	RB	O	however	advmod	13	SENT_82	[p2l1811t1090r1955b1122],
2	,	,	O	,	_	0	SENT_82	[p2l1811t1090r1955b1122],
3	two	CD	NUMBER	two	num	4	SENT_82	[p2l1977t1096r2029b1116],
4	characteristics	NNS	O	characteristic	nsubj	13	SENT_82	[p2l2051t1090r2260b1116],
5	of	IN	O	of	_	0	SENT_82	[p2l2282t1090r2314b1116],
6	the	DT	O	the	det	7	SENT_82	[p2l1671t1134r1715b1160],
7	vaccine	NN	O	vaccine	prep_of	4	SENT_82	[p2l1745t1134r1855b1160],
8	used	VBN	O	use	partmod	7	SENT_82	[p2l1885t1134r1952b1160],
9	in	IN	O	in	_	0	SENT_82	[p2l1981t1134r2008b1159],
10	the	DT	O	the	det	12	SENT_82	[p2l2038t1134r2082b1160],
11	STEP	NN	O	step	nn	12	SENT_82	[p2l2114t1134r2202b1160],
12	study	NN	O	study	prep_in	8	SENT_82	[p2l2231t1134r2309b1168],
13	suggest	VBP	O	suggest	_	0	SENT_82	[p2l1671t1184r1776b1212],
14	a	DT	O	a	det	15	SENT_82	[p2l1798t1187r1814b1203],
15	note	NN	O	note	dobj	13	SENT_82	[p2l1836t1183r1899b1204],
16	of	IN	O	of	_	0	SENT_82	[p2l1922t1178r1954b1204],
17	caution	NN	O	caution	prep_of	15	SENT_82	[p2l1971t1178r2081b1204],
18	to	TO	O	to	_	0	SENT_82	[p2l2103t1183r2130b1204],
19	premature	JJ	O	premature	amod	20	SENT_82	[p2l2152t1184r2307b1212],
20	generalization	NN	O	generalization	prep_to	13	SENT_82	[p2l1671t1222r1888b1256],
21	.	.	O	.	_	0	SENT_82	[p2l1671t1222r1888b1256],

1	First	RB	ORDINAL	first	advmod	10	SENT_83	[p2l1908t1222r1981b1254],
2	,	,	O	,	_	0	SENT_83	[p2l1908t1222r1981b1254],
3	the	DT	O	the	det	4	SENT_83	[p2l2000t1222r2044b1248],
4	enhancement	NN	O	enhancement	nsubjpass	10	SENT_83	[p2l2063t1222r2265b1248],
5	of	IN	O	of	_	0	SENT_83	[p2l2282t1222r2314b1248],
6	HIV	NN	MISC	hiv	nn	7	SENT_83	[p2l1671t1266r1740b1292],
7	infection	NN	O	infection	prep_of	4	SENT_83	[p2l1766t1266r1895b1292],
8	is	VBZ	O	be	auxpass	10	SENT_83	[p2l1922t1266r1941b1292],
9	only	RB	O	only	advmod	10	SENT_83	[p2l1969t1266r2032b1300],
10	detected	VBN	O	detect	_	0	SENT_83	[p2l2058t1266r2183b1292],
11	in	IN	O	in	_	0	SENT_83	[p2l2209t1266r2236b1291],
12	the	DT	O	the	det	13	SENT_83	[p2l2263t1266r2308b1292],
13	presence	NN	O	presence	prep_in	10	SENT_83	[p2l1670t1319r1799b1344],
14	of	IN	O	of	_	0	SENT_83	[p2l1813t1310r1845b1336],
15	pre-existing	JJ	O	pre-existing	amod	17	SENT_83	[p2l1853t1310r2027b1344],
16	adenoviral	JJ	O	adenoviral	amod	17	SENT_83	[p2l2040t1310r2197b1336],
17	immunity	NN	O	immunity	prep_of	13	SENT_83	[p2l2210t1310r2308b1336, p2l1671t1354r1734b1388],
18	.	.	O	.	_	0	SENT_83	[p2l2210t1310r2308b1336, p2l1671t1354r1734b1388],

1	Thus	RB	O	thus	advmod	9	SENT_84	[p2l1751t1354r1835b1386],
2	,	,	O	,	_	0	SENT_84	[p2l1751t1354r1835b1386],
3	the	DT	O	the	det	7	SENT_84	[p2l1853t1354r1897b1380],
4	injected	VBN	O	inject	amod	7	SENT_84	[p2l1914t1354r2030b1388],
5	adenoviral	JJ	O	adenoviral	amod	7	SENT_84	[p2l2046t1354r2202b1380],
6	vector	NN	O	vector	nn	7	SENT_84	[p2l2217t1359r2309b1380],
7	particle	NN	O	particle	nsubj	9	SENT_84	[p2l1670t1398r1780b1432],
8	might	MD	O	might	aux	9	SENT_84	[p2l1804t1398r1891b1432],
9	trigger	VB	O	trigger	_	0	SENT_84	[p2l1913t1398r2010b1432],
10	regulatory	JJ	O	regulatory	amod	11	SENT_84	[p2l2033t1398r2186b1432],
11	events	NNS	O	event	dobj	9	SENT_84	[p2l2208t1403r2307b1430],
12	,	,	O	,	_	0	SENT_84	[p2l2208t1403r2307b1430],
13	which	WDT	O	which	nsubj	17	SENT_84	[p2l1670t1441r1759b1467],
14	also	RB	O	also	advmod	15	SENT_84	[p2l1786t1441r1841b1467],
15	suppress	VBP	O	suppress	rcmod	11	SENT_84	[p2l1867t1450r1991b1475],
16	or	CC	O	or	_	0	SENT_84	[p2l2017t1450r2048b1467],
17	modulate	VBP	O	modulate	conj_or	15	SENT_84	[p2l2073t1441r2212b1467],
18	as	IN	O	as	_	0	SENT_84	[p2l2239t1450r2267b1467],
19	a	DT	O	a	det	21	SENT_84	[p2l2293t1450r2309b1466],
20	bystander	NN	O	bystander	nn	21	SENT_84	[p2l1670t1485r1816b1519],
21	effect	NN	O	effect	prep_as	15	SENT_84	[p2l1838t1485r1916b1511],
22	the	DT	O	the	det	26	SENT_84	[p2l1937t1485r1981b1511],
23	HIV-speciﬁc	JJ	O	hiv-speciﬁc	amod	26	SENT_84	[p2l2004t1485r2192b1519],
24	T	NN	O	t	nn	26	SENT_84	[p2l2214t1485r2238b1510],
25	cell	NN	O	cell	nn	26	SENT_84	[p2l2260t1485r2309b1511],
26	responses	NNS	O	response	dobj	15	SENT_84	[p2l1671t1538r1810b1563],
27	induced	VBN	O	induce	partmod	26	SENT_84	[p2l1846t1529r1965b1555],
28	by	IN	O	by	_	0	SENT_84	[p2l2000t1529r2036b1563],
29	the	DT	O	the	det	34	SENT_84	[p2l2071t1529r2115b1555],
30	adenoviral	JJ	O	adenoviral	amod	34	SENT_84	[p2l2152t1529r2309b1555],
31	vector-encoded	JJ	O	vector-encoded	amod	34	SENT_84	[p2l1670t1573r1900b1599],
32	HIV	NN	MISC	hiv	nn	34	SENT_84	[p2l1932t1573r2002b1599],
33	vaccine	NN	O	vaccine	nn	34	SENT_84	[p2l2033t1573r2143b1599],
34	antigens	NNS	O	antigen	agent	27	SENT_84	[p2l2177t1573r2306b1607],
35	.	.	O	.	_	0	SENT_84	[p2l2177t1573r2306b1607],

1	Second	RB	ORDINAL	second	advmod	10	SENT_85	[p2l1672t1617r1788b1649],
2	,	,	O	,	_	0	SENT_85	[p2l1672t1617r1788b1649],
3	the	DT	O	the	det	4	SENT_85	[p2l1800t1617r1845b1643],
4	absence	NN	O	absence	nsubj	10	SENT_85	[p2l1858t1617r1973b1643],
5	of	IN	O	of	_	0	SENT_85	[p2l1985t1617r2017b1643],
6	an	DT	O	a	det	8	SENT_85	[p2l2024t1626r2059b1642],
7	Env	NN	MISC	env	nn	8	SENT_85	[p2l2071t1617r2130b1643],
8	component	NN	O	component	prep_of	4	SENT_85	[p2l2141t1622r2309b1651],
9	might	MD	O	might	aux	10	SENT_85	[p2l1670t1661r1757b1695],
10	delay	VB	O	delay	_	0	SENT_85	[p2l1787t1661r1866b1695],
11	the	DT	O	the	dobj	10	SENT_85	[p2l1895t1661r1940b1687],
12	sensing	VBG	O	sense	amod	11	SENT_85	[p2l1971t1661r2078b1695],
13	of	IN	O	of	_	0	SENT_85	[p2l2107t1661r2139b1687],
14	the	DT	O	the	det	16	SENT_85	[p2l2164t1661r2209b1687],
15	HIV	NN	MISC	hiv	nn	16	SENT_85	[p2l2240t1661r2309b1687],
16	infection	NN	O	infection	prep_of	11	SENT_85	[p2l1671t1705r1799b1731],
17	by	IN	O	by	_	0	SENT_85	[p2l1814t1705r1850b1739],
18	antibodies	NNS	O	antibody	prep_by	10	SENT_85	[p2l1864t1705r2015b1731],
19	(	CD	NUMBER	(	dep	23	SENT_85	[p2l2031t1705r2107b1739],
20	even	RB	O	even	advmod	23	SENT_85	[p2l2031t1705r2107b1739],
21	nonneutralizing	JJ	O	nonneutralizing	amod	22	SENT_85	[p2l2122t1705r2308b1731, p2l1671t1748r1742b1782],
22	ones	NNS	O	one	nsubj	23	SENT_85	[p2l1766t1748r1839b1782],
23	)	VBP	O	)	dep	37	SENT_85	[p2l1766t1748r1839b1782],
24	at	IN	O	at	_	0	SENT_85	[p2l1865t1754r1892b1774],
25	an	DT	O	a	det	28	SENT_85	[p2l1917t1757r1952b1773],
26	early	JJ	O	early	amod	28	SENT_85	[p2l1977t1748r2049b1782],
27	infection	NN	O	infection	nn	28	SENT_85	[p2l2073t1748r2201b1774],
28	stage	NN	O	stage	prep_at	23	SENT_85	[p2l2226t1754r2307b1782],
29	,	,	O	,	_	0	SENT_85	[p2l2226t1754r2307b1782],
30	thereby	RB	O	thereby	advmod	31	SENT_85	[p2l1671t1792r1784b1826],
31	preventing	VBG	O	prevent	csubj	37	SENT_85	[p2l1801t1792r1961b1826],
32	timely	JJ	O	timely	amod	33	SENT_85	[p2l1978t1792r2070b1826],
33	recruitment	NN	O	recruitment	dobj	31	SENT_85	[p2l2088t1792r2263b1818],
34	of	IN	O	of	_	0	SENT_85	[p2l2282t1792r2314b1818],
35	vaccine	NN	O	vaccine	nn	36	SENT_85	[p2l1670t1836r1913b1862],
36	—	NN	O	—	prep_of	33	SENT_85	[p2l1670t1836r1913b1862],
37	induced	VBD	O	induce	rcmod	18	SENT_85	[p2l1670t1836r1913b1862],
38	effector	NN	O	effector	nn	39	SENT_85	[p2l1938t1836r2049b1862],
39	mechanisms	NNS	O	mechanism	dobj	37	SENT_85	[p2l2073t1836r2255b1862],
40	to	TO	O	to	_	0	SENT_85	[p2l2280t1842r2308b1862],
41	the	DT	O	the	det	44	SENT_85	[p2l1671t1880r1715b1906],
42	early	JJ	O	early	amod	44	SENT_85	[p2l1743t1880r1816b1914],
43	replication	NN	O	replication	nn	44	SENT_85	[p2l1842t1880r2000b1914],
44	sites	NNS	O	site	prep_to	37	SENT_85	[p2l2027t1880r2086b1906],
45	of	IN	O	of	_	0	SENT_85	[p2l2114t1880r2146b1906],
46	HIV	NN	O	hiv	prep_of	44	SENT_85	[p2l2168t1880r2244b1906],
47	.	.	O	.	_	0	SENT_85	[p2l2168t1880r2244b1906],

1	As	IN	O	as	mark	9	SENT_86	[p2l2271t1880r2308b1906],
2	neither	DT	O	neither	preconj	3	SENT_86	[p2l1671t1924r1776b1950],
3	humoral	JJ	O	humoral	nsubj	9	SENT_86	[p2l1806t1924r1933b1950],
4	nor	CC	O	nor	_	0	SENT_86	[p2l1964t1933r2015b1950],
5	cellular	JJ	O	cellular	amod	7	SENT_86	[p2l2046t1924r2154b1950],
6	immune	JJ	O	immune	amod	7	SENT_86	[p2l2185t1924r2308b1950],
7	responses	NNS	O	response	nsubj	9	SENT_86	[p2l1671t1977r1810b2002],
8	alone	RB	O	alone	advmod	9	SENT_86	[p2l1829t1968r1908b1994],
9	seem	VBP	O	seem	advcl	23	SENT_86	[p2l1927t1977r2001b1994],
10	to	TO	O	to	aux	12	SENT_86	[p2l2019t1974r2046b1994],
11	be	VB	O	be	cop	12	SENT_86	[p2l2064t1968r2098b1994],
12	sufficient	JJ	O	sufficient	xcomp	9	SENT_86	[p2l2118t1968r2250b1994],
13	for	IN	O	for	_	0	SENT_86	[p2l2267t1968r2309b1994],
14	protection	NN	O	protection	prep_for	12	SENT_86	[p2l1670t2011r1823b2045],
15	from	IN	O	from	_	0	SENT_86	[p2l1844t2011r1915b2037],
16	HIV	NN	MISC	hiv	prep_from	12	SENT_86	[p2l1936t2011r2013b2043],
17	,	,	O	,	_	0	SENT_86	[p2l1936t2011r2013b2043],
18	vaccines	NNS	O	vaccine	nsubj	23	SENT_86	[p2l2034t2011r2158b2037],
19	inducing	VBG	O	induce	partmod	18	SENT_86	[p2l2179t2011r2309b2045],
20	both	CC	O	both	prep	19	SENT_86	[p2l1670t2055r1738b2081],
21	effector	NN	O	effector	nn	22	SENT_86	[p2l1750t2055r1861b2081],
22	arms	NNS	O	arm	dep	20	SENT_86	[p2l1872t2064r1943b2081],
23	need	VBP	O	need	_	0	SENT_86	[p2l1955t2055r2026b2081],
24	to	TO	O	to	aux	26	SENT_86	[p2l2038t2061r2065b2081],
25	be	VB	O	be	auxpass	26	SENT_86	[p2l2077t2055r2111b2081],
26	evaluated	VBN	O	evaluate	xcomp	23	SENT_86	[p2l2124t2055r2272b2081],
27	.	.	O	.	_	0	SENT_86	[p2l2124t2055r2272b2081],

1	It	PRP	O	it	nsubj	4	SENT_87	[p2l2286t2055r2309b2081],
2	seems	VBZ	O	seem	cop	4	SENT_87	[p2l1671t2108r1756b2125],
3	too	RB	O	too	advmod	4	SENT_87	[p2l1786t2105r1832b2125],
4	early	JJ	O	early	_	0	SENT_87	[p2l1861t2099r1933b2133],
5	to	TO	O	to	aux	6	SENT_87	[p2l1961t2104r1989b2125],
6	dispense	VB	O	dispense	xcomp	4	SENT_87	[p2l2018t2099r2141b2133],
7	with	IN	O	with	_	0	SENT_87	[p2l2170t2099r2234b2125],
8	the	DT	O	the	det	9	SENT_87	[p2l2263t2099r2308b2125],
9	potential	NN	O	potential	prep_with	6	SENT_87	[p2l1670t2143r1801b2177],
10	of	IN	O	of	_	0	SENT_87	[p2l1818t2143r1850b2169],
11	adenoviral	JJ	O	adenoviral	amod	14	SENT_87	[p2l1862t2143r2019b2169],
12	vector-based	JJ	O	vector-based	amod	14	SENT_87	[p2l2034t2143r2224b2169],
13	HIV	NN	MISC	hiv	nn	14	SENT_87	[p2l2240t2143r2309b2169],
14	vaccines	NNS	O	vaccine	prep_of	9	SENT_87	[p2l1670t2187r1793b2213],
15	since	IN	O	since	mark	17	SENT_87	[p2l1814t2187r1885b2213],
16	they	PRP	O	they	nsubj	17	SENT_87	[p2l1905t2187r1968b2221],
17	are	VBP	O	be	advcl	6	SENT_87	[p2l1987t2196r2032b2213],
18	among	IN	O	among	_	0	SENT_87	[p2l2052t2196r2155b2221],
19	the	DT	O	the	det	22	SENT_87	[p2l2173t2187r2218b2213],
20	most	RBS	O	most	advmod	21	SENT_87	[p2l2238t2192r2309b2213],
21	efficient	JJ	O	efficient	amod	22	SENT_87	[p2l1671t2231r1788b2257],
22	inducers	NNS	O	inducer	prep_among	17	SENT_87	[p2l1820t2231r1944b2257],
23	of	IN	O	of	_	0	SENT_87	[p2l1978t2231r2009b2257],
24	cytotoxic	JJ	O	cytotoxic	amod	27	SENT_87	[p2l2037t2231r2170b2265],
25	T	NN	O	t	nn	27	SENT_87	[p2l2203t2231r2227b2256],
26	cell	NN	O	cell	nn	27	SENT_87	[p2l2260t2231r2309b2257],
27	responses	NNS	O	response	prep_of	22	SENT_87	[p2l1671t2284r1810b2309],
28	in	IN	O	in	_	0	SENT_87	[p2l1826t2275r1854b2300],
29	humans	NNS	O	human	prep_in	27	SENT_87	[p2l1869t2275r1986b2301],
30	and	CC	O	and	_	0	SENT_87	[p2l2002t2275r2058b2301],
31	a	DT	O	a	det	33	SENT_87	[p2l2073t2284r2089b2300],
32	large	JJ	O	large	amod	33	SENT_87	[p2l2103t2275r2175b2309],
33	number	NN	O	number	conj_and	22	SENT_87	[p2l2191t2275r2309b2301],
34	of	IN	O	of	_	0	SENT_87	[p2l1671t2319r1703b2345],
35	animal	NN	O	animal	nn	36	SENT_87	[p2l1713t2319r1814b2344],
36	models	NNS	O	model	prep_of	33	SENT_87	[p2l1827t2319r1939b2345],
37	.	.	O	.	_	0	SENT_87	[p2l1827t2319r1939b2345],

1	Whatever	WDT	O	whatever	nsubj	5	SENT_88	[p2l1707t2364r1854b2390],
2	the	DT	O	the	det	4	SENT_88	[p2l1866t2364r1910b2390],
3	precise	JJ	O	precise	amod	4	SENT_88	[p2l1922t2364r2024b2398],
4	mechanism	NN	O	mechanism	nsubj	5	SENT_88	[p2l2037t2364r2207b2390],
5	is	VBZ	O	be	_	0	SENT_88	[p2l2219t2364r2239b2390],
6	that	IN	O	that	complm	7	SENT_88	[p2l2251t2364r2309b2390],
7	led	VBN	O	lead	ccomp	5	SENT_88	[p2l1670t2408r1714b2434],
8	to	TO	O	to	_	0	SENT_88	[p2l1747t2413r1775b2434],
9	enhanced	VBN	O	enhance	amod	10	SENT_88	[p2l1809t2408r1953b2434],
10	acquisition	NN	O	acquisition	prep_to	7	SENT_88	[p2l1986t2408r2146b2442],
11	of	IN	O	of	_	0	SENT_88	[p2l2180t2408r2212b2434],
12	HIV	NN	MISC	hiv	nn	13	SENT_88	[p2l2240t2408r2309b2434],
13	infection	NN	O	infection	prep_of	10	SENT_88	[p2l1671t2452r1799b2478],
14	in	IN	O	in	_	0	SENT_88	[p2l1811t2452r1839b2477],
15	the	DT	O	the	det	19	SENT_88	[p2l1851t2452r1896b2478],
16	STEP	NN	O	step	nn	19	SENT_88	[p2l1910t2452r1998b2478],
17	study	NN	O	study	nn	19	SENT_88	[p2l2010t2452r2088b2486],
18	vaccine	NN	O	vaccine	nn	19	SENT_88	[p2l2098t2452r2209b2478],
19	group	NN	O	group	prep_in	13	SENT_88	[p2l2221t2461r2308b2486],
20	with	IN	O	with	_	0	SENT_88	[p2l1670t2495r1734b2521],
21	pre-existing	JJ	O	pre-existing	amod	23	SENT_88	[p2l1751t2495r1925b2529],
22	adenovirus	NN	O	adenovirus	nn	23	SENT_88	[p2l1941t2495r2103b2521],
23	immunity	NN	O	immunity	prep_with	19	SENT_88	[p2l2119t2495r2272b2529],
24	,	,	O	,	_	0	SENT_88	[p2l2119t2495r2272b2529],
25	it	PRP	O	it	appos	23	SENT_88	[p2l2290t2495r2309b2521],
26	most	RBS	O	most	advmod	27	SENT_88	[p2l1670t2544r1742b2565],
27	likely	JJ	O	likely	amod	28	SENT_88	[p2l1759t2539r1837b2573],
28	acts	NNS	O	act	dep	25	SENT_88	[p2l1854t2544r1909b2565],
29	at	IN	O	at	_	0	SENT_88	[p2l1928t2545r1955b2565],
30	a	DT	O	a	det	31	SENT_88	[p2l1973t2548r1989b2564],
31	stage	NN	O	stage	prep_at	10	SENT_88	[p2l2007t2544r2079b2573],
32	subsequent	JJ	O	subsequent	_	0	SENT_88	[p2l2098t2539r2263b2573],
33	to	TO	O	to	_	0	SENT_88	[p2l2280t2545r2308b2565],
34	infection	NN	O	infection	prep_subsequent_to	31	SENT_88	[p2l1671t2583r1799b2609],
35	of	IN	O	of	_	0	SENT_88	[p2l1819t2583r1851b2609],
36	the	DT	O	the	det	38	SENT_88	[p2l1864t2583r1909b2609],
37	ﬁrst	NN	O	ﬁrst	nn	38	SENT_88	[p2l1927t2583r1983b2609],
38	cell	NN	O	cell	prep_of	34	SENT_88	[p2l2002t2583r2050b2609],
39	in	IN	O	in	_	0	SENT_88	[p2l2069t2583r2096b2608],
40	the	DT	O	the	det	42	SENT_88	[p2l2115t2583r2159b2609],
41	recipient	JJ	O	recipient	amod	42	SENT_88	[p2l2179t2583r2309b2617],
42	individual	NN	O	individual	prep_in	38	SENT_88	[p2l1671t2627r1826b2653],
43	.	.	O	.	_	0	SENT_88	[p2l1671t2627r1826b2653],

1	The	DT	O	the	det	3	SENT_89	[p2l1853t2627r1913b2653],
2	barrier	NN	O	barrier	nn	3	SENT_89	[p2l1938t2627r2040b2653],
3	function	NN	O	function	nsubjpass	11	SENT_89	[p2l2064t2627r2187b2653],
4	of	IN	O	of	_	0	SENT_89	[p2l2212t2627r2244b2653],
5	the	DT	O	the	det	7	SENT_89	[p2l2263t2627r2308b2653],
6	mucosal	JJ	O	mucosal	amod	7	SENT_89	[p2l1670t2671r1792b2697],
7	epithelia	NN	O	epithelium	prep_of	3	SENT_89	[p2l1812t2671r1938b2705],
8	should	MD	O	should	aux	11	SENT_89	[p2l1957t2671r2055b2697],
9	not	RB	O	not	neg	11	SENT_89	[p2l2073t2677r2122b2697],
10	be	VB	O	be	auxpass	11	SENT_89	[p2l2140t2671r2173b2697],
11	affected	VBN	O	affect	_	0	SENT_89	[p2l2194t2671r2309b2697],
12	by	IN	O	by	_	0	SENT_89	[p2l1670t2715r1707b2749],
13	the	DT	O	the	det	15	SENT_89	[p2l1733t2715r1778b2741],
14	intramuscular	JJ	O	intramuscular	amod	15	SENT_89	[p2l1806t2715r2014b2741],
15	vaccination	NN	O	vaccination	agent	11	SENT_89	[p2l2040t2715r2218b2741],
16	.	.	O	.	_	0	SENT_89	[p2l2040t2715r2218b2741],

1	The	DT	O	the	det	2	SENT_90	[p2l2248t2715r2308b2741],
2	number	NN	O	number	nsubjpass	17	SENT_90	[p2l1671t2758r1788b2784],
3	of	IN	O	of	_	0	SENT_90	[p2l1812t2758r1844b2784],
4	HIV-susceptible	JJ	O	hiv-susceptible	amod	5	SENT_90	[p2l1862t2758r2103b2792],
5	cells	NNS	O	cell	prep_of	2	SENT_90	[p2l2128t2758r2188b2784],
6	in	IN	O	in	_	0	SENT_90	[p2l2212t2758r2239b2783],
7	the	DT	O	the	det	9	SENT_90	[p2l2263t2758r2308b2784],
8	lamina	NN	O	lamina	nn	9	SENT_90	[p2l1670t2802r1773b2827],
9	propria	NN	O	proprium	prep_in	5	SENT_90	[p2l1796t2802r1907b2836],
10	prior	RB	O	prior	_	0	SENT_90	[p2l1931t2802r2005b2836],
11	to	TO	O	to	_	0	SENT_90	[p2l2029t2808r2057b2828],
12	HIV	NN	MISC	hiv	nn	13	SENT_90	[p2l2082t2802r2152b2828],
13	exposure	NN	O	exposure	prep_prior_to	17	SENT_90	[p2l2176t2811r2307b2836],
14	should	MD	O	should	aux	17	SENT_90	[p2l1671t2846r1769b2872],
15	not	RB	O	not	neg	17	SENT_90	[p2l1788t2851r1837b2872],
16	be	VB	O	be	auxpass	17	SENT_90	[p2l1856t2846r1890b2872],
17	enhanced	VBN	O	enhance	_	0	SENT_90	[p2l1912t2846r2055b2872],
18	above	IN	O	above	_	0	SENT_90	[p2l2076t2846r2162b2872],
19	the	DT	O	the	det	22	SENT_90	[p2l2183t2846r2228b2872],
20	preexisting	VBG	O	preexist	amod	22	SENT_90	[p2l2248t2855r2308b2880, p2l1671t2890r1784b2924],
21	background	NN	O	background	nn	22	SENT_90	[p2l1801t2890r1979b2924],
22	level	NN	O	level	prep_above	17	SENT_90	[p2l1997t2890r2064b2916],
23	given	VBN	O	give	partmod	22	SENT_90	[p2l2082t2890r2161b2924],
24	the	DT	O	the	det	26	SENT_90	[p2l2180t2890r2224b2916],
25	continous	JJ	O	continous	amod	26	SENT_90	[p2l2244t2899r2308b2916, p2l1671t2934r1759b2960],
26	exposure	NN	O	exposure	dobj	23	SENT_90	[p2l1778t2943r1909b2968],
27	to	TO	O	to	_	0	SENT_90	[p2l1927t2939r1954b2960],
28	antigens	NNS	O	antigen	prep_to	23	SENT_90	[p2l1973t2934r2094b2968],
29	and	CC	O	and	_	0	SENT_90	[p2l2112t2934r2167b2960],
30	frequent	JJ	O	frequent	amod	31	SENT_90	[p2l2183t2934r2309b2968],
31	infections	NNS	O	infection	prep_to	23	SENT_90	[p2l1671t2978r1811b3004],
32	with	IN	O	with	_	0	SENT_90	[p2l1826t2978r1891b3004],
33	all	DT	O	all	det	34	SENT_90	[p2l1906t2978r1940b3003],
34	kinds	NNS	O	kind	prep_with	23	SENT_90	[p2l1954t2978r2030b3004],
35	of	IN	O	of	_	0	SENT_90	[p2l2046t2978r2078b3004],
36	pathogens	NNS	O	pathogen	prep_of	34	SENT_90	[p2l2087t2978r2238b3012],
37	and	CC	O	and	_	0	SENT_90	[p2l2254t2978r2309b3004],
38	commensals	NNS	O	commensal	prep_of	34	SENT_90	[p2l1671t3022r1858b3048],
39	.	.	O	.	_	0	SENT_90	[p2l1671t3022r1858b3048],

1	Since	IN	O	since	_	0	SENT_91	[p2l1873t3022r1951b3048],
2	all	PDT	O	all	predet	5	SENT_91	[p2l1964t3022r1997b3047],
3	the	DT	O	the	det	5	SENT_91	[p2l2008t3022r2053b3048],
4	vaccine	NN	O	vaccine	nn	5	SENT_91	[p2l2064t3022r2174b3048],
5	antigens	NNS	O	antigen	pobj	1	SENT_91	[p2l2187t3022r2308b3056],

1	August	NNP	DATE	August	_	0	SENT_92	[p2l1631t3144r1729b3174],
2	2008	CD	DATE	2008	num	4	SENT_92	[p2l1742t3145r1807b3167],
3	|	NNP	O	|	nn	4	SENT_92	[p2l1828t3142r1830b3175],
4	Volume	NN	O	volume	dep	1	SENT_92	[p2l1850t3143r1955b3167],
5	4	CD	NUMBER	4	number	6	SENT_92	[p2l1973t3145r1989b3167],
6	|	CD	NUMBER	|	dep	4	SENT_92	[p2l2009t3142r2011b3175],
7	Issue	NN	O	issue	nn	10	SENT_92	[p2l2033t3144r2099b3167],
8	8	CD	NUMBER	8	num	10	SENT_92	[p2l2117t3145r2132b3167],
9	|	NN	O	|	nn	10	SENT_92	[p2l2152t3142r2155b3175],
10	e1000114	NN	O	e1000114	dep	1	SENT_92	[p2l2175t3145r2309b3167],

1	used	VBN	O	use	partmod	39	SENT_93	[p3l243t255r309b281],
2	in	IN	O	in	mark	8	SENT_93	[p3l327t255r354b280],
3	the	DT	O	the	det	5	SENT_93	[p3l372t255r417b281],
4	STEP	NN	O	step	nn	5	SENT_93	[p3l437t255r525b281],
5	study	NN	O	study	nsubj	12	SENT_93	[p3l543t255r621b289],
6	are	VBP	O	be	cop	8	SENT_93	[p3l638t264r683b281],
7	intracellular	JJ	O	intracellular	amod	8	SENT_93	[p3l701t255r881b281],
8	proteins	NNS	O	protein	advcl	1	SENT_93	[p3l242t299r361b333],
9	and	CC	O	and	_	0	SENT_93	[p3l377t299r432b325],
10	usually	RB	O	usually	advmod	12	SENT_93	[p3l446t299r549b333],
11	not	RB	O	not	neg	12	SENT_93	[p3l564t305r612b325],
12	expressed	VBN	O	express	advcl	1	SENT_93	[p3l626t299r769b333],
13	on	IN	O	on	_	0	SENT_93	[p3l784t308r820b325],
14	the	DT	O	the	det	15	SENT_93	[p3l835t299r880b325],
15	surface	NN	O	surface	prep_on	12	SENT_93	[p3l243t342r346b368],
16	of	IN	O	of	_	0	SENT_93	[p3l377t342r409b368],
17	HIV-infected	JJ	MISC	hiv-infected	amod	18	SENT_93	[p3l433t342r632b368],
18	cells	NNS	O	cell	prep_of	15	SENT_93	[p3l661t342r722b368],
19	or	CC	O	or	_	0	SENT_93	[p3l752t351r783b368],
20	HIV	NN	MISC	hiv	nn	21	SENT_93	[p3l812t342r881b368],
21	particles	NNS	O	particle	conj_or	18	SENT_93	[p3l242t386r374b420],
22	,	,	O	,	_	0	SENT_93	[p3l242t386r374b420],
23	only	RB	O	only	advmod	26	SENT_93	[p3l391t386r455b420],
24	infected	JJ	O	infected	amod	26	SENT_93	[p3l469t386r586b412],
25	recipient	JJ	O	recipient	amod	26	SENT_93	[p3l602t386r731b420],
26	cells	NNS	O	cell	nsubj	39	SENT_93	[p3l747t386r815b418],
27	,	,	O	,	_	0	SENT_93	[p3l747t386r815b418],
28	but	CC	O	but	_	0	SENT_93	[p3l832t386r881b412],
29	not	RB	O	not	_	0	SENT_93	[p3l243t435r291b455],
30	the	DT	O	the	det	33	SENT_93	[p3l315t429r360b455],
31	initial	JJ	O	initial	amod	33	SENT_93	[p3l385t429r468b455],
32	virus	NN	O	virus	nn	33	SENT_93	[p3l491t429r562b455],
33	particle	NN	O	particle	conj_negcc	26	SENT_93	[p3l586t429r696b463],
34	leading	VBG	O	lead	partmod	33	SENT_93	[p3l721t429r829b463],
35	to	TO	O	to	_	0	SENT_93	[p3l852t435r880b455],
36	infection	NN	O	infection	prep_to	34	SENT_93	[p3l243t473r380b505],
37	,	,	O	,	_	0	SENT_93	[p3l243t473r380b505],
38	can	MD	O	can	aux	39	SENT_93	[p3l397t482r448b499],
39	trigger	VB	O	trigger	_	0	SENT_93	[p3l464t473r562b507],
40	the	DT	O	the	det	43	SENT_93	[p3l577t473r622b499],
41	vaccine-induced	JJ	O	vaccine-induced	amod	43	SENT_93	[p3l637t473r881b499],
42	enhancer	NN	O	enhancer	nn	43	SENT_93	[p3l243t516r381b542],
43	cells	NNS	O	cell	dobj	39	SENT_93	[p3l395t516r455b542],
44	to	TO	O	to	aux	45	SENT_93	[p3l469t522r497b542],
45	mediate	VB	O	mediate	xcomp	39	SENT_93	[p3l512t516r629b542],
46	their	PRP$	O	they	poss	48	SENT_93	[p3l644t516r712b542],
47	enhancing	JJ	O	enhancing	amod	48	SENT_93	[p3l727t516r881b550],
48	effect	NN	O	effect	dobj	45	SENT_93	[p3l243t560r328b586],
49	.	.	O	.	_	0	SENT_93	[p3l243t560r328b586],

1	A	DT	O	a	det	3	SENT_94	[p3l279t604r305b629],
2	likely	JJ	O	likely	amod	3	SENT_94	[p3l324t604r402b638],
3	candidate	NN	O	candidate	nsubj	10	SENT_94	[p3l422t604r565b630],
4	for	IN	O	for	_	0	SENT_94	[p3l586t604r628b630],
5	these	DT	O	these	det	7	SENT_94	[p3l648t604r721b630],
6	enhancer	NN	O	enhancer	nn	7	SENT_94	[p3l743t604r881b630],
7	cells	NNS	O	cell	prep_for	3	SENT_94	[p3l243t647r303b673],
8	are	VBP	O	be	cop	10	SENT_94	[p3l318t656r363b673],
9	vaccine-primed	JJ	O	vaccine-primed	amod	10	SENT_94	[p3l376t647r608b681],
10	CD4	NN	O	cd4	_	0	SENT_94	[p3l622t647r714b673],
11	+	CC	O	+	_	0	SENT_94	[p3l622t647r714b673],
12	T	NN	O	t	nn	13	SENT_94	[p3l728t647r752b672],
13	cells	NNS	O	cell	conj_+	10	SENT_94	[p3l766t647r826b673],
14	reactivated	VBN	O	reactivate	partmod	13	SENT_94	[p3l841t656r880b673, p3l243t691r376b717],
15	by	IN	O	by	_	0	SENT_94	[p3l396t691r432b725],
16	HIV	NN	O	hiv	nn	17	SENT_94	[p3l451t691r520b716],
17	peptides	NNS	O	peptide	agent	14	SENT_94	[p3l538t691r661b725],
18	presented	VBN	O	present	partmod	17	SENT_94	[p3l680t691r824b725],
19	on	IN	O	on	_	0	SENT_94	[p3l844t700r880b717],
20	MHC	NN	O	mhc	nn	21	SENT_94	[p3l243t734r331b760],
21	molecules	NNS	O	molecule	prep_on	18	SENT_94	[p3l361t734r506b760],
22	of	IN	O	of	_	0	SENT_94	[p3l534t734r566b760],
23	antigen	NN	O	antigen	nn	25	SENT_94	[p3l589t734r698b768],
24	presenting	NN	O	presenting	nn	25	SENT_94	[p3l726t734r881b768],
25	cells	NNS	O	cell	prep_of	21	SENT_94	[p3l243t778r303b804],
26	and	CC	O	and	_	0	SENT_94	[p3l334t778r407b804],
27	/	:	O	/	punct	28	SENT_94	[p3l334t778r407b804],
28	or	CC	O	or	dep	25	SENT_94	[p3l411t787r441b804],
29	HIV-infected	JJ	O	hiv-infected	dep	28	SENT_94	[p3l471t778r670b804],
30	cells	NNS	O	cell	prep_of	21	SENT_94	[p3l700t778r768b804],
31	.	.	O	.	_	0	SENT_94	[p3l700t778r768b804],

1	Since	IN	O	since	mark	16	SENT_95	[p3l802t778r880b804],
2	encounter	NN	O	encounter	nsubj	16	SENT_95	[p3l243t828r393b848],
3	of	IN	O	of	_	0	SENT_95	[p3l421t822r453b848],
4	a	DT	O	a	det	9	SENT_95	[p3l477t831r492b847],
5	vaccine-induced	JJ	O	vaccine-induced	amod	9	SENT_95	[p3l519t822r770b854],
6	,	,	O	,	_	0	SENT_95	[p3l519t822r770b854],
7	HIVspeciﬁc	NN	O	hivspeciﬁc	dep	9	SENT_95	[p3l800t822r880b848, p3l243t865r350b899],
8	enhancer	NN	O	enhancer	nn	9	SENT_95	[p3l363t865r500b891],
9	cell	NN	O	cell	prep_of	2	SENT_95	[p3l512t865r560b891],
10	and	CC	O	and	_	0	SENT_95	[p3l573t865r628b891],
11	the	DT	O	the	det	12	SENT_95	[p3l640t865r684b891],
12	ﬁrst	NN	O	ﬁrst	conj_and	9	SENT_95	[p3l696t865r752b891],
13	infected	JJ	O	infected	amod	15	SENT_95	[p3l764t865r881b891],
14	recipient	JJ	O	recipient	amod	15	SENT_95	[p3l243t909r373b943],
15	cell	NN	O	cell	dep	12	SENT_95	[p3l399t909r448b935],
16	seems	VBZ	O	seem	advcl	28	SENT_95	[p3l475t918r560b935],
17	to	TO	O	to	aux	21	SENT_95	[p3l587t915r614b935],
18	be	VB	O	be	cop	21	SENT_95	[p3l642t909r675b935],
19	an	DT	O	a	det	21	SENT_95	[p3l703t918r738b934],
20	unlikely	JJ	O	unlikely	amod	21	SENT_95	[p3l765t909r881b943],
21	event	NN	O	event	xcomp	16	SENT_95	[p3l243t958r330b984],
22	,	,	O	,	_	0	SENT_95	[p3l243t958r330b984],
23	the	DT	O	the	det	24	SENT_95	[p3l344t952r389b978],
24	enhancement	NN	O	enhancement	nsubj	28	SENT_95	[p3l403t952r604b978],
25	of	IN	O	of	_	0	SENT_95	[p3l618t952r650b978],
26	infection	NN	O	infection	prep_of	24	SENT_95	[p3l658t952r786b978],
27	probably	RB	O	probably	advmod	28	SENT_95	[p3l799t952r880b986, p3l243t996r305b1030],
28	acts	VBZ	O	act	_	0	SENT_95	[p3l319t1002r374b1022],
29	at	IN	O	at	_	0	SENT_95	[p3l389t1002r416b1022],
30	one	CD	NUMBER	one	prep_at	28	SENT_95	[p3l430t1005r482b1022],
31	of	IN	O	of	_	0	SENT_95	[p3l498t996r530b1022],
32	the	DT	O	the	det	34	SENT_95	[p3l539t996r584b1022],
33	subsequent	JJ	O	subsequent	amod	34	SENT_95	[p3l600t996r764b1030],
34	rounds	NNS	O	round	prep_of	30	SENT_95	[p3l779t996r880b1022],
35	of	IN	O	of	_	0	SENT_95	[p3l243t1039r275b1065],
36	infection	NN	O	infection	prep_of	34	SENT_95	[p3l302t1039r438b1065],
37	.	.	O	.	_	0	SENT_95	[p3l302t1039r438b1065],

1	It	PRP	O	it	nsubj	3	SENT_96	[p3l472t1039r495b1065],
2	is	VBZ	O	be	cop	3	SENT_96	[p3l526t1039r546b1065],
3	worth	JJ	O	worth	_	0	SENT_96	[p3l577t1039r665b1065],
4	noting	VBG	O	note	xcomp	3	SENT_96	[p3l697t1039r792b1073],
5	that	IN	O	that	complm	10	SENT_96	[p3l823t1039r881b1065],
6	vaccination	NN	O	vaccination	nsubj	10	SENT_96	[p3l242t1083r413b1109],
7	did	VBD	O	do	aux	10	SENT_96	[p3l428t1083r475b1109],
8	not	RB	O	not	neg	10	SENT_96	[p3l489t1089r537b1109],
9	notably	RB	O	notably	advmod	10	SENT_96	[p3l552t1083r663b1117],
10	enhance	VB	O	enhance	ccomp	4	SENT_96	[p3l677t1083r800b1109],
11	viral	JJ	O	viral	amod	12	SENT_96	[p3l815t1083r881b1109],
12	load	NN	O	load	dobj	10	SENT_96	[p3l243t1127r306b1153],
13	in	IN	O	in	_	0	SENT_96	[p3l322t1127r349b1152],
14	infected	JJ	O	infected	amod	15	SENT_96	[p3l365t1127r482b1153],
15	individuals	NNS	O	individual	prep_in	12	SENT_96	[p3l497t1127r657b1153],
16	but	CC	O	but	_	0	SENT_96	[p3l673t1127r722b1153],
17	enhanced	VBD	O	enhance	conj_but	10	SENT_96	[p3l737t1127r881b1153],
18	the	DT	O	the	det	19	SENT_96	[p3l243t1170r287b1196],
19	incidence	NN	O	incidence	dobj	17	SENT_96	[p3l322t1170r462b1196],
20	of	IN	O	of	_	0	SENT_96	[p3l497t1170r529b1196],
21	infected	JJ	O	infected	amod	22	SENT_96	[p3l557t1170r674b1196],
22	persons	NNS	O	person	prep_of	19	SENT_96	[p3l707t1179r818b1204],
23	as	IN	O	as	mark	24	SENT_96	[p3l853t1179r880b1196],
24	diagnosed	VBN	O	diagnose	advcl	3	SENT_96	[p3l243t1214r392b1248],
25	by	IN	O	by	_	0	SENT_96	[p3l411t1214r447b1248],
26	seroconversion	NN	O	seroconversion	prep_by	24	SENT_96	[p3l465t1214r693b1240],
27	.	.	O	.	_	0	SENT_96	[p3l465t1214r693b1240],

1	If	IN	O	if	mark	6	SENT_97	[p3l715t1214r741b1239],
2	the	DT	O	the	det	3	SENT_97	[p3l755t1214r800b1240],
3	vaccine	NN	O	vaccine	nsubj	6	SENT_97	[p3l819t1223r880b1240, p3l243t1257r302b1283],
4	does	VBZ	O	do	aux	6	SENT_97	[p3l315t1257r380b1283],
5	not	RB	O	not	neg	6	SENT_97	[p3l393t1263r441b1283],
6	enhance	VB	O	enhance	advcl	15	SENT_97	[p3l453t1257r575b1283],
7	infection	NN	O	infection	dobj	6	SENT_97	[p3l589t1257r717b1283],
8	at	IN	O	at	_	0	SENT_97	[p3l730t1263r756b1283],
9	the	DT	O	the	det	11	SENT_97	[p3l768t1257r813b1283],
10	ﬁrst	JJ	O	ﬁrst	amod	11	SENT_97	[p3l825t1257r881b1283],
11	stage	NN	O	stage	prep_at	6	SENT_97	[p3l243t1307r324b1335],
12	,	,	O	,	_	0	SENT_97	[p3l243t1307r324b1335],
13	it	PRP	O	it	nsubj	15	SENT_97	[p3l340t1301r359b1327],
14	must	MD	O	must	aux	15	SENT_97	[p3l372t1307r444b1327],
15	enhance	VB	O	enhance	_	0	SENT_97	[p3l458t1301r581b1327],
16	the	DT	O	the	det	17	SENT_97	[p3l596t1301r641b1327],
17	frequency	NN	O	frequency	dobj	15	SENT_97	[p3l655t1301r803b1335],
18	with	IN	O	with	_	0	SENT_97	[p3l816t1301r880b1327],
19	which	WDT	O	which	rel	21	SENT_97	[p3l242t1345r331b1371],
20	vaccinees	NNS	O	vaccinee	nsubj	21	SENT_97	[p3l350t1345r490b1371],
21	progress	VBP	O	progress	rcmod	17	SENT_97	[p3l510t1354r632b1379],
22	through	IN	O	through	_	0	SENT_97	[p3l652t1345r770b1379],
23	subsequent	JJ	O	subsequent	amod	24	SENT_97	[p3l791t1345r880b1371, p3l243t1394r328b1422],
24	stages	NNS	O	stage	prep_through	21	SENT_97	[p3l359t1394r451b1422],
25	.	.	O	.	_	0	SENT_97	[p3l359t1394r451b1422],

1	This	DT	O	this	nsubj	2	SENT_98	[p3l484t1388r550b1414],
2	implies	VBZ	O	imply	_	0	SENT_98	[p3l581t1388r685b1422],
3	that	IN	O	that	complm	9	SENT_98	[p3l716t1388r774b1414],
4	some	DT	O	some	det	6	SENT_98	[p3l805t1397r880b1414],
5	unvaccinated	JJ	O	unvaccinated	amod	6	SENT_98	[p3l243t1432r441b1458],
6	individuals	NNS	O	individual	nsubj	9	SENT_98	[p3l458t1432r618b1458],
7	must	MD	O	must	aux	9	SENT_98	[p3l635t1438r707b1458],
8	be	VB	O	be	cop	9	SENT_98	[p3l723t1432r757b1458],
9	able	JJ	O	able	ccomp	2	SENT_98	[p3l775t1432r835b1458],
10	to	TO	O	to	aux	11	SENT_98	[p3l852t1438r880b1458],
11	control	VB	O	control	xcomp	9	SENT_98	[p3l243t1475r348b1501],
12	transition	NN	O	transition	dobj	11	SENT_98	[p3l363t1475r503b1501],
13	from	IN	O	from	_	0	SENT_98	[p3l518t1475r589b1501],
14	the	DT	O	the	det	16	SENT_98	[p3l605t1475r650b1501],
15	early	JJ	O	early	amod	16	SENT_98	[p3l666t1475r738b1509],
16	stages	NNS	O	stage	prep_from	11	SENT_98	[p3l753t1481r838b1509],
17	of	IN	O	of	prep	16	SENT_98	[p3l854t1475r886b1501],

1	References	NNS	O	reference	nsubj	2	SENT_99	[p3l245t1564r458b1595],
2	l.	VBP	O	l.	_	0	SENT_99	[p3l261t1633r276b1653],
3	Flynn	NNP	PERSON	Flynn	nn	4	SENT_99	[p3l300t1633r365b1659],
4	NIVI	NNP	O	NIVI	nsubj	36	SENT_99	[p3l377t1633r431b1657],
5	,	,	O	,	_	0	SENT_99	[p3l377t1633r431b1657],
6	Forthal	NNP	O	Forthal	nn	10	SENT_99	[p3l444t1633r528b1653],
7	DN	JJ	O	dn	amod	10	SENT_99	[p3l540t1632r589b1657],
8	,	,	O	,	_	0	SENT_99	[p3l540t1632r589b1657],
9	Harro	NNP	PERSON	Harro	dep	10	SENT_99	[p3l602t1633r673b1653],
10	CD	NNP	O	CD	dep	28	SENT_99	[p3l686t1632r733b1657],
11	,	,	O	,	_	0	SENT_99	[p3l686t1632r733b1657],
12	Judson	NNP	ORGANIZATION	Judson	nn	13	SENT_99	[p3l741t1633r824b1659],
13	FN	NN	ORGANIZATION	fn	appos	10	SENT_99	[p3l837t1633r879b1657],
14	,	,	O	,	_	0	SENT_99	[p3l837t1633r879b1657],
15	Mayer	NNP	ORGANIZATION	Mayer	nn	16	SENT_99	[p3l300t1666r376b1692],
16	KH	NNP	ORGANIZATION	KH	appos	10	SENT_99	[p3l390t1666r441b1690],
17	,	,	O	,	_	0	SENT_99	[p3l390t1666r441b1690],
18	Para	NNP	O	Para	appos	10	SENT_99	[p3l456t1665r509b1685],
19	MF	NN	O	mf	dep	28	SENT_99	[p3l522t1666r565b1685],
20	(	CD	NUMBER	(	num	19	SENT_99	[p3l579t1666r648b1692],
21	2005	CD	DATE	2005	number	22	SENT_99	[p3l579t1666r648b1692],
22	)	CD	NUMBER	)	num	28	SENT_99	[p3l579t1666r648b1692],
23	Placebo	NNP	O	Placebo	nn	28	SENT_99	[p3l663t1665r880b1686],
24	—	CD	NUMBER	—	num	28	SENT_99	[p3l663t1665r880b1686],
25	controlled	JJ	O	controlled	amod	28	SENT_99	[p3l663t1665r880b1686],
26	phase	NN	O	phase	dep	25	SENT_99	[p3l300t1698r364b1725],
27	3	CD	NUMBER	3	num	26	SENT_99	[p3l379t1699r390b1719],
28	trial	NN	O	trial	dep	4	SENT_99	[p3l404t1698r449b1719],
29	of	IN	O	of	_	0	SENT_99	[p3l462t1698r487b1719],
30	a	DT	O	a	det	34	SENT_99	[p3l496t1706r509b1718],
31	recombinant	JJ	O	recombinant	amod	34	SENT_99	[p3l521t1698r669b1719],
32	glycoprotein	NN	O	glycoprotein	nn	34	SENT_99	[p3l682t1698r825b1725],
33	l20	NN	O	l20	nn	34	SENT_99	[p3l842t1699r880b1719],
34	vaccine	NN	O	vaccine	prep_of	28	SENT_99	[p3l299t1732r385b1753],
35	to	TO	O	to	aux	36	SENT_99	[p3l399t1738r420b1753],
36	prevent	VB	O	prevent	xcomp	2	SENT_99	[p3l433t1738r520b1759],
37	HIV-1	NN	O	hiv-1	nn	38	SENT_99	[p3l533t1733r606b1753],
38	infection	NN	O	infection	dobj	36	SENT_99	[p3l623t1732r728b1753],
39	.	.	O	.	_	0	SENT_99	[p3l623t1732r728b1753],

1	J	NNP	O	J	nn	3	SENT_100	[p3l737t1733r751b1759],
2	Infect	NNP	O	Infect	nn	3	SENT_100	[p3l764t1732r830b1753],
3	Dis	NNP	O	Dis	_	0	SENT_100	[p3l843t1732r880b1753],
4	191	CD	NUMBER	191	num	3	SENT_100	[p3l303t1766r348b1786],
5	:	:	O	:	_	0	SENT_100	[p3l303t1766r348b1786],
6	654	CD	NUMBER	654	num	7	SENT_100	[p3l361t1766r467b1786],
7	~	NN	O	~	dep	3	SENT_100	[p3l361t1766r467b1786],
8	665	CD	NUMBER	665	dep	7	SENT_100	[p3l361t1766r467b1786],
9	.	.	O	.	_	0	SENT_100	[p3l361t1766r467b1786],

1	2	LS	NUMBER	2	_	0	SENT_101	[p3l258t1799r276b1819],
2	.	.	O	.	_	0	SENT_101	[p3l258t1799r276b1819],

1	Karlsson	NNP	PERSON	Karlsson	nn	3	SENT_102	[p3l300t1799r401b1819],
2	Hedestam	NNP	PERSON	Hedestam	nn	3	SENT_102	[p3l413t1799r530b1819],
3	GB	NNP	O	GB	_	0	SENT_102	[p3l541t1798r586b1823],
4	,	,	O	,	_	0	SENT_102	[p3l541t1798r586b1823],
5	Fouchier	JJ	O	fouchier	amod	6	SENT_102	[p3l597t1798r700b1819],
6	RA	NN	O	ra	appos	3	SENT_102	[p3l711t1798r756b1823],
7	,	,	O	,	_	0	SENT_102	[p3l711t1798r756b1823],
8	Phogat	NNP	O	Phogat	nn	9	SENT_102	[p3l768t1798r849b1825],
9	S	NNP	O	S	appos	3	SENT_102	[p3l860t1798r879b1823],
10	,	,	O	,	_	0	SENT_102	[p3l860t1798r879b1823],
11	Burton	NNP	PERSON	Burton	nn	12	SENT_102	[p3l300t1831r381b1852],
12	DR	NN	O	dr	appos	3	SENT_102	[p3l396t1831r444b1856],
13	,	,	O	,	_	0	SENT_102	[p3l396t1831r444b1856],
14	Sodroski	NNP	PERSON	Sodroski	nn	15	SENT_102	[p3l461t1831r560b1852],
15	J	NNP	PERSON	J	appos	3	SENT_102	[p3l570t1832r590b1858],
16	,	,	O	,	_	0	SENT_102	[p3l570t1832r590b1858],
17	\	CD	NUMBER	\	appos	3	SENT_102	[p3l606t1832r677b1858],
18	/	:	O	/	punct	25	SENT_102	[p3l606t1832r677b1858],
19	Vyatt	NNP	O	Vyatt	nn	20	SENT_102	[p3l606t1832r677b1858],
20	RT	NN	O	rt	dep	25	SENT_102	[p3l692t1831r732b1851],
21	(	CD	NUMBER	(	num	20	SENT_102	[p3l748t1832r817b1858],
22	2008	CD	DATE	2008	num	23	SENT_102	[p3l748t1832r817b1858],
23	)	CD	NUMBER	)	dep	20	SENT_102	[p3l748t1832r817b1858],
24	The	DT	O	the	det	25	SENT_102	[p3l833t1832r880b1852],
25	challenges	NNS	O	challenge	dep	17	SENT_102	[p3l300t1864r418b1891],
26	of	IN	O	of	_	0	SENT_102	[p3l433t1864r458b1884],
27	eliciting	VBG	O	elicit	prepc_of	17	SENT_102	[p3l469t1864r560b1891],
28	neutralizing	VBG	O	neutralize	amod	29	SENT_102	[p3l574t1864r712b1891],
29	antibodies	NNS	O	antibody	dobj	27	SENT_102	[p3l726t1864r844b1885],
30	to	TO	O	to	_	0	SENT_102	[p3l859t1869r880b1885],
31	HIV-1	NN	O	hiv-1	prep_to	27	SENT_102	[p3l300t1899r374b1919],
32	and	CC	O	and	_	0	SENT_102	[p3l387t1898r430b1919],
33	to	TO	O	to	_	0	SENT_102	[p3l440t1904r461b1919],
34	inﬂuenza	NN	O	inﬂuenza	nn	35	SENT_102	[p3l471t1898r577b1919],
35	virus	NN	O	virus	conj_and	31	SENT_102	[p3l586t1898r647b1919],
36	.	.	O	.	_	0	SENT_102	[p3l586t1898r647b1919],

1	Nat	NNP	PERSON	Nat	nn	3	SENT_103	[p3l658t1899r701b1919],
2	Rev	NN	PERSON	rev	nn	3	SENT_103	[p3l711t1898r757b1919],
3	l	NN	O	l	_	0	SENT_103	[p3l766t1898r881b1919],
4	\	CD	NUMBER	\	number	5	SENT_103	[p3l766t1898r881b1919],
5	’	CD	NUMBER	’	dep	3	SENT_103	[p3l766t1898r881b1919],
6	Iicrobiol	NN	O	iicrobiol	dep	5	SENT_103	[p3l766t1898r881b1919],
7	6	CD	NUMBER	6	num	6	SENT_103	[p3l300t1932r319b1951],
8	:	:	O	:	_	0	SENT_103	[p3l300t1932r319b1951],
9	l43	CD	NUMBER	l43	dep	3	SENT_103	[p3l335t1932r438b1952],
10	—	CD	NUMBER	—	num	11	SENT_103	[p3l335t1932r438b1952],
11	l55	NN	O	l55	dep	9	SENT_103	[p3l335t1932r438b1952],
12	.	.	O	.	_	0	SENT_103	[p3l335t1932r438b1952],

1	3	LS	NUMBER	3	_	0	SENT_104	[p3l258t1965r276b1985],
2	.	.	O	.	_	0	SENT_104	[p3l258t1965r276b1985],

1	Robertson	NNP	PERSON	Robertson	_	0	SENT_105	[p3l300t1964r421b1985],
2	l	NN	O	l	prep	1	SENT_105	[p3l428t1965r460b1989],
3	\	CD	NUMBER	\	num	4	SENT_105	[p3l428t1965r460b1989],
4	’	CD	NUMBER	’	dep	2	SENT_105	[p3l428t1965r460b1989],
5	I	PRP	O	I	dep	24	SENT_105	[p3l428t1965r460b1989],
6	,	,	O	,	_	0	SENT_105	[p3l428t1965r460b1989],
7	Casimiro	NNP	ORGANIZATION	Casimiro	nn	8	SENT_105	[p3l469t1964r574b1985],
8	DR	NN	O	dr	appos	5	SENT_105	[p3l582t1964r630b1989],
9	,	,	O	,	_	0	SENT_105	[p3l582t1964r630b1989],
10	De	NNP	PERSON	De	nn	12	SENT_105	[p3l639t1964r672b1985],
11	Rosa	NNP	PERSON	Rosa	nn	12	SENT_105	[p3l680t1964r738b1985],
12	S	NN	PERSON	s	appos	5	SENT_105	[p3l746t1964r766b1989],
13	,	,	O	,	_	0	SENT_105	[p3l746t1964r766b1989],
14	Dubey	NNP	PERSON	Dubey	nn	15	SENT_105	[p3l774t1964r852b1991],
15	S	NNP	O	S	appos	5	SENT_105	[p3l860t1964r879b1989],
16	,	,	O	,	_	0	SENT_105	[p3l860t1964r879b1989],
17	Kierstead	NNP	O	Kierstead	nn	18	SENT_105	[p3l300t1997r412b2018],
18	L	NNP	O	L	appos	5	SENT_105	[p3l427t1998r450b2022],
19	,	,	O	,	_	0	SENT_105	[p3l427t1998r450b2022],
20	lVIcElrath	NN	O	lvicelrath	appos	5	SENT_105	[p3l466t1998r577b2018],
21	J	NN	O	j	dep	24	SENT_105	[p3l588t1998r602b2024],
22	(	CD	NUMBER	(	num	21	SENT_105	[p3l619t1997r688b2024],
23	2008	CD	DATE	2008	num	24	SENT_105	[p3l619t1997r688b2024],
24	)	CD	NUMBER	)	dep	1	SENT_105	[p3l619t1997r688b2024],
25	Immunological	JJ	O	immunological	amod	26	SENT_105	[p3l704t1997r880b2024],
26	Characterization	NN	O	characterization	dep	24	SENT_105	[p3l300t2030r497b2051],
27	of	IN	O	of	_	0	SENT_105	[p3l519t2030r544b2050],
28	Subjects	NNS	O	subject	prep_of	1	SENT_105	[p3l562t2030r657b2057],
29	from	IN	O	from	_	0	SENT_105	[p3l678t2030r733b2051],
30	the	DT	O	the	det	32	SENT_105	[p3l755t2030r789b2051],
31	STEP	NN	O	step	nn	32	SENT_105	[p3l812t2030r881b2050],
32	Study	NN	O	study	prep_from	28	SENT_105	[p3l301t2064r372b2091],
33	:	:	O	:	_	0	SENT_105	[p3l301t2064r372b2091],
34	A	DT	O	a	det	38	SENT_105	[p3l385t2065r404b2084],
35	Phase	NN	O	phase	nn	38	SENT_105	[p3l415t2064r481b2085],
36	IIB	NN	O	iib	nn	38	SENT_105	[p3l493t2064r530b2084],
37	Test-of-Concept	JJ	O	test-of-concept	amod	38	SENT_105	[p3l542t2064r732b2091],
38	Trial	NN	O	trial	dep	1	SENT_105	[p3l743t2064r801b2084],
39	of	IN	O	of	_	0	SENT_105	[p3l813t2064r838b2085],
40	the	DT	O	the	prep_of	38	SENT_105	[p3l845t2065r880b2085],
41	.	.	O	.	_	0	SENT_105	[p3l300t2097r418b2118],

1	\	VBN	O	\	_	0	SENT_106	[p3l300t2097r418b2118],
2	IRKAd	NN	O	irkad	nn	5	SENT_106	[p3l300t2097r418b2118],
3	.5	CD	NUMBER	.5	num	5	SENT_106	[p3l300t2097r418b2118],
4	HIV-l	NN	O	hiv-l	nn	5	SENT_106	[p3l435t2098r508b2118],
5	Gag/Pol/Nef	NN	O	gag/pol/nef	tmod	1	SENT_106	[p3l528t2097r691b2124],
6	Trivalent	JJ	O	trivalent	amod	7	SENT_106	[p3l702t2097r810b2118],
7	Vaccine	NN	O	vaccine	dep	5	SENT_106	[p3l825t2098r880b2118, p3l300t2130r352b2151],
8	.	.	O	.	_	0	SENT_106	[p3l825t2098r880b2118, p3l300t2130r352b2151],

1	4	LS	NUMBER	4	_	0	SENT_107	[p3l258t2164r277b2184],
2	.	.	O	.	_	0	SENT_107	[p3l258t2164r277b2184],

1	Robertson	NNP	PERSON	Robertson	nn	2	SENT_108	[p3l302t2163r431b2184],
2	NI	NNP	O	NI	dep	8	SENT_108	[p3l454t2164r487b2188],
3	,	,	O	,	_	0	SENT_108	[p3l454t2164r487b2188],
4	l	NN	O	l	prep	2	SENT_108	[p3l510t2164r630b2184],
5	\	CD	NUMBER	\	dep	4	SENT_108	[p3l510t2164r630b2184],
6	’	CD	NUMBER	’	num	7	SENT_108	[p3l510t2164r630b2184],
7	Iehrotra	NN	O	iehrotra	dep	8	SENT_108	[p3l510t2164r630b2184],
8	D	NN	O	d	dep	27	SENT_108	[p3l652t2163r680b2188],
9	,	,	O	,	_	0	SENT_108	[p3l652t2163r680b2188],
10	Fitzgerald	NNP	ORGANIZATION	Fitzgerald	nn	11	SENT_108	[p3l704t2163r829b2190],
11	D	NNP	ORGANIZATION	D	appos	8	SENT_108	[p3l851t2163r879b2188],
12	,	,	O	,	_	0	SENT_108	[p3l851t2163r879b2188],
13	Duerr	NNP	PERSON	Duerr	nn	14	SENT_108	[p3l302t2196r384b2217],
14	A	NNP	O	A	appos	8	SENT_108	[p3l410t2197r438b2221],
15	,	,	O	,	_	0	SENT_108	[p3l410t2197r438b2221],
16	Casimiro	NNP	ORGANIZATION	Casimiro	nn	17	SENT_108	[p3l466t2196r593b2217],
17	DR	NN	O	dr	appos	8	SENT_108	[p3l620t2196r674b2221],
18	,	,	O	,	_	0	SENT_108	[p3l620t2196r674b2221],
19	l\/IcElrath	NN	O	l\/icelrath	nn	20	SENT_108	[p3l702t2197r834b2217],
20	J	NN	O	j	appos	8	SENT_108	[p3l856t2197r880b2223],
21	,	,	O	,	_	0	SENT_108	[p3l856t2197r880b2223],
22	Lawrence	NNP	PERSON	Lawrence	nn	23	SENT_108	[p3l302t2231r419b2251],
23	D	NNP	PERSON	D	appos	8	SENT_108	[p3l441t2230r468b2255],
24	,	,	O	,	_	0	SENT_108	[p3l441t2230r468b2255],
25	Buchbinder	NNP	PERSON	Buchbinder	nn	26	SENT_108	[p3l491t2230r632b2251],
26	S	NNP	O	S	appos	8	SENT_108	[p3l654t2230r667b2250],
27	(	VBD	O	(	_	0	SENT_108	[p3l691t2230r763b2257],
28	2008	CD	DATE	2008	num	30	SENT_108	[p3l691t2230r763b2257],
29	)	CD	NUMBER	)	num	30	SENT_108	[p3l691t2230r763b2257],
30	Efficacy	NN	O	efficacy	dobj	27	SENT_108	[p3l785t2230r881b2257],

1	PLoS	NN	O	plo	nsubj	2	SENT_109	[p3l344t3144r408b3167],
2	Pathogens	VBD	O	pathogen	_	0	SENT_109	[p3l423t3143r567b3174],
3	|	CD	NUMBER	|	num	4	SENT_109	[p3l587t3142r590b3175],
4	www	NN	O	www	dobj	2	SENT_109	[p3l610t3143r949b3174],
5	.	.	O	.	_	0	SENT_109	[p3l610t3143r949b3174],

1	p	NN	O	p	_	0	SENT_110	[p3l610t3143r949b3174],
2	|	SYM	O	|	dep	3	SENT_110	[p3l610t3143r949b3174],
3	ospathogens.org	NN	O	ospathogens.org	rcmod	1	SENT_110	[p3l610t3143r949b3174],
4	infection	NN	O	infection	dep	1	SENT_110	[p3l957t255r1085b281],
5	to	TO	O	to	_	0	SENT_110	[p3l1103t261r1130b281],
6	later	JJ	O	later	amod	7	SENT_110	[p3l1147t255r1214b281],
7	ones	NNS	O	one	prep_to	4	SENT_110	[p3l1231t264r1304b281],
8	.	.	O	.	_	0	SENT_110	[p3l1231t264r1304b281],

1	In	IN	O	in	_	0	SENT_111	[p3l1323t255r1354b280],
2	the	DT	O	the	det	3	SENT_111	[p3l1371t255r1416b281],
3	absence	NN	O	absence	prep_in	17	SENT_111	[p3l1434t255r1549b281],
4	of	IN	O	of	_	0	SENT_111	[p3l1568t255r1600b281],
5	seroconversion	NN	O	seroconversion	prep_of	3	SENT_111	[p3l957t299r1186b331],
6	,	,	O	,	_	0	SENT_111	[p3l957t299r1186b331],
7	infections	NNS	O	infection	nsubjpass	17	SENT_111	[p3l1212t299r1353b325],
8	that	WDT	O	that	nsubjpass	10	SENT_111	[p3l1378t299r1435b325],
9	are	VBP	O	be	auxpass	10	SENT_111	[p3l1460t308r1505b325],
10	contained	VBN	O	contain	rcmod	7	SENT_111	[p3l1530t308r1594b325, p3l957t342r1049b368],
11	at	IN	O	at	_	0	SENT_111	[p3l1081t348r1108b368],
12	these	DT	O	these	det	14	SENT_111	[p3l1140t342r1213b368],
13	early	JJ	O	early	amod	14	SENT_111	[p3l1247t342r1319b376],
14	stages	NNS	O	stage	prep_at	10	SENT_111	[p3l1351t348r1436b376],
15	are	VBP	O	be	auxpass	17	SENT_111	[p3l1469t351r1514b368],
16	not	RB	O	not	neg	17	SENT_111	[p3l1547t348r1595b368],
17	diagnosed	VBN	O	diagnose	_	0	SENT_111	[p3l957t386r1113b420],
18	.	.	O	.	_	0	SENT_111	[p3l957t386r1113b420],

1	Evidence	NN	O	evidence	nsubj	12	SENT_112	[p3l995t429r1130b455],
2	for	IN	O	for	_	0	SENT_112	[p3l1140t429r1182b455],
3	the	DT	O	the	det	4	SENT_112	[p3l1192t429r1237b455],
4	existence	NN	O	existence	prep_for	1	SENT_112	[p3l1248t429r1381b455],
5	of	IN	O	of	_	0	SENT_112	[p3l1392t429r1424b455],
6	such	JJ	O	such	amod	10	SENT_112	[p3l1430t429r1496b455],
7	occult	NN	O	occult	nn	10	SENT_112	[p3l1507t429r1595b455],
8	immunodeﬁciency	NN	O	immunodeﬁciency	nn	10	SENT_112	[p3l957t473r1233b507],
9	virus	NN	O	virus	nn	10	SENT_112	[p3l1265t473r1336b499],
10	infections	NNS	O	infection	prep_of	4	SENT_112	[p3l1371t473r1512b499],
11	has	VBZ	O	have	aux	12	SENT_112	[p3l1546t473r1594b499],
12	come	VBN	O	come	dep	20	SENT_112	[p3l957t525r1035b542],
13	so	RB	O	so	advmod	12	SENT_112	[p3l1066t525r1095b542],
14	far	RB	O	far	_	0	SENT_112	[p3l1125t516r1165b541],
15	from	IN	O	from	_	0	SENT_112	[p3l1194t516r1265b542],
16	frequently	RB	O	frequently	advmod	17	SENT_112	[p3l1295t516r1446b550],
17	exposed	VBN	O	expose	amod	19	SENT_112	[p3l1476t516r1595b550],
18	seronegative	JJ	O	seronegative	amod	19	SENT_112	[p3l957t560r1140b594],
19	individuals	NNS	O	individual	prep_far_from	12	SENT_112	[p3l1183t560r1343b586],
20	(	VBP	O	(	_	0	SENT_112	[p3l1385t560r1526b594],
21	reviewed	VBN	O	review	dep	20	SENT_112	[p3l1385t560r1526b594],
22	in	IN	O	in	_	0	SENT_112	[p3l1567t560r1594b585],
23	[	CD	NUMBER	[	number	24	SENT_112	[p3l961t604r1036b638],
24	7,8	CD	NUMBER	7,8	prep_in	21	SENT_112	[p3l961t604r1036b638],
25	]	CD	NUMBER	]	num	26	SENT_112	[p3l961t604r1036b638],
26	)	NN	O	)	dep	24	SENT_112	[p3l961t604r1036b638],
27	and	CC	O	and	_	0	SENT_112	[p3l1068t604r1123b630],
28	immunodeﬁciency	NN	O	immunodeﬁciency	nn	29	SENT_112	[p3l1154t604r1430b638],
29	virus	NN	O	virus	conj_and	24	SENT_112	[p3l1458t604r1594b630, p3l956t647r1042b681],
30	—	CD	NUMBER	—	nsubj	34	SENT_112	[p3l1458t604r1594b630, p3l956t647r1042b681],
31	exposed	VBN	O	expose	partmod	30	SENT_112	[p3l1458t604r1594b630, p3l956t647r1042b681],
32	non-human	JJ	O	non-human	amod	33	SENT_112	[p3l1057t647r1231b673],
33	primates	NNS	O	primate	dobj	31	SENT_112	[p3l1246t647r1374b681],
34	[	VBP	O	[	rcmod	29	SENT_112	[p3l1393t647r1486b681],
35	9	CD	NUMBER	9	nsubj	20	SENT_112	[p3l1393t647r1486b681],
36	,	,	O	,	_	0	SENT_112	[p3l1393t647r1486b681],
37	lO	NNP	O	lO	appos	35	SENT_112	[p3l1393t647r1486b681],
38	]	CD	NUMBER	]	num	37	SENT_112	[p3l1393t647r1486b681],
39	.	.	O	.	_	0	SENT_112	[p3l1393t647r1486b681],

1	In	IN	O	in	_	0	SENT_113	[p3l1503t647r1534b672],
2	the	DT	O	the	det	5	SENT_113	[p3l1549t647r1594b673],
3	latter	JJ	O	latter	amod	5	SENT_113	[p3l957t691r1034b717],
4	animal	NN	O	animal	nn	5	SENT_113	[p3l1047t691r1148b716],
5	models	NNS	O	model	prep_in	10	SENT_113	[p3l1161t691r1273b723],
6	,	,	O	,	_	0	SENT_113	[p3l1161t691r1273b723],
7	the	DT	O	the	det	8	SENT_113	[p3l1288t691r1332b717],
8	monkeys	NNS	O	monkey	nsubj	10	SENT_113	[p3l1346t691r1476b725],
9	remain	VBP	O	remain	cop	10	SENT_113	[p3l1490t691r1594b717],
10	seronegative	JJ	O	seronegative	_	0	SENT_113	[p3l957t734r1140b768],
11	despite	IN	O	despite	_	0	SENT_113	[p3l1164t734r1266b768],
12	detection	NN	O	detection	prep_despite	10	SENT_113	[p3l1289t734r1425b760],
13	of	IN	O	of	_	0	SENT_113	[p3l1448t734r1480b760],
14	simian	JJ	O	simian	amod	16	SENT_113	[p3l1498t734r1594b760],
15	immunodeﬁciency	NN	O	immunodeﬁciency	nn	16	SENT_113	[p3l957t778r1233b812],
16	virus	NN	O	virus	prep_of	12	SENT_113	[p3l1262t778r1460b812],
17	—	CD	NUMBER	—	num	21	SENT_113	[p3l1262t778r1460b812],
18	speciﬁc	NN	O	speciﬁc	nn	21	SENT_113	[p3l1262t778r1460b812],
19	T	NN	O	t	nn	21	SENT_113	[p3l1491t778r1515b803],
20	cell	NN	O	cell	nn	21	SENT_113	[p3l1546t778r1594b804],
21	responses	NNS	O	response	dep	16	SENT_113	[p3l957t831r1104b856],
22	.	.	O	.	_	0	SENT_113	[p3l957t831r1104b856],

1	Furthermore	RB	O	furthermore	advmod	10	SENT_114	[p3l1120t822r1319b854],
2	,	,	O	,	_	0	SENT_114	[p3l1120t822r1319b854],
3	low	JJ	O	low	amod	4	SENT_114	[p3l1333t822r1385b848],
4	levels	NNS	O	level	nsubjpass	10	SENT_114	[p3l1397t822r1476b848],
5	of	IN	O	of	_	0	SENT_114	[p3l1490t822r1522b848],
6	viral	JJ	O	viral	amod	7	SENT_114	[p3l1528t822r1594b847],
7	RNA	NN	O	rna	prep_of	4	SENT_114	[p3l957t865r1037b891],
8	can	MD	O	can	aux	10	SENT_114	[p3l1053t874r1104b891],
9	be	VB	O	be	auxpass	10	SENT_114	[p3l1122t865r1155b891],
10	detected	VBN	O	detect	_	0	SENT_114	[p3l1173t865r1298b891],
11	only	RB	O	only	advmod	10	SENT_114	[p3l1315t865r1378b899],
12	transiently	RB	O	transiently	advmod	10	SENT_114	[p3l1395t865r1551b899],
13	in	IN	O	in	_	0	SENT_114	[p3l1567t865r1594b890],
14	the	DT	O	the	det	15	SENT_114	[p3l957t909r1002b935],
15	blood	NN	O	blood	prep_in	10	SENT_114	[p3l1016t909r1100b935],
16	of	IN	O	of	_	0	SENT_114	[p3l1113t909r1145b935],
17	the	DT	O	the	det	19	SENT_114	[p3l1154t909r1198b935],
18	exposed	VBN	O	expose	amod	19	SENT_114	[p3l1213t909r1332b943],
19	animals	NNS	O	animal	prep_of	15	SENT_114	[p3l1346t909r1467b941],
20	,	,	O	,	_	0	SENT_114	[p3l1346t909r1467b941],
21	indicating	VBG	O	indicate	xcomp	10	SENT_114	[p3l1482t909r1594b935, p3l957t952r1003b986],
22	that	IN	O	that	complm	29	SENT_114	[p3l1013t952r1071b978],
23	control	NN	O	control	nsubj	29	SENT_114	[p3l1083t952r1187b978],
24	of	IN	O	of	_	0	SENT_114	[p3l1199t952r1231b978],
25	immunodeﬁciency	NN	O	immunodeﬁciency	nn	27	SENT_114	[p3l1237t952r1514b986],
26	virus	NN	O	virus	nn	27	SENT_114	[p3l1523t952r1594b978],
27	spread	NN	O	spread	prep_of	23	SENT_114	[p3l957t996r1054b1030],
28	is	VBZ	O	be	cop	29	SENT_114	[p3l1067t996r1087b1022],
29	possible	JJ	O	possible	ccomp	21	SENT_114	[p3l1100t996r1215b1030],
30	even	RB	O	even	advmod	29	SENT_114	[p3l1230t1005r1297b1022],
31	after	IN	O	after	_	0	SENT_114	[p3l1311t996r1378b1022],
32	production	NN	O	production	prep_after	29	SENT_114	[p3l1390t996r1554b1030],
33	of	IN	O	of	_	0	SENT_114	[p3l1568t996r1600b1022],
34	substantial	JJ	O	substantial	amod	35	SENT_114	[p3l957t1039r1114b1065],
35	amounts	NNS	O	amount	prep_of	32	SENT_114	[p3l1145t1045r1272b1065],
36	of	IN	O	of	_	0	SENT_114	[p3l1303t1039r1335b1065],
37	virus	NN	O	virus	nn	38	SENT_114	[p3l1360t1039r1431b1065],
38	particles	NNS	O	particle	prep_of	35	SENT_114	[p3l1462t1039r1592b1073],
39	.	.	O	.	_	0	SENT_114	[p3l1462t1039r1592b1073],

1	Assuming	VBG	O	assume	partmod	25	SENT_115	[p3l956t1083r1103b1117],
2	an	DT	O	a	det	4	SENT_115	[p3l1117t1092r1152b1108],
3	unbiased	JJ	O	unbiased	amod	4	SENT_115	[p3l1167t1083r1300b1109],
4	distribution	NN	O	distribution	dobj	1	SENT_115	[p3l1315t1083r1486b1109],
5	of	IN	O	of	_	0	SENT_115	[p3l1502t1083r1534b1109],
6	risk	NN	O	risk	nn	7	SENT_115	[p3l1544t1083r1595b1109],
7	factors	NNS	O	factor	prep_of	4	SENT_115	[p3l956t1126r1054b1152],
8	in	IN	O	in	_	0	SENT_115	[p3l1075t1126r1103b1151],
9	the	DT	O	the	det	13	SENT_115	[p3l1124t1126r1169b1152],
10	vaccine	NN	O	vaccine	nn	13	SENT_115	[p3l1189t1126r1300b1152],
11	and	CC	O	and	_	0	SENT_115	[p3l1322t1126r1377b1152],
12	placebo	NN	O	placebo	conj_and	10	SENT_115	[p3l1397t1126r1511b1160],
13	subgroups	NNS	O	subgroup	prep_in	7	SENT_115	[p3l1533t1126r1594b1152, p3l957t1179r1056b1204],
14	with	IN	O	with	_	0	SENT_115	[p3l1079t1170r1144b1196],
15	pre-existing	JJ	O	pre-existing	amod	17	SENT_115	[p3l1167t1170r1342b1204],
16	adenoviral	JJ	O	adenoviral	amod	17	SENT_115	[p3l1365t1170r1521b1196],
17	immunity	NN	O	immunity	prep_with	1	SENT_115	[p3l1545t1170r1594b1195, p3l957t1214r1070b1248],
18	,	,	O	,	_	0	SENT_115	[p3l1545t1170r1594b1195, p3l957t1214r1070b1248],
19	the	DT	O	the	det	20	SENT_115	[p3l1096t1214r1140b1240],
20	results	NNS	O	result	nsubj	25	SENT_115	[p3l1165t1214r1257b1240],
21	of	IN	O	of	_	0	SENT_115	[p3l1283t1214r1315b1240],
22	the	DT	O	the	det	24	SENT_115	[p3l1334t1214r1378b1240],
23	STEP	NN	O	step	nn	24	SENT_115	[p3l1405t1214r1493b1240],
24	study	NN	O	study	prep_of	20	SENT_115	[p3l1517t1214r1595b1248],
25	provide	VBP	O	provide	_	0	SENT_115	[p3l956t1257r1068b1291],
26	further	JJ	O	further	amod	27	SENT_115	[p3l1081t1257r1184b1283],
27	support	NN	O	support	dobj	25	SENT_115	[p3l1196t1263r1308b1291],
28	for	IN	O	for	_	0	SENT_115	[p3l1319t1257r1361b1283],
29	the	DT	O	the	det	30	SENT_115	[p3l1373t1257r1418b1283],
30	occurrence	NN	O	occurrence	prep_for	25	SENT_115	[p3l1431t1266r1594b1283],
31	of	IN	O	of	_	0	SENT_115	[p3l957t1301r989b1327],
32	occult	NN	O	occult	nn	34	SENT_115	[p3l1003t1301r1091b1327],
33	HIV	NN	MISC	hiv	nn	34	SENT_115	[p3l1110t1301r1179b1326],
34	infections	NNS	O	infection	prep_of	30	SENT_115	[p3l1197t1301r1338b1327],
35	in	IN	O	in	_	0	SENT_115	[p3l1357t1301r1384b1326],
36	humans	NNS	O	human	prep_in	34	SENT_115	[p3l1403t1301r1520b1327],
37	and	CC	O	and	_	0	SENT_115	[p3l1540t1301r1595b1327],
38	even	RB	O	even	advmod	25	SENT_115	[p3l957t1354r1025b1371],
39	allow	VB	O	allow	conj_and	25	SENT_115	[p3l1037t1345r1115b1371],
40	an	DT	O	a	det	41	SENT_115	[p3l1126t1354r1161b1370],
41	estimation	NN	O	estimation	dobj	39	SENT_115	[p3l1174t1345r1327b1371],
42	of	IN	O	of	_	0	SENT_115	[p3l1339t1345r1371b1371],
43	the	DT	O	the	det	45	SENT_115	[p3l1378t1345r1422b1371],
44	lower	JJR	O	lower	amod	45	SENT_115	[p3l1434t1345r1516b1371],
45	limit	NN	O	limit	prep_of	41	SENT_115	[p3l1527t1345r1595b1371],
46	of	IN	O	of	_	0	SENT_115	[p3l957t1388r989b1414],
47	the	DT	O	the	det	48	SENT_115	[p3l998t1388r1043b1414],
48	frequency	NN	O	frequency	prep_of	45	SENT_115	[p3l1057t1388r1205b1422],
49	of	IN	O	of	_	0	SENT_115	[p3l1218t1388r1250b1414],
50	occult	NN	O	occult	nn	52	SENT_115	[p3l1259t1388r1348b1414],
51	HIV	NN	MISC	hiv	nn	52	SENT_115	[p3l1362t1388r1430b1414],
52	infections	NNS	O	infection	prep_of	48	SENT_115	[p3l1444t1388r1592b1414],
53	.	.	O	.	_	0	SENT_115	[p3l1444t1388r1592b1414],

1	An	DT	O	a	det	4	SENT_116	[p3l956t1432r1000b1457],
2	approximate	JJ	O	approximate	amod	4	SENT_116	[p3l1026t1432r1214b1466],
3	2-fold	JJ	O	2-fold	amod	4	SENT_116	[p3l1241t1432r1326b1459],
4	increase	NN	O	increase	_	0	SENT_116	[p3l1351t1432r1470b1458],
5	in	IN	O	in	_	0	SENT_116	[p3l1496t1432r1523b1457],
6	the	DT	O	the	det	7	SENT_116	[p3l1549t1432r1594b1458],
7	incidence	NN	O	incidence	prep_in	4	SENT_116	[p3l957t1475r1097b1501],
8	of	IN	O	of	dep	4	SENT_116	[p3l1110t1475r1142b1501],
9	seropositive	JJ	O	seropositive	amod	11	SENT_116	[p3l1149t1475r1321b1509],
10	HIV	NN	MISC	hiv	nn	11	SENT_116	[p3l1334t1475r1403b1501],
11	infections	NNS	O	infection	pobj	8	SENT_116	[p3l1414t1475r1555b1501],
12	in	IN	O	in	dep	4	SENT_116	[p3l1567t1475r1594b1500],

1	Results	NNS	O	result	dep	9	SENT_117	[p3l1016t1633r1098b1654],
2	from	IN	O	from	_	0	SENT_117	[p3l1119t1633r1174b1653],
3	the	DT	O	the	det	4	SENT_117	[p3l1195t1634r1230b1654],
4	STEP	NN	O	step	prep_from	1	SENT_117	[p3l1252t1633r1321b1653],
5	Study	NN	O	study	dep	9	SENT_117	[p3l1342t1633r1408b1660],
6	(	CD	NUMBER	(	num	5	SENT_117	[p3l1429t1633r1511b1660],
7	Merck	NNP	ORGANIZATION	Merck	nn	9	SENT_117	[p3l1429t1633r1511b1660],
8	V520	NN	O	v520	nn	9	SENT_117	[p3l1531t1634r1594b1654],
9	Protocol	NNP	O	Protocol	dep	12	SENT_117	[p3l1016t1667r1113b1688],
10	023/HVTN	NN	O	023/hvtn	dep	9	SENT_117	[p3l1128t1667r1271b1688],
11	502	CD	NUMBER	502	num	12	SENT_117	[p3l1286t1668r1341b1694],
12	)	NN	O	)	_	0	SENT_117	[p3l1286t1668r1341b1694],
13	:	:	O	:	_	0	SENT_117	[p3l1286t1668r1341b1694],
14	A	DT	O	a	det	15	SENT_117	[p3l1356t1668r1376b1687],
15	Phase	NN	O	phase	dep	12	SENT_117	[p3l1390t1667r1455b1688],
16	II	CD	NUMBER	ii	num	18	SENT_117	[p3l1471t1668r1489b1687],
17	TestofConcept	NNP	O	TestofConcept	nn	18	SENT_117	[p3l1504t1667r1594b1688, p3l1016t1701r1114b1728],
18	Trial	NNP	O	Trial	dep	15	SENT_117	[p3l1123t1701r1181b1721],
19	of	IN	O	of	_	0	SENT_117	[p3l1190t1701r1215b1722],
20	the	DT	O	the	det	21	SENT_117	[p3l1220t1701r1254b1722],
21	l	NN	O	l	prep_of	18	SENT_117	[p3l1264t1701r1382b1722],
22	\	CD	NUMBER	\	number	23	SENT_117	[p3l1264t1701r1382b1722],
23	’	CD	NUMBER	’	dep	21	SENT_117	[p3l1264t1701r1382b1722],
24	IRKAd	NN	O	irkad	nn	27	SENT_117	[p3l1264t1701r1382b1722],
25	.5	CD	NUMBER	.5	num	27	SENT_117	[p3l1264t1701r1382b1722],
26	HIV-l	NN	O	hiv-l	nn	27	SENT_117	[p3l1392t1702r1466b1722],
27	Gag/Pol	NN	O	gag/pol	dep	23	SENT_117	[p3l1479t1701r1593b1728],
28	/	:	O	/	punct	15	SENT_117	[p3l1479t1701r1593b1728],
29	Nef	NN	O	nef	dep	15	SENT_117	[p3l1016t1735r1061b1756],
30	Trivalent	JJ	O	trivalent	amod	31	SENT_117	[p3l1068t1735r1175b1756],
31	Vaccine	NN	O	vaccine	dep	29	SENT_117	[p3l1186t1735r1286b1756],
32	.	.	O	.	_	0	SENT_117	[p3l1186t1735r1286b1756],

1	5	CD	NUMBER	5	_	0	SENT_118	[p3l972t1771r990b1790],
2	.	.	O	.	_	0	SENT_118	[p3l972t1771r990b1790],

1	Buchbinder	NNP	PERSON	Buchbinder	nn	2	SENT_119	[p3l1014t1770r1152b1791],
2	S	NNP	O	S	nsubj	3	SENT_119	[p3l1174t1770r1187b1790],
3	(	VBD	O	(	_	0	SENT_119	[p3l1209t1771r1279b1797],
4	2008	CD	DATE	2008	dobj	3	SENT_119	[p3l1209t1771r1279b1797],
5	)	CD	NUMBER	)	num	7	SENT_119	[p3l1209t1771r1279b1797],
6	STEP	NN	O	step	nn	7	SENT_119	[p3l1302t1770r1371b1790],
7	Trial	NN	O	trial	dep	4	SENT_119	[p3l1392t1770r1456b1790],
8	:	:	O	:	_	0	SENT_119	[p3l1392t1770r1456b1790],
9	Exploring	VBG	O	explore	amod	10	SENT_119	[p3l1479t1770r1595b1797],
10	hypotheses	NNS	O	hypothesis	dep	4	SENT_119	[p3l1014t1804r1140b1831],
11	for	IN	O	for	_	0	SENT_119	[p3l1152t1804r1184b1824],
12	differential	JJ	O	differential	amod	15	SENT_119	[p3l1195t1804r1320b1825],
13	HIV	NN	O	hiv	nn	15	SENT_119	[p3l1332t1805r1385b1824],
14	acquisition	NN	O	acquisition	nn	15	SENT_119	[p3l1397t1804r1522b1831],
15	rates	NNS	O	rate	prep_for	10	SENT_119	[p3l1534t1809r1593b1825],
16	.	.	O	.	_	0	SENT_119	[p3l1534t1809r1593b1825],

1	HVTN	NNP	ORGANIZATION	HVTN	_	0	SENT_120	[p3l1015t1839r1099b1859],
2	Full	JJ	ORGANIZATION	full	amod	4	SENT_120	[p3l1111t1839r1154b1859],
3	Group	NNP	ORGANIZATION	Group	nn	4	SENT_120	[p3l1166t1838r1241b1865],
4	l	NN	O	l	tmod	1	SENT_120	[p3l1253t1838r1350b1865],
5	\	CD	NUMBER	\	number	6	SENT_120	[p3l1253t1838r1350b1865],
6	’	CD	NUMBER	’	dep	1	SENT_120	[p3l1253t1838r1350b1865],
7	Ieeting	NNP	O	Ieeting	nn	8	SENT_120	[p3l1253t1838r1350b1865],
8	November	NNP	DATE	November	dep	6	SENT_120	[p3l1360t1839r1483b1859],
9	7	CD	DATE	7	num	8	SENT_120	[p3l1495t1839r1513b1863],
10	,	,	DATE	,	_	0	SENT_120	[p3l1495t1839r1513b1863],
11	2007	CD	DATE	2007	num	8	SENT_120	[p3l1526t1839r1588b1859],
12	.	.	O	.	_	0	SENT_120	[p3l1526t1839r1588b1859],

1	6	CD	NUMBER	6	_	0	SENT_121	[p3l972t1874r990b1894],
2	.	.	O	.	_	0	SENT_121	[p3l972t1874r990b1894],

1	l\/IcElrath	NN	O	l\/icelrath	nn	2	SENT_122	[p3l1014t1873r1125b1894],
2	J	NN	O	j	_	0	SENT_122	[p3l1140t1874r1160b1900],
3	,	,	O	,	_	0	SENT_122	[p3l1140t1874r1160b1900],
4	Casimiro	NNP	ORGANIZATION	Casimiro	nn	5	SENT_122	[p3l1181t1873r1286b1894],
5	DR	NN	O	dr	appos	2	SENT_122	[p3l1306t1873r1348b1893],
6	(	CD	NUMBER	(	num	5	SENT_122	[p3l1369t1873r1438b1900],
7	2008	CD	DATE	2008	number	8	SENT_122	[p3l1369t1873r1438b1900],
8	)	CD	NUMBER	)	num	11	SENT_122	[p3l1369t1873r1438b1900],
9	The	DT	O	the	det	11	SENT_122	[p3l1458t1874r1505b1894],
10	STEP	NN	O	step	nn	11	SENT_122	[p3l1526t1873r1595b1893],
11	Trial	NN	O	trial	dep	5	SENT_122	[p3l1014t1907r1077b1928],
12	.	.	O	.	_	0	SENT_122	[p3l1014t1907r1077b1928],

1	A	DT	O	a	det	2	SENT_123	[p3l1097t1908r1117b1927],
2	Pathway	NN	O	pathway	_	0	SENT_123	[p3l1136t1907r1235b1934],
3	Toward	IN	O	toward	_	0	SENT_123	[p3l1254t1907r1347b1928],
4	Understanding	VBG	O	understand	prepc_toward	2	SENT_123	[p3l1366t1907r1541b1934],
5	the	DT	O	the	det	7	SENT_123	[p3l1559t1908r1594b1928],
6	Biological	JJ	O	biological	amod	7	SENT_123	[p3l1014t1941r1127b1968],
7	Basis	NN	O	basis	dobj	4	SENT_123	[p3l1139t1941r1195b1961],
8	for	IN	O	for	_	0	SENT_123	[p3l1207t1941r1239b1961],
9	the	DT	O	the	det	12	SENT_123	[p3l1250t1942r1285b1962],
10	Vaccine	NNP	O	Vaccine	nn	12	SENT_123	[p3l1296t1941r1390b1962],
11	Efficacy	NNP	O	Efficacy	nn	12	SENT_123	[p3l1402t1941r1494b1968],
12	Results	NNS	O	result	prep_for	4	SENT_123	[p3l1505t1941r1593b1962],
13	.	.	O	.	_	0	SENT_123	[p3l1505t1941r1593b1962],

1	HVTN	NNP	O	HVTN	_	0	SENT_124	[p3l1014t1976r1099b1996],
2	Full	JJ	O	full	amod	4	SENT_124	[p3l1110t1975r1154b1996],
3	Group	NNP	O	Group	nn	4	SENT_124	[p3l1166t1975r1241b2002],
4	Nleeting	NNP	O	Nleeting	dep	1	SENT_124	[p3l1253t1975r1349b2002],
5	November	NNP	DATE	November	tmod	4	SENT_124	[p3l1360t1976r1483b1996],
6	7	CD	DATE	7	num	5	SENT_124	[p3l1495t1976r1513b2000],
7	,	,	DATE	,	_	0	SENT_124	[p3l1495t1976r1513b2000],
8	2007	CD	DATE	2007	num	5	SENT_124	[p3l1526t1976r1587b1996],
9	.	.	O	.	_	0	SENT_124	[p3l1526t1976r1587b1996],

1	7	CD	NUMBER	7	_	0	SENT_125	[p3l973t2011r990b2031],
2	.	.	O	.	_	0	SENT_125	[p3l973t2011r990b2031],

1	Rowland-Jones	NNP	O	Rowland-Jones	nn	4	SENT_126	[p3l1014t2010r1191b2037],
2	SL	NNP	O	SL	nn	4	SENT_126	[p3l1200t2010r1238b2035],
3	,	,	O	,	_	0	SENT_126	[p3l1200t2010r1238b2035],
4	lVIcl	NNP	O	lVIcl	nsubj	5	SENT_126	[p3l1247t2010r1381b2031],
5	\	VBD	O	\	_	0	SENT_126	[p3l1247t2010r1381b2031],
6	’	CD	NUMBER	’	num	7	SENT_126	[p3l1247t2010r1381b2031],
7	Iichael	NN	O	iichael	dobj	5	SENT_126	[p3l1247t2010r1381b2031],
8	A	DT	O	a	det	10	SENT_126	[p3l1389t2011r1408b2030],
9	(	NN	O	(	nn	10	SENT_126	[p3l1417t2011r1486b2037],
10	l995	NN	O	l995	dep	7	SENT_126	[p3l1417t2011r1486b2037],
11	)	CD	NUMBER	)	num	13	SENT_126	[p3l1417t2011r1486b2037],
12	Immune	JJ	O	immune	amod	13	SENT_126	[p3l1496t2011r1594b2031],
13	responses	NNS	O	response	dep	10	SENT_126	[p3l1014t2052r1122b2071],
14	in	IN	O	in	_	0	SENT_126	[p3l1143t2044r1164b2064],
15	HIV-exposed	JJ	O	hiv-exposed	amod	16	SENT_126	[p3l1184t2045r1340b2071],
16	seronegatives	NNS	O	seronegative	prep_in	5	SENT_126	[p3l1361t2044r1519b2071],
17	:	:	O	:	_	0	SENT_126	[p3l1361t2044r1519b2071],
18	have	VB	O	have	csubj	20	SENT_126	[p3l1541t2045r1594b2065],
19	they	PRP	O	they	dobj	18	SENT_126	[p3l1014t2079r1063b2105],
20	repelled	VBD	O	repel	parataxis	5	SENT_126	[p3l1076t2078r1168b2105],
21	the	DT	O	the	det	22	SENT_126	[p3l1181t2079r1216b2099],
22	virus	NN	O	virus	dobj	20	SENT_126	[p3l1229t2078r1295b2099],
23	?	.	O	?	_	0	SENT_126	[p3l1229t2078r1295b2099],

1	Curr	NNP	O	Curr	nn	3	SENT_127	[p3l1310t2078r1366b2099],
2	Opin	NNP	O	Opin	nn	3	SENT_127	[p3l1380t2078r1439b2105],
3	Immunol	NNP	O	Immunol	_	0	SENT_127	[p3l1453t2079r1561b2099],
4	7	CD	NUMBER	7	num	3	SENT_127	[p3l1576t2079r1593b2099],
5	:	:	O	:	_	0	SENT_127	[p3l1576t2079r1593b2099],
6	448	CD	NUMBER	448	num	7	SENT_127	[p3l1014t2113r1120b2133],
7	—	NN	O	—	dep	3	SENT_127	[p3l1014t2113r1120b2133],
8	455	CD	NUMBER	455	dep	7	SENT_127	[p3l1014t2113r1120b2133],
9	.	.	O	.	_	0	SENT_127	[p3l1014t2113r1120b2133],

1	8	CD	NUMBER	8	_	0	SENT_128	[p3l972t2148r991b2168],
2	.	.	O	.	_	0	SENT_128	[p3l972t2148r991b2168],

1	Kulkarni	NNP	PERSON	Kulkarni	nn	4	SENT_129	[p3l1015t2147r1121b2168],
2	PS	NNP	O	PS	nn	4	SENT_129	[p3l1143t2147r1180b2172],
3	,	,	O	,	_	0	SENT_129	[p3l1143t2147r1180b2172],
4	Butera	NNP	ORGANIZATION	Butera	dep	12	SENT_129	[p3l1203t2147r1282b2168],
5	ST	JJ	ORGANIZATION	st	dep	4	SENT_129	[p3l1304t2147r1345b2172],
6	,	,	O	,	_	0	SENT_129	[p3l1304t2147r1345b2172],
7	Duerr	NNP	ORGANIZATION	Duerr	appos	5	SENT_129	[p3l1367t2147r1439b2168],
8	AC	NN	ORGANIZATION	ac	dep	12	SENT_129	[p3l1460t2147r1499b2167],
9	(	CD	NUMBER	(	num	8	SENT_129	[p3l1522t2147r1594b2174],
10	2003	CD	DATE	2003	num	12	SENT_129	[p3l1522t2147r1594b2174],
11	)	CD	NUMBER	)	num	12	SENT_129	[p3l1522t2147r1594b2174],
12	Resistance	NN	O	resistance	dep	18	SENT_129	[p3l1015t2181r1136b2202],
13	to	TO	O	to	_	0	SENT_129	[p3l1154t2186r1176b2202],
14	HIV-1	NN	O	hiv-1	nn	15	SENT_129	[p3l1194t2182r1267b2202],
15	infection	NN	O	infection	prep_to	12	SENT_129	[p3l1288t2181r1394b2202],
16	:	:	O	:	_	0	SENT_129	[p3l1288t2181r1394b2202],
17	lessons	NNS	O	lesson	nsubj	18	SENT_129	[p3l1413t2182r1491b2202],
18	learned	VBD	O	learn	_	0	SENT_129	[p3l1508t2182r1594b2202],
19	from	IN	O	from	_	0	SENT_129	[p3l1015t2215r1072b2236],
20	studies	NNS	O	study	prep_from	18	SENT_129	[p3l1094t2215r1175b2236],
21	of	IN	O	of	prep	20	SENT_129	[p3l1198t2215r1224b2236],
22	highly	RB	O	highly	pcomp	21	SENT_129	[p3l1242t2215r1316b2242],
23	exposed	VBN	O	expose	partmod	20	SENT_129	[p3l1338t2216r1435b2242],
24	persistently	RB	O	persistently	advmod	23	SENT_129	[p3l1457t2215r1595b2242],
25	the	DT	O	the	det	27	SENT_129	[p3l1671t256r1715b282],
26	vaccine	NN	O	vaccine	nn	27	SENT_129	[p3l1742t256r1853b282],
27	subgroup	NN	O	subgroup	nsubj	32	SENT_129	[p3l1880t256r2018b290],
28	with	IN	O	with	_	0	SENT_129	[p3l2044t256r2108b282],
29	pre-existing	JJ	O	pre-existing	amod	31	SENT_129	[p3l2135t256r2309b290],
30	adenoviral	JJ	O	adenoviral	amod	31	SENT_129	[p3l1671t300r1828b326],
31	immunity	NN	O	immunity	prep_with	27	SENT_129	[p3l1842t300r1987b334],
32	suggests	VBZ	O	suggest	ccomp	23	SENT_129	[p3l2000t306r2117b334],
33	that	IN	O	that	complm	53	SENT_129	[p3l2132t300r2189b326],
34	at	IN	O	at	quantmod	36	SENT_129	[p3l2204t306r2230b326],
35	least	JJS	O	least	quantmod	36	SENT_129	[p3l2244t300r2309b326],
36	half	NN	O	half	nsubjpass	53	SENT_129	[p3l1671t345r1731b370],
37	of	IN	O	of	_	0	SENT_129	[p3l1738t345r1770b371],
38	all	DT	O	all	det	42	SENT_129	[p3l1777t345r1810b370],
39	early	JJ	O	early	amod	42	SENT_129	[p3l1822t345r1895b379],
40	stage	NN	O	stage	nn	42	SENT_129	[p3l1906t351r1978b379],
41	HIV	NN	O	hiv	nn	42	SENT_129	[p3l1991t345r2060b371],
42	infections	NNS	O	infection	prep_of	36	SENT_129	[p3l2071t345r2212b371],
43	of	IN	O	of	_	0	SENT_129	[p3l2224t345r2256b371],
44	the	DT	O	the	det	47	SENT_129	[p3l2263t345r2308b371],
45	non-immunized	JJ	O	non-immunized	amod	47	SENT_129	[p3l1671t389r1909b415],
46	study	NN	O	study	nn	47	SENT_129	[p3l1937t389r2015b423],
47	participants	NNS	O	participant	prep_of	42	SENT_129	[p3l2042t389r2216b423],
48	with	IN	O	with	_	0	SENT_129	[p3l2244t389r2308b415],
49	pre-existing	JJ	O	pre-existing	amod	51	SENT_129	[p3l1670t433r1845b467],
50	adenoviral	JJ	O	adenoviral	amod	51	SENT_129	[p3l1858t433r2014b459],
51	immunity	NN	O	immunity	prep_with	47	SENT_129	[p3l2027t433r2172b467],
52	are	VBP	O	be	auxpass	53	SENT_129	[p3l2185t442r2230b459],
53	contained	VBN	O	contain	ccomp	32	SENT_129	[p3l2244t442r2308b459, p3l1671t478r1763b504],
54	prior	RB	O	prior	_	0	SENT_129	[p3l1791t478r1865b512],
55	to	TO	O	to	_	0	SENT_129	[p3l1894t484r1922b504],
56	seroconversion	NN	O	seroconversion	prep_prior_to	53	SENT_129	[p3l1952t478r2180b504],
57	.	.	O	.	_	0	SENT_129	[p3l1952t478r2180b504],

1	If	IN	O	if	mark	9	SENT_130	[p3l2212t478r2239b503],
2	the	DT	O	the	det	4	SENT_130	[p3l2263t478r2308b504],
3	enhancing	JJ	O	enhancing	amod	4	SENT_130	[p3l1671t522r1826b556],
4	effect	NN	O	effect	nsubj	9	SENT_130	[p3l1845t522r1923b548],
5	of	IN	O	of	_	0	SENT_130	[p3l1942t522r1974b548],
6	vaccination	NN	O	vaccination	prep_of	4	SENT_130	[p3l1986t522r2157b548],
7	does	VBZ	O	do	aux	9	SENT_130	[p3l2177t522r2241b548],
8	not	RB	O	not	neg	9	SENT_130	[p3l2261t528r2309b548],
9	mediate	VB	O	mediate	advcl	33	SENT_130	[p3l1671t567r1788b593],
10	progression	NN	O	progression	dobj	9	SENT_130	[p3l1801t567r1971b601],
11	of	IN	O	of	_	0	SENT_130	[p3l1985t567r2017b593],
12	all	DT	O	all	det	16	SENT_130	[p3l2024t567r2058b592],
13	early	JJ	O	early	amod	16	SENT_130	[p3l2070t567r2143b601],
14	stage	NN	O	stage	nn	16	SENT_130	[p3l2155t573r2226b601],
15	HIV	NN	O	hiv	nn	16	SENT_130	[p3l2240t567r2309b592],
16	infections	NNS	O	infection	prep_of	10	SENT_130	[p3l1671t611r1811b637],
17	into	IN	O	into	_	0	SENT_130	[p3l1827t611r1883b637],
18	established	JJ	O	established	amod	20	SENT_130	[p3l1899t611r2060b637],
19	HIV	NN	MISC	hiv	nn	20	SENT_130	[p3l2075t611r2144b637],
20	infections	NNS	O	infection	prep_into	9	SENT_130	[p3l2158t611r2307b643],
21	,	,	O	,	_	0	SENT_130	[p3l2158t611r2307b643],
22	the	DT	O	the	det	23	SENT_130	[p3l1671t655r1715b681],
23	ratio	NN	O	ratio	nsubj	33	SENT_130	[p3l1739t655r1806b681],
24	of	IN	O	of	_	0	SENT_130	[p3l1829t655r1861b681],
25	occult	NN	O	occult	nn	26	SENT_130	[p3l1878t655r1966b681],
26	infections	NNS	O	infection	prep_of	23	SENT_130	[p3l1988t655r2128b681],
27	to	TO	O	to	_	0	SENT_130	[p3l2151t661r2178b681],
28	evident	JJ	O	evident	amod	29	SENT_130	[p3l2201t655r2309b681],
29	infections	NNS	O	infection	prep_to	26	SENT_130	[p3l1671t700r1811b726],
30	should	MD	O	should	aux	33	SENT_130	[p3l1826t700r1923b726],
31	even	RB	O	even	advmod	33	SENT_130	[p3l1937t709r2004b726],
32	be	VB	O	be	cop	33	SENT_130	[p3l2018t700r2052b726],
33	larger	JJR	O	larger	_	0	SENT_130	[p3l2066t700r2152b734],
34	than	IN	O	than	_	0	SENT_130	[p3l2166t700r2232b726],
35	two	CD	NUMBER	two	prep_than	33	SENT_130	[p3l2246t706r2306b726],
36	.	.	O	.	_	0	SENT_130	[p3l2246t706r2306b726],

1	Therefore	RB	O	therefore	advmod	6	SENT_131	[p3l1671t744r1828b776],
2	,	,	O	,	_	0	SENT_131	[p3l1671t744r1828b776],
3	occult	NN	O	occult	nn	5	SENT_131	[p3l1846t744r1934b770],
4	HIV	NN	MISC	hiv	nn	5	SENT_131	[p3l1950t744r2019b770],
5	infections	NNS	O	infection	nsubj	6	SENT_131	[p3l2034t744r2175b770],
6	seem	VBP	O	seem	_	0	SENT_131	[p3l2192t753r2264b770],
7	to	TO	O	to	aux	11	SENT_131	[p3l2280t750r2308b770],
8	be	VB	O	be	cop	11	SENT_131	[p3l1671t789r1704b815],
9	much	RB	O	much	advmod	11	SENT_131	[p3l1729t789r1812b815],
10	more	RBR	O	more	advmod	11	SENT_131	[p3l1836t798r1912b815],
11	frequent	JJ	O	frequent	xcomp	6	SENT_131	[p3l1935t789r2061b823],
12	than	IN	O	than	mark	14	SENT_131	[p3l2084t789r2150b815],
13	generally	RB	O	generally	advmod	14	SENT_131	[p3l2174t789r2309b823],
14	assumed	VBN	O	assume	ccomp	11	SENT_131	[p3l1671t833r1804b859],
15	.	.	O	.	_	0	SENT_131	[p3l1671t833r1804b859],

1	A	DT	O	a	det	3	SENT_132	[p3l1826t833r1852b858],
2	better	JJR	O	better	amod	3	SENT_132	[p3l1872t833r1959b859],
3	understanding	NN	O	understanding	nsubjpass	12	SENT_132	[p3l1979t833r2194b867],
4	of	IN	O	of	_	0	SENT_132	[p3l2215t833r2247b859],
5	the	DT	O	the	det	6	SENT_132	[p3l2263t833r2308b859],
6	determinants	NNS	O	determinant	prep_of	3	SENT_132	[p3l1671t878r1865b904],
7	of	IN	O	of	_	0	SENT_132	[p3l1878t878r1910b904],
8	occult	NN	O	occult	nn	9	SENT_132	[p3l1917t878r2005b904],
9	infections	NNS	O	infection	prep_of	6	SENT_132	[p3l2016t878r2157b904],
10	is	VBZ	O	be	auxpass	12	SENT_132	[p3l2169t878r2189b904],
11	urgently	RB	O	urgently	advmod	12	SENT_132	[p3l2200t884r2308b912, p3l1670t922r1696b956],
12	needed	VBN	O	need	_	0	SENT_132	[p3l1730t922r1836b948],
13	and	CC	O	and	_	0	SENT_132	[p3l1872t922r1927b948],
14	might	MD	O	might	aux	15	SENT_132	[p3l1961t922r2047b956],
15	provide	VB	O	provide	conj_and	12	SENT_132	[p3l2081t922r2194b956],
16	novel	JJ	O	novel	amod	17	SENT_132	[p3l2229t922r2309b948],
17	strategies	NNS	O	strategy	dobj	15	SENT_132	[p3l1671t966r1806b1000],
18	for	IN	O	for	_	0	SENT_132	[p3l1820t966r1862b992],
19	HIV	NN	MISC	hiv	nn	21	SENT_132	[p3l1876t966r1945b992],
20	vaccine	NN	O	vaccine	nn	21	SENT_132	[p3l1957t966r2068b992],
21	development	NN	O	development	prep_for	15	SENT_132	[p3l2083t966r2282b1000],
22	.	.	O	.	_	0	SENT_132	[p3l2083t966r2282b1000],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_133	[p3l1671t1057r2040b1096],

1	The	DT	O	the	det	2	SENT_134	[p3l1670t1130r1724b1153],
2	author	NN	O	author	nsubj	4	SENT_134	[p3l1741t1130r1829b1153],
3	would	MD	O	would	aux	4	SENT_134	[p3l1845t1130r1925b1153],
4	like	VB	O	like	_	0	SENT_134	[p3l1941t1130r1986b1153],
5	to	TO	O	to	aux	6	SENT_134	[p3l2003t1135r2027b1153],
6	thank	VB	O	thank	xcomp	4	SENT_134	[p3l2044t1130r2119b1153],
7	the	DT	O	the	det	9	SENT_134	[p3l2135t1130r2175b1153],
8	principal	JJ	O	principal	amod	9	SENT_134	[p3l2191t1130r2309b1160],
9	investigators	NNS	O	investigator	dobj	6	SENT_134	[p3l1671t1169r1834b1199],
10	of	IN	O	of	_	0	SENT_134	[p3l1844t1169r1873b1192],
11	the	DT	O	the	det	13	SENT_134	[p3l1878t1169r1918b1192],
12	STEP	NN	O	step	nn	13	SENT_134	[p3l1929t1169r2008b1191],
13	study	NN	O	study	prep_of	9	SENT_134	[p3l2017t1169r2086b1199],
14	for	IN	O	for	_	0	SENT_134	[p3l2096t1169r2132b1192],
15	sharing	VBG	O	share	prepc_for	6	SENT_134	[p3l2142t1169r2239b1199],
16	their	PRP$	O	they	poss	17	SENT_134	[p3l2248t1169r2309b1192],
17	results	NNS	O	result	dobj	15	SENT_134	[p3l1670t1208r1752b1231],
18	so	RB	O	so	advmod	19	SENT_134	[p3l1766t1216r1792b1231],
19	rapidly	RB	O	rapidly	advmod	15	SENT_134	[p3l1805t1208r1897b1238],
20	and	CC	O	and	_	0	SENT_134	[p3l1910t1208r1959b1231],
21	openly	RB	O	openly	advmod	15	SENT_134	[p3l1972t1208r2060b1238],
22	with	IN	O	with	_	0	SENT_134	[p3l2072t1208r2129b1231],
23	the	DT	O	the	det	25	SENT_134	[p3l2142t1208r2182b1231],
24	scientiﬁc	NN	O	scientiﬁc	nn	25	SENT_134	[p3l2195t1208r2308b1231],
25	community	NN	O	community	prep_with	15	SENT_134	[p3l1671t1247r1828b1277],
26	.	.	O	.	_	0	SENT_134	[p3l1671t1247r1828b1277],

1	The	DT	O	the	det	2	SENT_135	[p3l1849t1247r1903b1270],
2	author	NN	O	author	_	0	SENT_135	[p3l1923t1247r2011b1270],
3	thanks	NNS	O	thanks	dep	2	SENT_135	[p3l2031t1247r2116b1270],
4	lVIartin	NNP	O	lVIartin	nn	5	SENT_135	[p3l2136t1247r2228b1270],
5	Cranage	NNP	O	Cranage	dep	2	SENT_135	[p3l2249t1246r2308b1269, p3l1671t1294r1740b1316],
6	,	,	O	,	_	0	SENT_135	[p3l2249t1246r2308b1269, p3l1671t1294r1740b1316],
7	Christiane	NNP	PERSON	Christiane	nn	8	SENT_135	[p3l1754t1285r1890b1309],
8	Stahl-Hennig	NNP	PERSON	Stahl-Hennig	dep	2	SENT_135	[p3l1905t1286r2089b1316],
9	,	,	O	,	_	0	SENT_135	[p3l1905t1286r2089b1316],
10	Norbert	NNP	PERSON	Norbert	nn	11	SENT_135	[p3l2102t1286r2209b1309],
11	Brockmeyer	NNP	PERSON	Brockmeyer	conj_and	5	SENT_135	[p3l2221t1286r2308b1309, p3l1671t1334r1760b1356],
12	,	,	O	,	_	0	SENT_135	[p3l2221t1286r2308b1309, p3l1671t1334r1760b1356],
13	and	CC	O	and	_	0	SENT_135	[p3l1786t1326r1835b1349],
14	lVIatthias	NNP	O	lVIatthias	nn	15	SENT_135	[p3l1859t1326r1977b1349],
15	Tenbusch	NNP	O	Tenbusch	conj_and	5	SENT_135	[p3l2001t1326r2133b1349],
16	for	IN	O	for	_	0	SENT_135	[p3l2158t1326r2195b1349],
17	critical	JJ	O	critical	amod	18	SENT_135	[p3l2219t1326r2309b1349],
18	discussion	NN	O	discussion	prep_for	15	SENT_135	[p3l1671t1365r1809b1393],
19	,	,	O	,	_	0	SENT_135	[p3l1671t1365r1809b1393],
20	and	CC	O	and	_	0	SENT_135	[p3l1827t1365r1876b1388],
21	the	DT	O	the	det	23	SENT_135	[p3l1892t1365r1932b1388],
22	EUROPRISE	NNP	O	EUROPRISE	nn	23	SENT_135	[p3l1949t1364r2138b1387],
23	Network	NNP	O	Network	conj_and	5	SENT_135	[p3l2154t1365r2269b1388],
24	of	IN	O	of	_	0	SENT_135	[p3l2285t1365r2313b1388],
25	Excellence	NNP	O	Excellence	prep_of	23	SENT_135	[p3l1671t1404r1811b1427],
26	for	IN	O	for	_	0	SENT_135	[p3l1824t1404r1860b1427],
27	support	NN	O	support	prep_for	25	SENT_135	[p3l1872t1409r1978b1434],
28	.	.	O	.	_	0	SENT_135	[p3l1872t1409r1978b1434],

1	seronegative	JJ	O	seronegative	_	0	SENT_136	[p3l1729t1633r1871b1660],
2	(	CD	NUMBER	(	num	3	SENT_136	[p3l1890t1633r1975b1660],
3	HEPS	NN	O	hep	dep	1	SENT_136	[p3l1890t1633r1975b1660],
4	)	CD	NUMBER	)	num	5	SENT_136	[p3l1890t1633r1975b1660],
5	individuals	NNS	O	individual	dep	3	SENT_136	[p3l1992t1633r2123b1654],
6	.	.	O	.	_	0	SENT_136	[p3l1992t1633r2123b1654],

1	AIDS	NNP	O	AIDS	nn	2	SENT_137	[p3l2141t1633r2207b1653],
2	Rev	NN	O	rev	_	0	SENT_137	[p3l2225t1633r2271b1654],
3	5	CD	NUMBER	5	num	2	SENT_137	[p3l2288t1634r2307b1654],
4	:	:	O	:	_	0	SENT_137	[p3l2288t1634r2307b1654],
5	87	CD	NUMBER	87	number	6	SENT_137	[p3l1729t1668r1820b1688],
6	*	CD	NUMBER	*	num	7	SENT_137	[p3l1729t1668r1820b1688],
7	l03	NN	O	l03	dep	2	SENT_137	[p3l1729t1668r1820b1688],
8	.	.	O	.	_	0	SENT_137	[p3l1729t1668r1820b1688],

1	9	CD	NUMBER	9	_	0	SENT_138	[p3l1686t1703r1704b1723],
2	.	.	O	.	_	0	SENT_138	[p3l1686t1703r1704b1723],

1	lVIcChesney	NN	O	lvicchesney	nn	2	SENT_139	[p3l1728t1702r1869b1729],
2	NIB	NN	ORGANIZATION	nib	dep	26	SENT_139	[p3l1890t1702r1940b1727],
3	,	,	O	,	_	0	SENT_139	[p3l1890t1702r1940b1727],
4	Collins	NNP	ORGANIZATION	Collins	nn	5	SENT_139	[p3l1963t1702r2044b1723],
5	JR	NNP	ORGANIZATION	JR	appos	2	SENT_139	[p3l2060t1702r2102b1729],
6	,	,	O	,	_	0	SENT_139	[p3l2060t1702r2102b1729],
7	Lu	NNP	PERSON	Lu	nn	8	SENT_139	[p3l2125t1703r2156b1723],
8	D	NNP	PERSON	D	appos	2	SENT_139	[p3l2177t1702r2205b1727],
9	,	,	O	,	_	0	SENT_139	[p3l2177t1702r2205b1727],
10	Lu	NNP	PERSON	Lu	nn	11	SENT_139	[p3l2227t1703r2258b1723],
11	X	NNP	PERSON	X	appos	2	SENT_139	[p3l2280t1703r2307b1727],
12	,	,	O	,	_	0	SENT_139	[p3l2280t1703r2307b1727],
13	Torten	NNP	O	Torten	nn	14	SENT_139	[p3l1728t1737r1809b1757],
14	J	NNP	O	J	appos	2	SENT_139	[p3l1823t1737r1843b1763],
15	,	,	O	,	_	0	SENT_139	[p3l1823t1737r1843b1763],
16	Ashley	NNP	PERSON	Ashley	nn	17	SENT_139	[p3l1862t1737r1940b1763],
17	RL	NNP	PERSON	RL	appos	2	SENT_139	[p3l1958t1736r2002b1761],
18	,	,	O	,	_	0	SENT_139	[p3l1958t1736r2002b1761],
19	Cloyd	NNP	PERSON	Cloyd	nn	20	SENT_139	[p3l2022t1736r2092b1763],
20	IVIVV	NNP	LOCATION	IVIVV	appos	2	SENT_139	[p3l2110t1737r2170b1761],
21	,	,	O	,	_	0	SENT_139	[p3l2110t1737r2170b1761],
22	Nliller	NNP	O	Nliller	nn	23	SENT_139	[p3l2190t1736r2260b1757],
23	CJ	NNP	O	CJ	appos	2	SENT_139	[p3l2279t1736r2308b1763],
24	(	CD	NUMBER	(	dep	26	SENT_139	[p3l1729t1771r1798b1797],
25	1998	CD	DATE	1998	num	26	SENT_139	[p3l1729t1771r1798b1797],
26	)	CD	NUMBER	)	dep	36	SENT_139	[p3l1729t1771r1798b1797],
27	Occult	NNP	O	Occult	nn	29	SENT_139	[p3l1816t1770r1894b1791],
28	systemic	JJ	O	systemic	amod	29	SENT_139	[p3l1911t1770r2006b1797],
29	infection	NN	O	infection	dep	26	SENT_139	[p3l2023t1770r2123b1791],
30	and	CC	O	and	_	0	SENT_139	[p3l2140t1770r2183b1791],
31	persistent	JJ	O	persistent	amod	34	SENT_139	[p3l2200t1770r2309b1797],
32	simian	JJ	O	simian	amod	34	SENT_139	[p3l1729t1804r1806b1824],
33	immunodeﬁciency	NN	O	immunodeﬁciency	nn	34	SENT_139	[p3l1828t1804r2049b1831],
34	virus	NN	O	virus	dep	26	SENT_139	[p3l2070t1804r2127b1825],
35	(	CD	NUMBER	(	num	36	SENT_139	[p3l2149t1804r2308b1831],
36	SIV	NN	O	siv	_	0	SENT_139	[p3l2149t1804r2308b1831],
37	)	SYM	O	)	dep	41	SENT_139	[p3l2149t1804r2308b1831],
38	-	:	O	-	_	0	SENT_139	[p3l2149t1804r2308b1831],
39	specific	JJ	O	specific	amod	41	SENT_139	[p3l2149t1804r2308b1831],
40	CD4	NN	O	cd4	nn	41	SENT_139	[p3l1729t1838r1892b1865],
41	(	NN	O	(	dep	36	SENT_139	[p3l1729t1838r1892b1865],
42	+	CC	O	+	nsubj	45	SENT_139	[p3l1729t1838r1892b1865],
43	)	SYM	O	)	dep	45	SENT_139	[p3l1729t1838r1892b1865],
44	-	:	O	-	_	0	SENT_139	[p3l1729t1838r1892b1865],
45	T-cell	NN	O	t-cell	rcmod	41	SENT_139	[p3l1729t1838r1892b1865],
46	proliferative	JJ	O	proliferative	amod	47	SENT_139	[p3l1911t1838r2050b1865],
47	responses	NNS	O	response	npadvmod	45	SENT_139	[p3l2069t1846r2178b1865],
48	in	IN	O	in	_	0	SENT_139	[p3l2197t1838r2218b1858],
49	rhesus	NN	O	rhesus	nn	50	SENT_139	[p3l2237t1838r2308b1859],
50	macaques	NNS	O	macaque	prep_in	45	SENT_139	[p3l1728t1880r1843b1899],
51	that	WDT	O	that	nsubj	54	SENT_139	[p3l1865t1872r1910b1893],
52	were	VBD	O	be	cop	54	SENT_139	[p3l1930t1880r1985b1893],
53	transiently	RB	O	transiently	advmod	54	SENT_139	[p3l2006t1872r2128b1899],
54	viremic	JJ	O	viremic	rcmod	50	SENT_139	[p3l2148t1872r2235b1893],
55	after	IN	O	after	_	0	SENT_139	[p3l2256t1872r2309b1893],
56	intravaginal	JJ	O	intravaginal	amod	57	SENT_139	[p3l1728t1906r1869b1933],
57	inoculation	NN	O	inoculation	prep_after	54	SENT_139	[p3l1890t1906r2022b1927],
58	of	IN	O	of	_	0	SENT_139	[p3l2044t1906r2069b1926],
59	SIV	NN	O	siv	prep_of	57	SENT_139	[p3l2087t1906r2139b1926],
60	.	.	O	.	_	0	SENT_139	[p3l2087t1906r2139b1926],

1	J	NNP	O	J	nn	2	SENT_140	[p3l2156t1907r2170b1933],
2	Virol	NNP	O	Virol	_	0	SENT_140	[p3l2191t1906r2252b1927],
3	72	CD	NUMBER	72	num	2	SENT_140	[p3l2274t1907r2307b1927],
4	:	:	O	:	_	0	SENT_140	[p3l2274t1907r2307b1927],
5	l0029	CD	NUMBER	l0029	num	7	SENT_140	[p3l1732t1941r1893b1961],
6	—	CD	NUMBER	—	num	7	SENT_140	[p3l1732t1941r1893b1961],
7	l0035	NN	O	l0035	dep	2	SENT_140	[p3l1732t1941r1893b1961],
8	.	.	O	.	_	0	SENT_140	[p3l1732t1941r1893b1961],

1	lo	NN	O	lo	_	0	SENT_141	[p3l1674t1976r1707b1996],
2	.	.	O	.	_	0	SENT_141	[p3l1674t1976r1707b1996],

1	Tasca	NNP	PERSON	Tasca	nn	2	SENT_142	[p3l1731t1976r1805b1996],
2	S	NNP	PERSON	S	_	0	SENT_142	[p3l1828t1975r1849b2000],
3	,	,	O	,	_	0	SENT_142	[p3l1828t1975r1849b2000],
4	Tsai	NNP	PERSON	Tsai	nn	5	SENT_142	[p3l1874t1975r1927b1995],
5	L	NNP	PERSON	L	appos	2	SENT_142	[p3l1950t1976r1974b2000],
6	,	,	O	,	_	0	SENT_142	[p3l1950t1976r1974b2000],
7	Trunova	NNP	ORGANIZATION	Trunova	nn	8	SENT_142	[p3l1998t1976r2107b1996],
8	N	NNP	ORGANIZATION	N	appos	2	SENT_142	[p3l2130t1976r2158b2000],
9	,	,	O	,	_	0	SENT_142	[p3l2130t1976r2158b2000],
10	Gettie	NNP	O	Gettie	nn	11	SENT_142	[p3l2182t1975r2258b1996],
11	A	NNP	O	A	appos	2	SENT_142	[p3l2281t1976r2307b2000],
12	,	,	O	,	_	0	SENT_142	[p3l2281t1976r2307b2000],
13	Saifuddin	NNP	PERSON	Saifuddin	appos	2	SENT_142	[p3l1732t2009r1842b2030],
14	l	NN	O	l	tmod	13	SENT_142	[p3l1857t2010r1889b2034],
15	\	CD	NUMBER	\	number	16	SENT_142	[p3l1857t2010r1889b2034],
16	’	CD	NUMBER	’	dep	2	SENT_142	[p3l1857t2010r1889b2034],
17	I	PRP	O	I	dep	16	SENT_142	[p3l1857t2010r1889b2034],
18	,	,	O	,	_	0	SENT_142	[p3l1857t2010r1889b2034],
19	Bohm	NNP	PERSON	Bohm	nn	20	SENT_142	[p3l1904t2009r1974b2029],
20	R	NNP	O	R	appos	2	SENT_142	[p3l1988t2009r2014b2034],
21	,	,	O	,	_	0	SENT_142	[p3l1988t2009r2014b2034],
22	Chakrabarti	NNP	PERSON	Chakrabarti	nn	23	SENT_142	[p3l2030t2009r2171b2030],
23	L	NNP	O	L	appos	2	SENT_142	[p3l2185t2010r2207b2034],
24	,	,	O	,	_	0	SENT_142	[p3l2185t2010r2207b2034],
25	ChengMayer	NNP	O	ChengMayer	nn	26	SENT_142	[p3l2223t2009r2308b2036, p3l1731t2044r1808b2070],
26	C	NNP	O	C	appos	2	SENT_142	[p3l1817t2043r1835b2063],
27	(	JJ	O	(	amod	26	SENT_142	[p3l1846t2043r1916b2070],
28	2007	CD	DATE	2007	tmod	27	SENT_142	[p3l1846t2043r1916b2070],
29	)	CD	NUMBER	)	num	30	SENT_142	[p3l1846t2043r1916b2070],
30	Induction	NN	O	induction	dep	2	SENT_142	[p3l1926t2043r2039b2064],
31	of	IN	O	of	_	0	SENT_142	[p3l2048t2043r2073b2064],
32	potent	JJ	O	potent	amod	35	SENT_142	[p3l2079t2048r2152b2070],
33	local	JJ	O	local	amod	35	SENT_142	[p3l2161t2043r2215b2064],
34	cellular	JJ	O	cellular	amod	35	SENT_142	[p3l2225t2044r2309b2064],
35	immunity	NN	O	immunity	prep_of	30	SENT_142	[p3l1732t2077r1848b2104],
36	with	IN	O	with	_	0	SENT_142	[p3l1870t2077r1921b2098],
37	low	JJ	O	low	amod	40	SENT_142	[p3l1943t2077r1985b2097],
38	dose	NN	O	dose	nn	40	SENT_142	[p3l2006t2078r2058b2098],
39	X4	NN	O	x4	nn	40	SENT_142	[p3l2080t2078r2117b2097],
40	SHIV	NN	O	shiv	prep_with	35	SENT_142	[p3l2140t2077r2308b2104],
41	(	CD	NUMBER	(	num	42	SENT_142	[p3l2140t2077r2308b2104],
42	SF33A	NN	O	sf33a	dep	2	SENT_142	[p3l2140t2077r2308b2104],
43	)	CD	NUMBER	)	num	45	SENT_142	[p3l2140t2077r2308b2104],
44	vaginal	JJ	O	vaginal	amod	45	SENT_142	[p3l1731t2111r1814b2138],
45	exposure	NN	O	exposure	dep	42	SENT_142	[p3l1825t2119r1934b2138],
46	.	.	O	.	_	0	SENT_142	[p3l1825t2119r1934b2138],

1	Virology	NNP	O	Virology	_	0	SENT_143	[p3l1946t2111r2048b2138],
2	367	CD	NUMBER	367	num	1	SENT_143	[p3l2060t2112r2106b2132],
3	:	:	O	:	_	0	SENT_143	[p3l2060t2112r2106b2132],
4	l96	CD	NUMBER	l96	number	5	SENT_143	[p3l2123t2112r2202b2132],
5	—	CD	NUMBER	—	num	7	SENT_143	[p3l2123t2112r2202b2132],
6	2l	NN	O	2l	nn	7	SENT_143	[p3l2123t2112r2202b2132],
7	l.	NN	O	l.	dep	1	SENT_143	[p3l2210t2112r2225b2132],

1	l	NN	O	l	nsubj	2	SENT_144	[p3l1674t2147r1680b2166],
2	l.	VBD	O	l.	_	0	SENT_144	[p3l1689t2147r1704b2167],
3	Haase	NNP	PERSON	Haase	dobj	2	SENT_144	[p3l1728t2147r1799b2167],
4	AT	IN	O	at	_	0	SENT_144	[p3l1809t2147r1848b2166],
5	(	CD	NUMBER	(	num	8	SENT_144	[p3l1860t2146r1929b2173],
6	2005	CD	DATE	2005	num	8	SENT_144	[p3l1860t2146r1929b2173],
7	)	CD	NUMBER	)	num	8	SENT_144	[p3l1860t2146r1929b2173],
8	Perils	NNS	O	peril	prep_at	2	SENT_144	[p3l1941t2146r2002b2167],
9	at	IN	O	at	_	0	SENT_144	[p3l2014t2151r2034b2167],
10	mucosal	JJ	O	mucosal	amod	12	SENT_144	[p3l2044t2147r2139b2167],
11	front	NN	O	front	nn	12	SENT_144	[p3l2149t2146r2205b2167],
12	lines	NNS	O	line	prep_at	8	SENT_144	[p3l2215t2146r2266b2167],
13	for	IN	O	for	_	0	SENT_144	[p3l2277t2146r2309b2166],
14	HIV	NN	O	hiv	prep_for	2	SENT_144	[p3l1728t2181r1781b2201],
15	and	CC	O	and	_	0	SENT_144	[p3l1792t2181r1834b2201],
16	SIV	NN	O	siv	prep_for	2	SENT_144	[p3l1846t2180r1891b2200],
17	and	CC	O	and	_	0	SENT_144	[p3l1901t2180r1944b2201],
18	their	PRP$	O	they	poss	19	SENT_144	[p3l1954t2180r2008b2201],
19	hosts	NNS	O	host	prep_for	2	SENT_144	[p3l2018t2181r2080b2201],
20	.	.	O	.	_	0	SENT_144	[p3l2018t2181r2080b2201],

1	Nat	NNP	PERSON	Nat	nn	3	SENT_145	[p3l2092t2181r2134b2201],
2	Rev	NN	PERSON	rev	nn	3	SENT_145	[p3l2145t2180r2191b2201],
3	Immunol	NNP	PERSON	Immunol	_	0	SENT_145	[p3l2201t2181r2308b2201],
4	5	CD	NUMBER	5	dep	3	SENT_145	[p3l1728t2215r1747b2235],
5	:	:	O	:	_	0	SENT_145	[p3l1728t2215r1747b2235],
6	783	CD	NUMBER	783	num	7	SENT_145	[p3l1761t2215r1865b2235],
7	—	NN	O	—	dep	3	SENT_145	[p3l1761t2215r1865b2235],
8	792	CD	NUMBER	792	dep	7	SENT_145	[p3l1761t2215r1865b2235],
9	.	.	O	.	_	0	SENT_145	[p3l1761t2215r1865b2235],

1	August	NNP	DATE	August	_	0	SENT_146	[p3l1631t3144r1729b3174],
2	2008	CD	DATE	2008	num	4	SENT_146	[p3l1742t3145r1807b3167],
3	|	NNP	O	|	nn	4	SENT_146	[p3l1828t3142r1830b3175],
4	Volume	NN	O	volume	dep	1	SENT_146	[p3l1850t3143r1955b3167],
5	4	CD	NUMBER	4	number	6	SENT_146	[p3l1973t3145r1989b3167],
6	|	CD	NUMBER	|	dep	4	SENT_146	[p3l2009t3142r2011b3175],
7	Issue	NN	O	issue	nn	10	SENT_146	[p3l2033t3144r2099b3167],
8	8	CD	NUMBER	8	num	10	SENT_146	[p3l2117t3145r2132b3167],
9	|	NN	O	|	nn	10	SENT_146	[p3l2152t3142r2155b3175],
10	e1000114	NN	O	e1000114	dep	1	SENT_146	[p3l2175t3145r2309b3167],

